{"87c3f8df8117449f32e3dc7410ba7300b1c6271c": [["INTRODUCTIONThe novel coronavirus Severe Acute Respiratory Syndrome coronavirus 2 (SARS-COV-2), which causes the respiratory disease Coronavirus disease-19 (COVID- 19) , was first identified as a cluster of cases of pneumonia in Wuhan, Hubei Province of China on December 31, 2019.", [["respiratory", "ANATOMY", 113, 124], ["coronavirus", "DISEASE", 22, 33], ["Acute Respiratory Syndrome coronavirus", "DISEASE", 41, 79], ["SARS-COV-2", "CHEMICAL", 83, 93], ["respiratory disease", "DISEASE", 113, 132], ["Coronavirus disease", "DISEASE", 133, 152], ["pneumonia", "DISEASE", 216, 225], ["coronavirus", "ORGANISM", 22, 33], ["Severe Acute Respiratory Syndrome coronavirus 2", "ORGANISM", 34, 81], ["SARS-COV-2", "ORGANISM", 83, 93], ["coronavirus", "SPECIES", 22, 33], ["coronavirus Severe Acute Respiratory Syndrome coronavirus", "SPECIES", 22, 79], ["SARS-COV-2", "SPECIES", 83, 93], ["novel coronavirus Severe Acute Respiratory Syndrome coronavirus", "PROBLEM", 16, 79], ["SARS", "TEST", 83, 87], ["COV", "TEST", 88, 91], ["the respiratory disease Coronavirus disease", "PROBLEM", 109, 152], ["COVID", "TEST", 157, 162], ["pneumonia", "PROBLEM", 216, 225], ["coronavirus", "OBSERVATION_MODIFIER", 22, 33], ["Severe", "OBSERVATION_MODIFIER", 34, 40], ["Acute", "OBSERVATION_MODIFIER", 41, 46], ["Respiratory Syndrome", "OBSERVATION", 47, 67], ["respiratory disease", "OBSERVATION", 113, 132], ["Coronavirus disease", "OBSERVATION", 133, 152], ["pneumonia", "OBSERVATION", 216, 225]]], ["1 Within a month, the disease had spread significantly, leading the World Health Organization (WHO) to designate COVID-19, a Public Health Emergency of International Concern (PHEIC).", [["the disease", "PROBLEM", 18, 29], ["disease", "OBSERVATION", 22, 29]]], ["On March 11, 2020 , the WHO declared COVID-19 a global pandemic.", [["COVID", "TEST", 37, 42], ["a global pandemic", "PROBLEM", 46, 63], ["pandemic", "OBSERVATION", 55, 63]]], ["2 As of May 7, 2020, the virus has infected more than 3.6 million people, with over 250,000 deaths worldwide.", [["deaths", "DISEASE", 92, 98], ["people", "ORGANISM", 66, 72], ["people", "SPECIES", 66, 72], ["the virus", "PROBLEM", 21, 30], ["infected", "OBSERVATION_MODIFIER", 35, 43]]], ["3 The dramatic impact the spread of COVID-19 has had on social, economic, and healthcare issues throughout the world has been reviewed.", [["COVID-19", "CHEMICAL", 36, 44], ["dramatic", "OBSERVATION_MODIFIER", 6, 14], ["impact", "OBSERVATION_MODIFIER", 15, 21], ["spread", "OBSERVATION_MODIFIER", 26, 32]]], ["4 Prior to the 21st century, members of the coronavirus family had minimal impact on human health.", [["coronavirus", "ORGANISM", 44, 55], ["human", "ORGANISM", 85, 90], ["coronavirus", "SPECIES", 44, 55], ["human", "SPECIES", 85, 90], ["human", "SPECIES", 85, 90]]], ["5 However, in the past 20 years, outbreaks have highlighted an emerging importance of coronaviruses in morbidity and mortality on a global scale.", [["coronaviruses", "DISEASE", 86, 99], ["coronaviruses", "ORGANISM", 86, 99], ["coronaviruses in morbidity", "PROBLEM", 86, 112], ["a global scale", "TREATMENT", 130, 144]]], ["Although less prevalent than COVID-19, severe acute respiratory syndrome (SARS) in 2002-2003 and Middle Eastern respiratory syndrome (MERS) in 2012 likely had higher mortality rates than the current pandemic.", [["acute respiratory syndrome", "DISEASE", 46, 72], ["SARS", "DISEASE", 74, 78], ["Middle Eastern respiratory syndrome", "DISEASE", 97, 132], ["COVID", "TEST", 29, 34], ["severe acute respiratory syndrome", "PROBLEM", 39, 72], ["SARS", "PROBLEM", 74, 78], ["Middle Eastern respiratory syndrome", "PROBLEM", 97, 132], ["higher mortality rates", "PROBLEM", 159, 181], ["less prevalent", "OBSERVATION_MODIFIER", 9, 23], ["severe", "OBSERVATION_MODIFIER", 39, 45], ["acute", "OBSERVATION_MODIFIER", 46, 51], ["respiratory syndrome", "OBSERVATION", 52, 72], ["Middle", "ANATOMY_MODIFIER", 97, 103], ["respiratory syndrome", "OBSERVATION", 112, 132]]], ["The challenges presented to health care providers by such novel viral pathogens are numerous, including methods for rapid diagnosis, prevention, and treatment.", [["novel viral pathogens", "PROBLEM", 58, 79], ["treatment", "TREATMENT", 149, 158]]], ["In the current study, we focus on diagnosis issues, which were evident with COVID19 with the time required to develop rapid and effective diagnostic modalities.INTRODUCTIONWe have previously reported the utility of using artificial intelligence (AI) in the histopathologic diagnosis of cancer.", [["cancer", "ANATOMY", 286, 292], ["cancer", "DISEASE", 286, 292], ["cancer", "CANCER", 286, 292], ["the current study", "TEST", 3, 20], ["COVID19", "TREATMENT", 76, 83], ["artificial intelligence (AI", "TREATMENT", 221, 248], ["cancer", "PROBLEM", 286, 292], ["cancer", "OBSERVATION", 286, 292]]], ["[6] [7] [8] AI was first described in 1956 and involves the field of computer science in which machines are trained to learn from experience.", [["[6] [7] [8] AI", "SIMPLE_CHEMICAL", 0, 14]]], ["10 Current ML utilization employs deep learning with neural networks algorithms, which can recognize patterns and achieve complex computational tasks often far quicker and with increased precision than can humans.", [["neural networks", "ANATOMY", 53, 68], ["neural networks", "MULTI-TISSUE_STRUCTURE", 53, 68], ["humans", "ORGANISM", 206, 212], ["humans", "SPECIES", 206, 212], ["humans", "SPECIES", 206, 212], ["Current ML utilization employs", "TREATMENT", 3, 33], ["neural networks algorithms", "TREATMENT", 53, 79]]], ["14 In this manuscript, we examine the potential for AI to diagnose patients with COVID-19 pneumonia using chest radiographs (CXR) alone.", [["chest", "ANATOMY", 106, 111], ["pneumonia", "DISEASE", 90, 99], ["patients", "ORGANISM", 67, 75], ["chest", "ORGAN", 106, 111], ["patients", "SPECIES", 67, 75], ["AI", "PROBLEM", 52, 54], ["COVID", "TEST", 81, 86], ["pneumonia", "PROBLEM", 90, 99], ["chest radiographs", "TEST", 106, 123], ["CXR", "TEST", 125, 128], ["pneumonia", "OBSERVATION", 90, 99], ["chest", "ANATOMY", 106, 111]]], ["15 Employing AI to both screen and diagnose emerging health emergencies such as COVID-19 has the potential to dramatically change how we approach medical care in the future.", [["COVID-19", "CHEMICAL", 80, 88], ["medical care", "TREATMENT", 146, 158]]], ["In addition, we describe the creation of a publicly available website that could augment COVID-19 pneumonia CXR diagnosis.Training DatasetOne hundred three CXR images of COVID-19 were downloaded from GitHub covid-chest-xray dataset.", [["pneumonia", "DISEASE", 98, 107], ["COVID-19", "DNA", 170, 178], ["GitHub covid-chest-xray dataset", "DNA", 200, 231], ["COVID", "TEST", 89, 94], ["pneumonia", "PROBLEM", 98, 107], ["CXR diagnosis", "TEST", 108, 121], ["CXR images", "TEST", 156, 166], ["COVID", "TEST", 170, 175], ["GitHub", "TEST", 200, 206], ["covid", "TEST", 207, 212], ["pneumonia", "OBSERVATION", 98, 107], ["chest", "ANATOMY", 213, 218]]], ["16 Five hundred images of non-COVID-19 pneumonia and 500 images of the normal lung were downloaded from the Kaggle RSNA Pneumonia Detection Challenge dataset.", [["lung", "ANATOMY", 78, 82], ["pneumonia", "DISEASE", 39, 48], ["Pneumonia", "DISEASE", 120, 129], ["lung", "ORGAN", 78, 82], ["non-COVID", "TEST", 26, 35], ["pneumonia", "PROBLEM", 39, 48], ["500 images", "TEST", 53, 63], ["the Kaggle RSNA Pneumonia", "PROBLEM", 104, 129], ["pneumonia", "OBSERVATION", 39, 48], ["normal", "OBSERVATION", 71, 77], ["lung", "ANATOMY", 78, 82], ["RSNA", "ANATOMY", 115, 119], ["Pneumonia", "OBSERVATION", 120, 129]]], ["17 To balance the dataset, we expanded the COVID-19 dataset to 500 images by slight rotation (probability=1, max rotation=5) and zooming (probability=0.5, percentage_area=0.9) of the original images using the Augmentor python package.", [["COVID-19 dataset", "DNA", 43, 59], ["the COVID", "TEST", 39, 48], ["slight rotation (probability", "TEST", 77, 105], ["max rotation", "TEST", 109, 121], ["zooming (probability", "TEST", 129, 149], ["percentage_area", "TEST", 155, 170], ["the original images", "TEST", 179, 198], ["the Augmentor python package", "TREATMENT", 205, 233]]], ["18Validation DatasetThirty random CXR images from the Veteran's Administration (VA) PAC system were obtained for the validation dataset.", [["DatasetThirty random CXR images", "TEST", 13, 44], ["VA) PAC system", "TREATMENT", 80, 94], ["the validation dataset", "TEST", 113, 135]]], ["This dataset included ten CXR images from hospitalized COVID-19 patients, ten CXR pneumonia images from non-COVID-19 patients, and ten normal CXRs.", [["CXRs", "ANATOMY", 142, 146], ["pneumonia", "DISEASE", 82, 91], ["patients", "ORGANISM", 64, 72], ["patients", "ORGANISM", 117, 125], ["CXRs", "CANCER", 142, 146], ["patients", "SPECIES", 64, 72], ["patients", "SPECIES", 117, 125], ["This dataset", "TEST", 0, 12], ["ten CXR images", "TEST", 22, 36], ["hospitalized COVID", "TEST", 42, 60], ["ten CXR pneumonia images", "TEST", 74, 98], ["non-COVID", "TEST", 104, 113], ["pneumonia", "OBSERVATION", 82, 91]]], ["COVID-19 diagnoses were confirmed with a positive test result from the Xpert\u00ae Xpress SARS-CoV-2 PCR platform.", [["CoV", "TEST", 90, 93], ["PCR platform", "TEST", 96, 108]]], ["19Microsoft CustomVisionMicrosoft CustomVision is an automated image classification and object detection system that is a part of Microsoft Azure Cognitive Services.", [["an automated image classification", "TEST", 50, 83]]], ["No coding skills are necessary.Model TrainingIn Microsoft CustomVision, we created a new project with the following setup: project type -classification, classification type -multiclass (single tag per image), domains -compact general for small size and easy export to TensorFlow.js model format.", [["coding skills", "PROBLEM", 3, 16], ["small size", "PROBLEM", 238, 248], ["small", "OBSERVATION_MODIFIER", 238, 243], ["size", "OBSERVATION_MODIFIER", 244, 248]]], ["Each class was uploaded separately and tagged with the appropriate label (covid_pneumonia, non-covid pneumonia, and normal lung).", [["lung", "ANATOMY", 123, 127], ["pneumonia", "DISEASE", 101, 110], ["lung", "ORGAN", 123, 127], ["non-covid pneumonia", "PROBLEM", 91, 110], ["pneumonia", "OBSERVATION", 101, 110], ["normal", "OBSERVATION", 116, 122], ["lung", "ANATOMY", 123, 127]]], ["The system rejected 16 COVID-19 images as duplicates.", [["COVID", "DNA", 23, 28]]], ["The final CustomVision training dataset consisted of 484 images of COVID-19 pneumonia, 500 images of non-COVID-19 pneumonia, and 500 images of normal lung.", [["lung", "ANATOMY", 150, 154], ["pneumonia", "DISEASE", 76, 85], ["pneumonia", "DISEASE", 114, 123], ["lung", "ORGAN", 150, 154], ["COVID", "TEST", 67, 72], ["pneumonia", "PROBLEM", 76, 85], ["non-COVID", "TEST", 101, 110], ["pneumonia", "PROBLEM", 114, 123], ["pneumonia", "OBSERVATION", 76, 85], ["pneumonia", "OBSERVATION", 114, 123], ["normal", "OBSERVATION", 143, 149], ["lung", "ANATOMY", 150, 154]]], ["(Figure 1)Website CreationMicrosoft Azure Custom Vision was used to train the model.", [["Website CreationMicrosoft Azure Custom Vision", "TREATMENT", 10, 55]]], ["An Angular web app was created with TensorFlow.js.", [["An Angular web app", "TEST", 0, 18], ["Angular", "OBSERVATION_MODIFIER", 3, 10], ["web", "OBSERVATION", 11, 14]]], ["Within a user's web browser, the model is executed when an image of a CXR is submitted.", [["CXR", "DNA", 70, 73], ["a CXR", "TEST", 68, 73]]], ["Confidence values for each classification are returned.", [["Confidence values", "TEST", 0, 17], ["each classification", "TEST", 22, 41]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted May 26, 2020. . https://doi.org/10.1101/2020.05.21.20106518 doi: medRxiv preprint page and model is downloaded, the web page no longer needs to access any server components and performs all operations in the browser.", [["CC", "CHEMICAL", 0, 2], ["CC", "TEST", 0, 2], ["ND", "PROBLEM", 9, 11], ["The copyright holder", "TREATMENT", 201, 221], ["all operations", "TREATMENT", 446, 460], ["NC", "ANATOMY", 6, 8], ["med", "ANATOMY", 105, 108]]], ["At no time does an image get submitted to the cloud.RESULTSOverall, our trained model showed 92.9% precision and recall.", [["our trained model", "TEST", 68, 85]]], ["Precision and recall results for each individual label were 98.9% and 94.8% for COVID-19 pneumonia, 91.8% and 89% for non-COVID-19 pneumonia, and 88.8% and 95% for normal lung.", [["lung", "ANATOMY", 171, 175], ["pneumonia", "DISEASE", 89, 98], ["pneumonia", "DISEASE", 131, 140], ["lung", "ORGAN", 171, 175], ["COVID-19", "SPECIES", 80, 88], ["non-COVID-19", "SPECIES", 118, 130], ["each individual label", "TEST", 33, 54], ["COVID", "TEST", 80, 85], ["pneumonia", "PROBLEM", 89, 98], ["non-COVID", "TEST", 118, 127], ["pneumonia", "PROBLEM", 131, 140], ["pneumonia", "OBSERVATION", 89, 98], ["pneumonia", "OBSERVATION", 131, 140], ["lung", "ANATOMY", 171, 175]]], ["Our model performed very well with 100% sensitivity (recall), 95% specificity, 97% accuracy, 91% positive predictive value (precision), and 100% negative predictive value.DISCUSSIONWe have successfully demonstrated the potential of using AI algorithms in assessing CXRs for COVID-19.", [["CXRs", "DNA", 265, 269], ["accuracy", "TEST", 83, 91], ["AI algorithms", "TREATMENT", 238, 251], ["CXRs", "TEST", 265, 269], ["COVID", "TEST", 274, 279]]], ["We first trained the Microsoft CustomVision automated image classification and object detection system to differentiate cases of COVID-19 from pneumonia from other etiologies as well as normal lung CXRs.", [["lung", "ANATOMY", 193, 197], ["pneumonia", "DISEASE", 143, 152], ["lung", "ORGAN", 193, 197], ["object detection system", "TEST", 79, 102], ["COVID", "TEST", 129, 134], ["pneumonia", "PROBLEM", 143, 152], ["pneumonia", "OBSERVATION", 143, 152], ["lung", "ANATOMY", 193, 197], ["CXRs", "OBSERVATION", 198, 202]]], ["We then tested our model against known patients from our medical center.", [["patients", "ORGANISM", 39, 47], ["patients", "SPECIES", 39, 47]]], ["The program achieved 100% sensitivity (recall), 95% specificity, 97% accuracy, 91% positive predictive value (precision), and 100% negative predictive value in differentiating the three scenarios.", [["accuracy", "TEST", 69, 77]]], ["Using the trained ML model, we proceeded to create a website that could augment COVID-19 CXR diagnosis.", [["the trained ML model", "TREATMENT", 6, 26], ["COVID", "TEST", 80, 85], ["CXR diagnosis", "TEST", 89, 102]]], ["One can take a CXR photo with a mobile phone or upload it from the file.", [["a CXR photo", "TEST", 13, 24]]], ["The ML algorithm would provide the probability of COVID-19 pneumonia, non-COVID-19 pneumonia, or normal lung X-ray diagnosis.", [["lung", "ANATOMY", 104, 108], ["pneumonia", "DISEASE", 59, 68], ["pneumonia", "DISEASE", 83, 92], ["lung", "ORGAN", 104, 108], ["The ML algorithm", "TEST", 0, 16], ["COVID", "TEST", 50, 55], ["pneumonia", "PROBLEM", 59, 68], ["non-COVID", "TEST", 70, 79], ["pneumonia", "PROBLEM", 83, 92], ["pneumonia", "OBSERVATION", 59, 68], ["pneumonia", "OBSERVATION", 83, 92], ["lung", "ANATOMY", 104, 108]]], ["(Figure 3 ) Emerging diseases such as COVID-19 present numerous challenges to healthcare providers, governments, and businesses, as well as to individual members of society.", [["Emerging diseases", "PROBLEM", 12, 29], ["diseases", "OBSERVATION", 21, 29]]], ["As evidenced with COVID-19, the time from first recognition of an emerging pathogen to the development of methods for reliable diagnosis and treatment can be months, even with a concerted international effort.", [["COVID", "TEST", 18, 23], ["treatment", "TREATMENT", 141, 150]]], ["The gold standard for diagnosis of COVID-19 is by reverse transcriptase polymerase chain reaction (RT-PCR) technologies, but early RT-PCR testing produced less than optimal results.", [["COVID-19", "DNA", 35, 43], ["reverse transcriptase", "PROTEIN", 50, 71], ["COVID", "TEST", 35, 40], ["reverse transcriptase polymerase chain reaction", "PROBLEM", 50, 97], ["RT-PCR) technologies", "TEST", 99, 119], ["early RT-PCR testing", "TEST", 125, 145]]], ["[21] [22] [23] Even after the development of reliable tests for detection, making test kits readily available to health care providers on an adequate scale presents an additional challenge as evident with COVID-19.DISCUSSIONThe lack of availability of diagnostic RT-PCR with COVID-19 initially placed increased reliability on presumptive diagnoses via imaging in some situations.", [["COVID-19", "CHEMICAL", 205, 213], ["COVID-19", "CHEMICAL", 275, 283], ["COVID-19", "DNA", 275, 283], ["reliable tests", "TEST", 45, 59], ["detection", "TEST", 64, 73], ["test kits", "TEST", 82, 91], ["COVID", "TEST", 205, 210], ["diagnostic RT-PCR", "TEST", 252, 269], ["COVID", "TEST", 275, 280], ["imaging", "TEST", 352, 359]]], ["24 Most of the literature evaluating radiographs of COVID-19 patients .", [["patients", "ORGANISM", 61, 69], ["patients", "SPECIES", 61, 69], ["radiographs", "TEST", 37, 48], ["COVID", "TEST", 52, 57]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted May 26, 2020. . https://doi.org/10.1101/2020.05.21.20106518 doi: medRxiv preprint focuses on chest computed tomography (CT) findings, with initial results suggesting CT was more accurate than early RT-PCR methodologies.", [["CC", "CHEMICAL", 0, 2], ["chest", "ORGAN", 353, 358], ["CC", "TEST", 0, 2], ["ND", "PROBLEM", 9, 11], ["The copyright holder", "TREATMENT", 201, 221], ["chest computed tomography", "TEST", 353, 378], ["CT)", "TEST", 380, 383], ["CT", "TEST", 426, 428], ["early RT-PCR methodologies", "TEST", 452, 478], ["NC", "ANATOMY", 6, 8], ["med", "ANATOMY", 105, 108], ["chest", "ANATOMY", 353, 358]]], ["22, 23, 25 The Radiological Society of North America Expert consensus statement on chest CT for COVID-19 states that CT findings can even precede positivity on RT-PCR in some cases.", [["chest", "ANATOMY", 83, 88], ["chest", "ORGAN", 83, 88], ["chest CT", "TEST", 83, 91], ["COVID", "TEST", 96, 101], ["CT findings", "TEST", 117, 128], ["RT", "TEST", 160, 162], ["PCR", "TEST", 163, 166], ["chest", "ANATOMY", 83, 88]]], ["23 However, currently they do not recommend the use of CT scanning as a screening tool.", [["CT scanning", "TEST", 55, 66], ["a screening tool", "TEST", 70, 86]]], ["Furthermore, the actual sensitivity and specificity of CT interpretation by radiologists for COVID-19 are unknown.", [["the actual sensitivity", "TEST", 13, 35], ["CT interpretation", "TEST", 55, 72], ["COVID", "TEST", 93, 98]]], ["23 Characteristic CT findings include ground-glass opacities (GGOs) and consolidation most commonly in the lung periphery, though a diffuse distribution was found in a minority of patients.", [["lung periphery", "ANATOMY", 107, 121], ["GGOs", "DISEASE", 62, 66], ["lung periphery", "MULTI-TISSUE_STRUCTURE", 107, 121], ["patients", "ORGANISM", 180, 188], ["patients", "SPECIES", 180, 188], ["Characteristic CT findings", "TEST", 3, 29], ["ground-glass opacities (GGOs)", "PROBLEM", 38, 67], ["consolidation", "PROBLEM", 72, 85], ["a diffuse distribution", "PROBLEM", 130, 152], ["ground-glass opacities", "OBSERVATION", 38, 60], ["consolidation", "OBSERVATION", 72, 85], ["lung", "ANATOMY", 107, 111], ["periphery", "ANATOMY_MODIFIER", 112, 121], ["diffuse", "OBSERVATION_MODIFIER", 132, 139], ["distribution", "OBSERVATION_MODIFIER", 140, 152]]], ["22, 24, [26] [27] [28] Lomoro and colleagues recently summarized the CT findings from several reports which described abnormalities as most often bilateral and peripheral, subpleural and affecting the lower lobes.", [["subpleural", "ANATOMY", 172, 182], ["lower lobes", "ANATOMY", 201, 212], ["lower lobes", "MULTI-TISSUE_STRUCTURE", 201, 212], ["the CT findings", "TEST", 65, 80], ["peripheral, subpleural and affecting the lower lobes", "PROBLEM", 160, 212], ["abnormalities", "OBSERVATION", 118, 131], ["most often", "OBSERVATION_MODIFIER", 135, 145], ["bilateral", "ANATOMY_MODIFIER", 146, 155], ["peripheral", "ANATOMY_MODIFIER", 160, 170], ["subpleural", "ANATOMY_MODIFIER", 172, 182], ["lower lobes", "ANATOMY", 201, 212]]], ["27 Not surprisingly, CT appears more sensitive at detecting changes with COVID-19 than CXR, with reports that a minority of patients had CT changes before changes visible on CXR.", [["patients", "ORGANISM", 124, 132], ["CXR", "PROTEIN", 174, 177], ["patients", "SPECIES", 124, 132], ["CT", "TEST", 21, 23], ["COVID", "TEST", 73, 78], ["CXR", "TEST", 87, 90], ["CT changes", "PROBLEM", 137, 147], ["CXR", "TEST", 174, 177]]], ["24, 27 We focused our study on the potential of AI in the examination of CXRs in patients with COVID-19, as there are several limitations to the routine use of CT scans with conditions such as COVID-19.", [["CXRs", "CANCER", 73, 77], ["patients", "ORGANISM", 81, 89], ["patients", "SPECIES", 81, 89], ["our study", "TEST", 18, 27], ["the examination", "TEST", 54, 69], ["CXRs", "TEST", 73, 77], ["COVID", "TEST", 95, 100], ["CT scans", "TEST", 160, 168], ["COVID", "TEST", 193, 198]]], ["Aside from the more considerable time required to obtain CTs, there are issues with contamination of CT suites, sometimes requiring a dedicated COVID-19 CT scanner.", [["COVID", "DNA", 144, 149], ["CTs", "TEST", 57, 60], ["CT suites", "TEST", 101, 110], ["a dedicated COVID", "TEST", 132, 149], ["CT scanner", "TEST", 153, 163]]], ["24, 29 The time constraints of decontamination or limited utilization of CT suites can delay or disrupt services for both COVID-19 and non-COVID-19 patients.", [["patients", "ORGANISM", 148, 156], ["patients", "SPECIES", 148, 156], ["decontamination", "TREATMENT", 31, 46], ["CT suites", "TEST", 73, 82], ["COVID", "TEST", 122, 127], ["non-COVID", "TEST", 135, 144]]], ["Because of these factors, CXR may be a better resource to minimize the risk of infection to other patients.", [["infection", "DISEASE", 79, 88], ["patients", "ORGANISM", 98, 106], ["CXR", "PROTEIN", 26, 29], ["patients", "SPECIES", 98, 106], ["these factors", "PROBLEM", 11, 24], ["CXR", "TEST", 26, 29], ["infection", "PROBLEM", 79, 88], ["infection", "OBSERVATION", 79, 88]]], ["Besides, accurate assessment of abnormalities on CXR for COVID-19 may identify patients in whom the CXR was performed for other purposes.", [["patients", "ORGANISM", 79, 87], ["CXR", "DNA", 49, 52], ["patients", "SPECIES", 79, 87], ["abnormalities", "PROBLEM", 32, 45], ["CXR", "TEST", 49, 52], ["COVID", "TEST", 57, 62], ["the CXR", "TEST", 96, 103]]], ["24 CXR is more readily available than CT, especially in more remote or underdeveloped areas.", [["CXR", "PROTEIN", 3, 6], ["CXR", "TEST", 3, 6], ["CT", "TEST", 38, 40]]], ["29 Finally, as with CT, CXR abnormalities are reported to have appeared before RT-PCR tests became positive in a minority of patients.", [["patients", "ORGANISM", 125, 133], ["CXR", "PROTEIN", 24, 27], ["patients", "SPECIES", 125, 133], ["CT", "TEST", 20, 22], ["CXR abnormalities", "TEST", 24, 41], ["RT-PCR tests", "TEST", 79, 91], ["positive", "PROBLEM", 99, 107]]], ["24 CXR findings described in COVID-19 patients are similar to those of CT and include GGOs, consolidation, and hazy increased opacities.", [["GGOs", "DISEASE", 86, 90], ["opacities", "DISEASE", 126, 135], ["patients", "ORGANISM", 38, 46], ["patients", "SPECIES", 38, 46], ["CXR findings", "TEST", 3, 15], ["CT", "TEST", 71, 73], ["GGOs", "PROBLEM", 86, 90], ["consolidation", "PROBLEM", 92, 105], ["hazy increased opacities", "PROBLEM", 111, 135], ["consolidation", "OBSERVATION", 92, 105], ["hazy", "OBSERVATION_MODIFIER", 111, 115], ["increased", "OBSERVATION_MODIFIER", 116, 125], ["opacities", "OBSERVATION", 126, 135]]], ["24, 26, 27, 29, 30 Like CT, the majority of patients demonstrated greater involvement in the lower zones and peripherally 24, 26, 27, 29, 30 Most patients showed bilateral involvement.", [["lower zones", "ANATOMY", 93, 104], ["patients", "ORGANISM", 44, 52], ["patients", "ORGANISM", 146, 154], ["patients", "SPECIES", 44, 52], ["patients", "SPECIES", 146, 154], ["CT", "TEST", 24, 26], ["greater involvement in the lower zones", "PROBLEM", 66, 104], ["bilateral involvement", "PROBLEM", 162, 183], ["greater", "OBSERVATION_MODIFIER", 66, 73], ["involvement", "OBSERVATION", 74, 85], ["lower", "ANATOMY_MODIFIER", 93, 98], ["zones", "ANATOMY_MODIFIER", 99, 104], ["peripherally", "ANATOMY_MODIFIER", 109, 121], ["bilateral", "ANATOMY_MODIFIER", 162, 171], ["involvement", "OBSERVATION", 172, 183]]], ["However, while these findings are common in COVID-19 patients, they are not specific and can be seen in other conditions such as other viral pneumonia, bacterial pneumonia, injury from drug toxicity, inhalation injury, connective tissue disease, and idiopathic conditions.", [["connective tissue", "ANATOMY", 219, 236], ["viral pneumonia", "DISEASE", 135, 150], ["bacterial pneumonia", "DISEASE", 152, 171], ["drug toxicity", "DISEASE", 185, 198], ["inhalation injury", "DISEASE", 200, 217], ["connective tissue disease", "DISEASE", 219, 244], ["patients", "ORGANISM", 53, 61], ["connective tissue", "TISSUE", 219, 236], ["patients", "SPECIES", 53, 61], ["other viral pneumonia", "PROBLEM", 129, 150], ["bacterial pneumonia", "PROBLEM", 152, 171], ["injury", "PROBLEM", 173, 179], ["drug toxicity", "PROBLEM", 185, 198], ["inhalation injury", "PROBLEM", 200, 217], ["connective tissue disease", "PROBLEM", 219, 244], ["idiopathic conditions", "PROBLEM", 250, 271], ["viral", "OBSERVATION_MODIFIER", 135, 140], ["pneumonia", "OBSERVATION", 141, 150], ["bacterial", "OBSERVATION_MODIFIER", 152, 161], ["pneumonia", "OBSERVATION", 162, 171], ["drug toxicity", "OBSERVATION", 185, 198], ["connective tissue disease", "OBSERVATION", 219, 244], ["idiopathic", "OBSERVATION_MODIFIER", 250, 260]]], ["Applications of AI in interpreting radiographs of various types are numerous, and extensive literature has been written on the topic.", [["AI", "TREATMENT", 16, 18], ["radiographs", "TEST", 35, 46], ["numerous", "OBSERVATION_MODIFIER", 68, 76]]], ["31 Using deep learning algorithms, AI has multiple possible roles to augment traditional radiograph interpretation.", [["deep learning algorithms", "TREATMENT", 9, 33], ["traditional radiograph interpretation", "TEST", 77, 114]]], ["These include the potential for screening, triaging, and increasing the speed to render diagnoses.", [["screening", "TEST", 32, 41], ["triaging", "TEST", 43, 51]]], ["With COVID-19, imaging studies have been shown to correlate with disease severity and mortality, and AI could assist in monitoring the course of the disease as it progresses and potentially identifies patients at greatest risk.", [["patients", "ORGANISM", 201, 209], ["patients", "SPECIES", 201, 209], ["COVID", "TEST", 5, 10], ["imaging studies", "TEST", 15, 30], ["disease severity", "PROBLEM", 65, 81], ["AI", "PROBLEM", 101, 103], ["the disease", "PROBLEM", 145, 156], ["disease", "OBSERVATION", 149, 156]]], ["28 There is excellent potential should a rapid diagnostic test as simple as a CXR be able to reliably impact containment and prevention of the spread of contagions such as COVID-19 early in its course.(which was not certified by peer review)Few studies have assessed using AI in the radiologic diagnosis of COVID-19, most of which utilize CT scanning.", [["contagions", "DISEASE", 153, 163], ["a rapid diagnostic test", "TEST", 39, 62], ["a CXR", "TEST", 76, 81], ["the spread of contagions", "PROBLEM", 139, 163], ["COVID", "TEST", 172, 177], ["Few studies", "TEST", 241, 252], ["COVID", "TEST", 307, 312], ["CT scanning", "TEST", 339, 350], ["excellent", "OBSERVATION_MODIFIER", 12, 21]]], ["Bai and colleagues demonstrated increased accuracy, sensitivity, and specificity in distinguishing chest CTs of COVID-19 patients from other types of pneumonia.", [["chest", "ANATOMY", 99, 104], ["COVID", "DISEASE", 112, 117], ["pneumonia", "DISEASE", 150, 159], ["chest CTs", "CANCER", 99, 108], ["patients", "ORGANISM", 121, 129], ["patients", "SPECIES", 121, 129], ["increased accuracy", "PROBLEM", 32, 50], ["sensitivity", "TEST", 52, 63], ["chest CTs", "TEST", 99, 108], ["COVID", "TEST", 112, 117], ["pneumonia", "PROBLEM", 150, 159], ["increased", "OBSERVATION_MODIFIER", 32, 41], ["chest", "ANATOMY", 99, 104], ["pneumonia", "OBSERVATION", 150, 159]]], ["22, 32 A separate study demonstrated the utility of using AI to differentiate COVID-19 from community-acquired pneumonia with CT.", [["pneumonia", "DISEASE", 111, 120], ["A separate study", "TEST", 7, 23], ["AI", "TREATMENT", 58, 60], ["COVID", "TEST", 78, 83], ["community-acquired pneumonia", "PROBLEM", 92, 120], ["CT", "TEST", 126, 128], ["pneumonia", "OBSERVATION", 111, 120]]], ["33 However, the effective utility of AI for CXR interpretation has been demonstrated as well.", [["AI", "SIMPLE_CHEMICAL", 37, 39], ["CXR", "PROTEIN", 44, 47], ["CXR interpretation", "TEST", 44, 62]]], ["14, 34 Implementation of convolutional neural network layers has allowed for reliable differentiation of viral and bacterial pneumonia with CXR imaging.", [["convolutional neural network layers", "ANATOMY", 25, 60], ["pneumonia", "DISEASE", 125, 134], ["neural network layers", "MULTI-TISSUE_STRUCTURE", 39, 60], ["convolutional neural network layers", "TREATMENT", 25, 60], ["viral and bacterial pneumonia", "PROBLEM", 105, 134], ["CXR imaging", "TEST", 140, 151], ["viral", "OBSERVATION", 105, 110], ["bacterial", "OBSERVATION_MODIFIER", 115, 124], ["pneumonia", "OBSERVATION", 125, 134]]], ["35 Evidence suggests that there is great potential in the application of AI in the interpretation of radiographs of all types.(which was not certified by peer review)Finally, as mentioned, we have developed a publicly available website based on our studies.", [["radiographs", "TEST", 101, 112], ["our studies", "TEST", 245, 256], ["great", "OBSERVATION_MODIFIER", 35, 40], ["potential", "OBSERVATION_MODIFIER", 41, 50], ["all types", "OBSERVATION_MODIFIER", 116, 125]]], ["The information on the website, including texts, graphics, images, or other material, is for research purposes and may not be appropriate for all circumstances.", [["images", "TEST", 59, 65], ["research purposes", "TEST", 93, 110]]], ["Medical advice should be sought from a qualified health care professional for any questions, and the website should not be used for medical diagnosis or treatment.CONCLUSIONSWe have utilized a readily available, commercial platform to demonstrate the potential of AI to assist in the successful diagnosis of COVID-19 pneumonia on CXR images.", [["pneumonia", "DISEASE", 317, 326], ["treatment", "TREATMENT", 153, 162], ["AI", "PROBLEM", 264, 266], ["COVID-19 pneumonia", "PROBLEM", 308, 326], ["CXR images", "TEST", 330, 340], ["pneumonia", "OBSERVATION", 317, 326]]], ["While this technology has numerous applications in radiology, we have focused on the potential impact on future world health crises such as COVID-19.", [["COVID", "TEST", 140, 145]]], ["The findings have implications for screening and triage, initial diagnosis, monitoring disease progression, and identifying patients at increased risk of morbidity and mortality.", [["patients", "ORGANISM", 124, 132], ["patients", "SPECIES", 124, 132], ["screening", "TEST", 35, 44], ["triage", "TEST", 49, 55], ["monitoring disease progression", "PROBLEM", 76, 106], ["morbidity", "PROBLEM", 154, 163], ["mortality", "PROBLEM", 168, 177], ["morbidity", "OBSERVATION", 154, 163]]], ["Based on the data, a website was created to demonstrate how such technologies could be shared and distributed to others to combat entities such as COVID-19 moving forward.", [["COVID", "TEST", 147, 152]]], ["Our study offers a small window into the potential for how AI will likely dramatically change the practice of medicine in the future.CONCLUSIONS. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)CONCLUSIONSThe copyright holder for this preprint this version posted May 26, 2020. . https://doi.org/10.1101/2020.05.21.20106518 doi: medRxiv preprint", [["CC", "CHEMICAL", 146, 148], ["Our study", "TEST", 0, 9], ["a small window", "TREATMENT", 17, 31], ["CC", "TEST", 146, 148], ["ND", "PROBLEM", 155, 157], ["medRxiv", "TREATMENT", 483, 490], ["NC", "ANATOMY", 152, 154], ["med", "ANATOMY", 251, 254]]]], "3f2ac38dc10145dacb3f1b8e5d4ac6eb3c9ecf03": [["The global health emergency resulting from the COVID-19 pandemic is a special concern to rheumatologists and their patients, as most patients seen by rheumatologists have underlying immune dysfunction and are commonly treated with immunosuppressive therapies.", [["immune dysfunction", "DISEASE", 182, 200], ["patients", "ORGANISM", 115, 123], ["patients", "ORGANISM", 133, 141], ["patients", "SPECIES", 115, 123], ["patients", "SPECIES", 133, 141], ["the COVID", "TEST", 43, 52], ["underlying immune dysfunction", "PROBLEM", 171, 200], ["immunosuppressive therapies", "TREATMENT", 231, 258], ["global", "OBSERVATION_MODIFIER", 4, 10], ["immune dysfunction", "OBSERVATION", 182, 200]]], ["Such therapies are often highly effective for rheumatic disease treatment but can increase the risk of serious infections 1 , which has raised concern that these individuals might be more vulnerable to severe COVID-19 than the general population.", [["rheumatic disease", "DISEASE", 46, 63], ["infections", "DISEASE", 111, 121], ["COVID", "DISEASE", 209, 214], ["individuals", "ORGANISM", 162, 173], ["Such therapies", "TREATMENT", 0, 14], ["rheumatic disease treatment", "TREATMENT", 46, 73], ["serious infections", "PROBLEM", 103, 121], ["severe COVID", "PROBLEM", 202, 214], ["serious", "OBSERVATION_MODIFIER", 103, 110], ["infections", "OBSERVATION", 111, 121]]]], "64d973b1b7516d075f9cee1d7d625198f7277ddf": [["J o u r n a l P r e -p r o o fCaracterizaci\u00f3n de la miocarditis por COVID-19 mediante resonancia magn\u00e9tica cardiacaTo the Editor, Since its first description in December 2019 in Wuhan City (Hubei, China), a novel type of mutated coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has infected over 3.6 million people and caused more than 257 000 deaths worldwide (as of May 5, 2020) .", [["coronavirus", "DISEASE", 229, 240], ["acute respiratory syndrome coronavirus", "DISEASE", 255, 293], ["deaths", "DISEASE", 376, 382], ["coronavirus", "ORGANISM", 229, 240], ["severe acute respiratory syndrome coronavirus 2", "ORGANISM", 248, 295], ["SARS-CoV-2", "ORGANISM", 297, 307], ["people", "ORGANISM", 340, 346], ["people", "SPECIES", 340, 346], ["severe acute respiratory syndrome coronavirus", "SPECIES", 248, 293], ["SARS-CoV-2", "SPECIES", 297, 307], ["fCaracterizaci\u00f3n", "PROBLEM", 29, 45], ["COVID", "TEST", 68, 73], ["mutated coronavirus", "PROBLEM", 221, 240], ["severe acute respiratory syndrome coronavirus", "PROBLEM", 248, 293], ["severe", "OBSERVATION_MODIFIER", 248, 254], ["acute", "OBSERVATION_MODIFIER", 255, 260], ["respiratory syndrome", "OBSERVATION", 261, 281], ["infected", "OBSERVATION_MODIFIER", 314, 322]]], ["There is growing concern that acute respiratory disease occurring in coronavirus disease (COVID-19) is strongly associated with cardiovascular damage.", [["respiratory", "ANATOMY", 36, 47], ["cardiovascular", "ANATOMY", 128, 142], ["respiratory disease", "DISEASE", 36, 55], ["coronavirus disease", "DISEASE", 69, 88], ["cardiovascular damage", "DISEASE", 128, 149], ["coronavirus", "ORGANISM", 69, 80], ["cardiovascular", "ANATOMICAL_SYSTEM", 128, 142], ["acute respiratory disease", "PROBLEM", 30, 55], ["coronavirus disease", "PROBLEM", 69, 88], ["COVID", "TEST", 90, 95], ["cardiovascular damage", "PROBLEM", 128, 149], ["acute", "OBSERVATION_MODIFIER", 30, 35], ["respiratory disease", "OBSERVATION", 36, 55], ["coronavirus disease", "OBSERVATION", 69, 88], ["strongly associated with", "UNCERTAINTY", 103, 127], ["cardiovascular damage", "OBSERVATION", 128, 149]]], ["Patients with COVID-19 are at risk of cardiac arrhythmias, acute coronary syndromes, heart failure-related events, and fulminant myocarditis.", [["cardiac", "ANATOMY", 38, 45], ["coronary", "ANATOMY", 65, 73], ["heart", "ANATOMY", 85, 90], ["cardiac arrhythmias", "DISEASE", 38, 57], ["acute coronary syndromes", "DISEASE", 59, 83], ["heart failure", "DISEASE", 85, 98], ["myocarditis", "DISEASE", 129, 140], ["Patients", "ORGANISM", 0, 8], ["cardiac", "ORGAN", 38, 45], ["coronary", "MULTI-TISSUE_STRUCTURE", 65, 73], ["heart", "ORGAN", 85, 90], ["Patients", "SPECIES", 0, 8], ["COVID", "TEST", 14, 19], ["cardiac arrhythmias", "PROBLEM", 38, 57], ["acute coronary syndromes", "PROBLEM", 59, 83], ["heart failure", "PROBLEM", 85, 98], ["related events", "PROBLEM", 99, 113], ["fulminant myocarditis", "PROBLEM", 119, 140], ["cardiac", "ANATOMY", 38, 45], ["arrhythmias", "OBSERVATION", 46, 57], ["acute", "OBSERVATION_MODIFIER", 59, 64], ["coronary", "ANATOMY", 65, 73], ["syndromes", "OBSERVATION", 74, 83], ["heart", "ANATOMY", 85, 90], ["failure", "OBSERVATION", 91, 98], ["fulminant", "OBSERVATION_MODIFIER", 119, 128], ["myocarditis", "OBSERVATION", 129, 140]]], ["1 Myocardial injury may occur at different phases of COVID-19 disease (ie, viral, pulmonary, inflammatory, and recovery phase), even late after the onset of symptoms.", [["Myocardial", "ANATOMY", 2, 12], ["pulmonary", "ANATOMY", 82, 91], ["Myocardial injury", "DISEASE", 2, 19], ["Myocardial", "MULTI-TISSUE_STRUCTURE", 2, 12], ["pulmonary", "ORGAN", 82, 91], ["Myocardial injury", "PROBLEM", 2, 19], ["COVID-19 disease", "PROBLEM", 53, 69], ["viral, pulmonary, inflammatory", "PROBLEM", 75, 105], ["symptoms", "PROBLEM", 157, 165], ["Myocardial", "ANATOMY", 2, 12], ["injury", "OBSERVATION", 13, 19], ["pulmonary", "ANATOMY", 82, 91], ["inflammatory", "OBSERVATION", 93, 105]]], ["2 The mechanisms of cardiovascular injury from SARS-CoV- 2 have not yet been fully elucidated and are likely to be multifactorial.", [["cardiovascular", "ANATOMY", 20, 34], ["cardiovascular injury", "DISEASE", 20, 41], ["SARS", "DISEASE", 47, 51], ["cardiovascular", "ANATOMICAL_SYSTEM", 20, 34], ["SARS-CoV- 2", "GENE_OR_GENE_PRODUCT", 47, 58], ["cardiovascular injury", "PROBLEM", 20, 41], ["SARS-CoV", "TEST", 47, 55], ["cardiovascular", "ANATOMY", 20, 34], ["injury", "OBSERVATION", 35, 41], ["likely to be", "UNCERTAINTY", 102, 114], ["multifactorial", "OBSERVATION_MODIFIER", 115, 129]]], ["SARS-CoV-2 viral particles have been identified by real-time polymerase chain reaction (PCR) testing in cardiac tissue, providing evidence that direct cardiotoxicity might occur.", [["cardiac tissue", "ANATOMY", 104, 118], ["SARS", "DISEASE", 0, 4], ["cardiotoxicity", "DISEASE", 151, 165], ["SARS-CoV-2", "ORGANISM", 0, 10], ["cardiac tissue", "TISSUE", 104, 118], ["SARS", "TEST", 0, 4], ["CoV", "TEST", 5, 8], ["2 viral particles", "PROBLEM", 9, 26], ["PCR", "TEST", 88, 91], ["direct cardiotoxicity", "PROBLEM", 144, 165], ["cardiac tissue", "ANATOMY", 104, 118]]], ["1 In addition, SARS-CoV-2 has been shown to establish a receptor binding domain with angiotensin-converting enzyme 2 (ACE2) before entering the host cell via endocytosis.", [["cell", "ANATOMY", 149, 153], ["angiotensin", "CHEMICAL", 85, 96], ["SARS-CoV-2", "GENE_OR_GENE_PRODUCT", 15, 25], ["angiotensin-converting enzyme 2", "GENE_OR_GENE_PRODUCT", 85, 116], ["ACE2", "GENE_OR_GENE_PRODUCT", 118, 122], ["cell", "CELL", 149, 153], ["receptor binding domain", "PROTEIN", 56, 79], ["angiotensin-converting enzyme 2", "PROTEIN", 85, 116], ["ACE2", "PROTEIN", 118, 122], ["SARS-CoV", "SPECIES", 15, 23], ["angiotensin-converting enzyme", "TREATMENT", 85, 114], ["host cell", "OBSERVATION", 144, 153], ["endocytosis", "OBSERVATION", 158, 169]]], ["Since more than 7.5% of myocardial cells have positive ACE2 expression, this could mediate SARS-CoV-2 entry into cardiomyocytes and cause direct cardiotoxicity.", [["myocardial cells", "ANATOMY", 24, 40], ["cardiomyocytes", "ANATOMY", 113, 127], ["cardiotoxicity", "DISEASE", 145, 159], ["myocardial cells", "CELL", 24, 40], ["ACE2", "GENE_OR_GENE_PRODUCT", 55, 59], ["SARS-CoV-2", "GENE_OR_GENE_PRODUCT", 91, 101], ["cardiomyocytes", "CELL", 113, 127], ["myocardial cells", "CELL_TYPE", 24, 40], ["ACE2", "PROTEIN", 55, 59], ["cardiomyocytes", "CELL_TYPE", 113, 127], ["myocardial cells", "PROBLEM", 24, 40], ["positive ACE2 expression", "PROBLEM", 46, 70], ["CoV", "TEST", 96, 99], ["direct cardiotoxicity", "PROBLEM", 138, 159], ["ACE2 expression", "OBSERVATION", 55, 70], ["cardiomyocytes", "ANATOMY", 113, 127]]], ["3 Furthermore, hyperinflammation due to cytokine release mediated by the virus may lead to myocardial and vascular inflammation, plaque instability, a hypercoagulable state, and endothelial cell dysfunction.", [["myocardial", "ANATOMY", 91, 101], ["vascular", "ANATOMY", 106, 114], ["plaque", "ANATOMY", 129, 135], ["endothelial cell", "ANATOMY", 178, 194], ["hyperinflammation", "DISEASE", 15, 32], ["myocardial and vascular inflammation", "DISEASE", 91, 127], ["plaque instability", "DISEASE", 129, 147], ["endothelial cell dysfunction", "DISEASE", 178, 206], ["myocardial", "MULTI-TISSUE_STRUCTURE", 91, 101], ["vascular", "MULTI-TISSUE_STRUCTURE", 106, 114], ["endothelial cell", "CELL", 178, 194], ["cytokine", "PROTEIN", 40, 48], ["hyperinflammation", "PROBLEM", 15, 32], ["cytokine release", "PROBLEM", 40, 56], ["the virus", "PROBLEM", 69, 78], ["myocardial and vascular inflammation", "PROBLEM", 91, 127], ["plaque instability", "PROBLEM", 129, 147], ["a hypercoagulable state", "PROBLEM", 149, 172], ["endothelial cell dysfunction", "PROBLEM", 178, 206], ["virus", "OBSERVATION", 73, 78], ["myocardial", "ANATOMY", 91, 101], ["vascular", "ANATOMY", 106, 114], ["inflammation", "OBSERVATION", 115, 127], ["plaque", "OBSERVATION_MODIFIER", 129, 135], ["instability", "OBSERVATION", 136, 147], ["hypercoagulable state", "OBSERVATION", 151, 172], ["endothelial cell dysfunction", "OBSERVATION", 178, 206]]], ["Finally, cardiac injury may also be mediated by other systemic consequences of COVID-19 infection, including sepsis and disseminated intravascular coagulation.Caracterizaci\u00f3n de la miocarditis por COVID-19 mediante resonancia magn\u00e9tica cardiacaAccording to postmortem biopsies, the pathological features in cardiac tissue range from minimal changes to interstitial inflammatory infiltration and myocyte necrosis.", [["cardiac", "ANATOMY", 9, 16], ["intravascular", "ANATOMY", 133, 146], ["cardiac tissue", "ANATOMY", 307, 321], ["interstitial", "ANATOMY", 352, 364], ["myocyte", "ANATOMY", 395, 402], ["cardiac injury", "DISEASE", 9, 23], ["COVID-19", "CHEMICAL", 79, 87], ["infection", "DISEASE", 88, 97], ["sepsis", "DISEASE", 109, 115], ["disseminated intravascular coagulation", "DISEASE", 120, 158], ["necrosis", "DISEASE", 403, 411], ["cardiac", "ORGAN", 9, 16], ["COVID-19", "ORGANISM", 79, 87], ["intravascular", "IMMATERIAL_ANATOMICAL_ENTITY", 133, 146], ["postmortem biopsies", "MULTI-TISSUE_STRUCTURE", 257, 276], ["cardiac tissue", "TISSUE", 307, 321], ["myocyte", "CELL", 395, 402], ["cardiac injury", "PROBLEM", 9, 23], ["COVID-19 infection", "PROBLEM", 79, 97], ["sepsis", "PROBLEM", 109, 115], ["disseminated intravascular coagulation", "PROBLEM", 120, 158], ["Caracterizaci\u00f3n de la miocarditis", "TREATMENT", 159, 192], ["COVID", "TEST", 197, 202], ["postmortem biopsies", "TEST", 257, 276], ["minimal changes", "PROBLEM", 333, 348], ["interstitial inflammatory infiltration", "PROBLEM", 352, 390], ["myocyte necrosis", "PROBLEM", 395, 411], ["cardiac", "ANATOMY", 9, 16], ["injury", "OBSERVATION", 17, 23], ["infection", "OBSERVATION", 88, 97], ["sepsis", "OBSERVATION", 109, 115], ["disseminated", "OBSERVATION_MODIFIER", 120, 132], ["intravascular coagulation", "OBSERVATION", 133, 158], ["cardiac tissue", "ANATOMY", 307, 321], ["minimal", "OBSERVATION_MODIFIER", 333, 340], ["interstitial", "ANATOMY_MODIFIER", 352, 364], ["inflammatory infiltration", "OBSERVATION", 365, 390], ["myocyte", "ANATOMY", 395, 402], ["necrosis", "OBSERVATION", 403, 411]]], ["1 We describe 2 different presentations of myocarditis.", [["myocarditis", "DISEASE", 43, 54], ["myocarditis", "PROBLEM", 43, 54], ["2 different", "OBSERVATION_MODIFIER", 14, 25], ["myocarditis", "OBSERVATION", 43, 54]]], ["The first patient was an asymptomatic 26year-old-pregnant woman diagnosed with gestational diabetes who was admitted for delivery.", [["gestational diabetes", "DISEASE", 79, 99], ["patient", "ORGANISM", 10, 17], ["woman", "ORGANISM", 58, 63], ["patient", "SPECIES", 10, 17], ["woman", "SPECIES", 58, 63], ["gestational diabetes", "PROBLEM", 79, 99], ["delivery", "TREATMENT", 121, 129], ["diabetes", "OBSERVATION", 91, 99]]], ["She J o u r n a l P r e -p r o o f required a cesarean section.", [["a cesarean section", "TREATMENT", 44, 62]]], ["As part of the preoperative protocol a PCR test was performed, which was positive.", [["the preoperative protocol", "TEST", 11, 36], ["a PCR test", "TEST", 37, 47]]], ["The procedure was uneventful and the patient gave birth to a healthy neonate.", [["patient", "ORGANISM", 37, 44], ["neonate", "ORGANISM", 69, 76], ["patient", "SPECIES", 37, 44], ["The procedure", "TREATMENT", 0, 13]]], ["No abnormalities were observed on a chest X-ray performed the day after surgery and the patient was discharged after 2 days of hospitalization.", [["patient", "ORGANISM", 88, 95], ["patient", "SPECIES", 88, 95], ["abnormalities", "PROBLEM", 3, 16], ["a chest X-ray", "TEST", 34, 47], ["surgery", "TREATMENT", 72, 79], ["abnormalities", "OBSERVATION", 3, 16], ["chest", "ANATOMY", 36, 41]]], ["A week later, she was seen in the emergency department for chest pain radiating to her left arm and was prescribed nonsteroidal anti-inflammatory drugs and colchicine.", [["chest", "ANATOMY", 59, 64], ["left arm", "ANATOMY", 87, 95], ["nonsteroidal", "ANATOMY", 115, 127], ["chest pain", "DISEASE", 59, 69], ["colchicine", "CHEMICAL", 156, 166], ["colchicine", "CHEMICAL", 156, 166], ["chest", "ORGANISM_SUBDIVISION", 59, 64], ["nonsteroidal anti-inflammatory drugs", "SIMPLE_CHEMICAL", 115, 151], ["colchicine", "SIMPLE_CHEMICAL", 156, 166], ["chest pain", "PROBLEM", 59, 69], ["nonsteroidal anti-inflammatory drugs", "TREATMENT", 115, 151], ["colchicine", "TREATMENT", 156, 166], ["chest", "ANATOMY", 59, 64], ["left", "ANATOMY_MODIFIER", 87, 91], ["arm", "ANATOMY", 92, 95], ["anti-inflammatory drugs", "OBSERVATION", 128, 151]]], ["Due to persistent symptoms and tachycardia, she was admitted to hospital 1 week later.Caracterizaci\u00f3n de la miocarditis por COVID-19 mediante resonancia magn\u00e9tica cardiacaShe had no fever or respiratory symptoms.", [["respiratory", "ANATOMY", 191, 202], ["tachycardia", "DISEASE", 31, 42], ["fever", "DISEASE", 182, 187], ["respiratory symptoms", "DISEASE", 191, 211], ["persistent symptoms", "PROBLEM", 7, 26], ["tachycardia", "PROBLEM", 31, 42], ["Caracterizaci\u00f3n de la miocarditis", "PROBLEM", 86, 119], ["COVID", "TEST", 124, 129], ["fever", "PROBLEM", 182, 187], ["respiratory symptoms", "PROBLEM", 191, 211], ["persistent", "OBSERVATION_MODIFIER", 7, 17], ["symptoms", "OBSERVATION", 18, 26], ["tachycardia", "OBSERVATION", 31, 42], ["cardiaca", "ANATOMY", 163, 171], ["no", "UNCERTAINTY", 179, 181], ["fever", "OBSERVATION", 182, 187], ["respiratory", "ANATOMY", 191, 202], ["symptoms", "OBSERVATION", 203, 211]]], ["The results of chest X-ray and an electrocardiogram were normal.", [["chest", "ANATOMY", 15, 20], ["chest X-ray", "TEST", 15, 26], ["an electrocardiogram", "TEST", 31, 51], ["chest", "ANATOMY", 15, 20], ["normal", "OBSERVATION", 57, 63]]], ["Echocardiography showed normal systolic function.", [["Echocardiography", "TEST", 0, 16], ["normal", "OBSERVATION", 24, 30], ["systolic function", "OBSERVATION", 31, 48]]], ["Troponin T levels were high (319.4 ng/L).Caracterizaci\u00f3n de la miocarditis por COVID-19 mediante resonancia magn\u00e9tica cardiacaThe patient underwent cardiac magnetic resonance (CMR) on a 3T system (Magnetom VIDA, Siemens Healthineers, Erlangen, Germany).", [["Troponin T", "GENE_OR_GENE_PRODUCT", 0, 10], ["patient", "ORGANISM", 130, 137], ["patient", "SPECIES", 130, 137], ["Troponin T levels", "TEST", 0, 17], ["Caracterizaci\u00f3n de la miocarditis", "PROBLEM", 41, 74], ["COVID", "TEST", 79, 84], ["cardiac magnetic resonance", "TEST", 148, 174], ["cardiaca", "ANATOMY", 118, 126], ["cardiac", "ANATOMY", 148, 155]]], ["A conventional CMR protocol to rule out myocarditis was performed.", [["myocarditis", "DISEASE", 40, 51], ["A conventional CMR protocol", "TEST", 0, 27], ["myocarditis", "PROBLEM", 40, 51], ["myocarditis", "OBSERVATION", 40, 51]]], ["Cine images revealed normal systolic function (left ventricular ejection fraction 59%), with no regional wall motion abnormalities.", [["left ventricular", "ANATOMY", 47, 63], ["wall", "ANATOMY", 105, 109], ["ventricular", "MULTI-TISSUE_STRUCTURE", 52, 63], ["wall", "MULTI-TISSUE_STRUCTURE", 105, 109], ["Cine images", "TEST", 0, 11], ["left ventricular ejection fraction", "TEST", 47, 81], ["regional wall motion abnormalities", "PROBLEM", 96, 130], ["normal", "OBSERVATION", 21, 27], ["systolic function", "OBSERVATION", 28, 45], ["left ventricular", "ANATOMY", 47, 63], ["no", "UNCERTAINTY", 93, 95], ["regional", "ANATOMY_MODIFIER", 96, 104], ["wall", "ANATOMY_MODIFIER", 105, 109], ["motion abnormalities", "OBSERVATION", 110, 130]]], ["High signal intensity on T 2 maps (53 ms, normal value < 48 ms) and prolonged native T 1 values were observed in basal and mid-inferoseptal and inferior myocardial segments (1303 ms, normal value < 1200 ms).", [["basal", "ANATOMY", 113, 118], ["mid-inferoseptal", "ANATOMY", 123, 139], ["inferior myocardial segments", "ANATOMY", 144, 172], ["T 1", "GENE_OR_GENE_PRODUCT", 85, 88], ["mid-inferoseptal", "CANCER", 123, 139], ["inferior myocardial segments", "MULTI-TISSUE_STRUCTURE", 144, 172], ["High signal intensity", "PROBLEM", 0, 21], ["T 2 maps", "TEST", 25, 33], ["ms", "TEST", 38, 40], ["prolonged native T 1 values", "PROBLEM", 68, 95], ["signal", "OBSERVATION_MODIFIER", 5, 11], ["intensity", "OBSERVATION_MODIFIER", 12, 21], ["basal", "ANATOMY_MODIFIER", 113, 118], ["mid-inferoseptal", "ANATOMY_MODIFIER", 123, 139], ["inferior myocardial", "ANATOMY", 144, 163], ["segments", "ANATOMY_MODIFIER", 164, 172]]], ["4 Late gadolinium enhanced (LGE) images showed mesocardial and subepicardial enhancement of those segments, representing 14.2% of the total ventricular mass (figure 1).", [["mesocardial", "ANATOMY", 47, 58], ["subepicardial", "ANATOMY", 63, 76], ["ventricular mass", "ANATOMY", 140, 156], ["gadolinium", "CHEMICAL", 7, 17], ["gadolinium", "CHEMICAL", 7, 17], ["subepicardial", "MULTI-TISSUE_STRUCTURE", 63, 76], ["ventricular", "ORGAN", 140, 151], ["Late gadolinium enhanced (LGE) images", "TEST", 2, 39], ["mesocardial and subepicardial enhancement of those segments", "PROBLEM", 47, 106], ["the total ventricular mass", "PROBLEM", 130, 156], ["subepicardial", "ANATOMY_MODIFIER", 63, 76], ["enhancement", "OBSERVATION", 77, 88], ["segments", "ANATOMY_MODIFIER", 98, 106], ["14.2%", "OBSERVATION_MODIFIER", 121, 126], ["total ventricular", "ANATOMY", 134, 151], ["mass", "OBSERVATION", 152, 156]]], ["Based on CMR findings and the clinical and epidemiological context, a diagnosis of myocarditis due to SARS-CoV-2 infection was established.", [["myocarditis", "DISEASE", 83, 94], ["SARS-CoV-2 infection", "DISEASE", 102, 122], ["SARS-CoV-2", "ORGANISM", 102, 112], ["SARS-CoV-2", "SPECIES", 102, 112], ["CMR findings", "TEST", 9, 21], ["myocarditis", "PROBLEM", 83, 94], ["SARS", "PROBLEM", 102, 106], ["CoV", "PROBLEM", 107, 110], ["2 infection", "PROBLEM", 111, 122], ["myocarditis", "OBSERVATION", 83, 94], ["infection", "OBSERVATION", 113, 122]]], ["No myocardial biopsy was performed.Caracterizaci\u00f3n de la miocarditis por COVID-19 mediante resonancia magn\u00e9tica cardiacaThe second patient was a 13-year-old boy who was admitted after 2 days of fever (40\u00b0C).", [["myocardial", "ANATOMY", 3, 13], ["fever", "DISEASE", 194, 199], ["myocardial biopsy", "MULTI-TISSUE_STRUCTURE", 3, 20], ["patient", "ORGANISM", 131, 138], ["boy", "ORGANISM", 157, 160], ["patient", "SPECIES", 131, 138], ["boy", "SPECIES", 157, 160], ["myocardial biopsy", "TEST", 3, 20], ["Caracterizaci\u00f3n de la miocarditis", "PROBLEM", 35, 68], ["COVID", "TEST", 73, 78], ["fever", "PROBLEM", 194, 199], ["myocardial", "ANATOMY", 3, 13], ["biopsy", "OBSERVATION", 14, 20], ["cardiaca", "ANATOMY", 112, 120], ["fever", "OBSERVATION", 194, 199]]], ["He reported mild cough, odynophagia, abdominal pain, and vomiting in the past few days.", [["abdominal", "ANATOMY", 37, 46], ["cough", "DISEASE", 17, 22], ["odynophagia", "DISEASE", 24, 35], ["abdominal pain", "DISEASE", 37, 51], ["vomiting", "DISEASE", 57, 65], ["abdominal", "ORGANISM_SUBDIVISION", 37, 46], ["mild cough", "PROBLEM", 12, 22], ["odynophagia", "PROBLEM", 24, 35], ["abdominal pain", "PROBLEM", 37, 51], ["vomiting", "PROBLEM", 57, 65], ["mild", "OBSERVATION_MODIFIER", 12, 16], ["cough", "OBSERVATION", 17, 22], ["odynophagia", "OBSERVATION", 24, 35], ["abdominal", "ANATOMY", 37, 46], ["pain", "OBSERVATION", 47, 51]]], ["Laboratory tests showed mild elevation of C-reactive protein, D-dimer, ferritin, brain natriuretic peptide, and troponin I (190 pg/mL) levels.", [["C-reactive protein", "GENE_OR_GENE_PRODUCT", 42, 60], ["D-dimer", "GENE_OR_GENE_PRODUCT", 62, 69], ["ferritin", "GENE_OR_GENE_PRODUCT", 71, 79], ["brain natriuretic peptide", "GENE_OR_GENE_PRODUCT", 81, 106], ["troponin I", "GENE_OR_GENE_PRODUCT", 112, 122], ["C-reactive protein", "PROTEIN", 42, 60], ["D-dimer", "PROTEIN", 62, 69], ["ferritin", "PROTEIN", 71, 79], ["troponin I", "PROTEIN", 112, 122], ["Laboratory tests", "TEST", 0, 16], ["mild elevation of C-reactive protein", "PROBLEM", 24, 60], ["D-dimer", "TEST", 62, 69], ["ferritin", "TEST", 71, 79], ["brain natriuretic peptide", "TEST", 81, 106], ["troponin I", "TEST", 112, 122], ["levels", "TEST", 135, 141], ["mild", "OBSERVATION_MODIFIER", 24, 28], ["elevation", "OBSERVATION_MODIFIER", 29, 38], ["reactive protein", "OBSERVATION", 44, 60]]], ["His relatives were PCR-positive for SARS-CoV-2 and he also had a positive PCR-test.", [["SARS-CoV-2", "ORGANISM", 36, 46], ["SARS-CoV", "SPECIES", 36, 44], ["PCR", "TEST", 19, 22], ["SARS", "PROBLEM", 36, 40], ["CoV", "TEST", 41, 44], ["a positive PCR", "PROBLEM", 63, 77]]], ["The CMR study performed on a 1.5T system (Magnetom Aera, Siemens Healthineers, Erlangen, Germany) showed normal biventricular function, no regional wall motion abnormalities, slightly increased T2 (54 ms, normal < 52 ms) and native T1 values (1110 ms, CMR allows targeting of several features of myocarditis, such as contractile dysfunction, inflammatory edema, and necrosis, and has become the gold standard for the noninvasive assessment of the disease.", [["biventricular", "ANATOMY", 112, 125], ["wall", "ANATOMY", 148, 152], ["contractile", "ANATOMY", 317, 328], ["myocarditis", "DISEASE", 296, 307], ["contractile dysfunction", "DISEASE", 317, 340], ["edema", "DISEASE", 355, 360], ["necrosis", "DISEASE", 366, 374], ["wall", "MULTI-TISSUE_STRUCTURE", 148, 152], ["The CMR study", "TEST", 0, 13], ["regional wall motion abnormalities", "PROBLEM", 139, 173], ["slightly increased T2", "PROBLEM", 175, 196], ["ms", "TEST", 201, 203], ["CMR", "TEST", 252, 255], ["myocarditis", "PROBLEM", 296, 307], ["contractile dysfunction", "PROBLEM", 317, 340], ["inflammatory edema", "PROBLEM", 342, 360], ["necrosis", "PROBLEM", 366, 374], ["the noninvasive assessment", "TEST", 413, 439], ["the disease", "PROBLEM", 443, 454], ["normal", "OBSERVATION", 105, 111], ["biventricular function", "OBSERVATION", 112, 134], ["no", "UNCERTAINTY", 136, 138], ["regional", "OBSERVATION_MODIFIER", 139, 147], ["wall", "ANATOMY_MODIFIER", 148, 152], ["motion abnormalities", "OBSERVATION", 153, 173], ["slightly", "OBSERVATION_MODIFIER", 175, 183], ["increased", "OBSERVATION_MODIFIER", 184, 193], ["myocarditis", "OBSERVATION", 296, 307], ["contractile dysfunction", "OBSERVATION", 317, 340], ["inflammatory", "OBSERVATION_MODIFIER", 342, 354], ["edema", "OBSERVATION", 355, 360], ["necrosis", "OBSERVATION", 366, 374], ["disease", "OBSERVATION", 447, 454]]], ["The cornerstone of diagnosis are conventional cine images, T2-weighted sequences, T1 and T2 parametric maps, and LGE images.", [["T2", "DNA", 59, 61], ["conventional cine images", "TEST", 33, 57], ["LGE images", "TEST", 113, 123]]], ["Furthermore, the degree of myocardial necrosis determined by LGE is a strong predictor of prognosis.Caracterizaci\u00f3n de la miocarditis por COVID-19 mediante resonancia magn\u00e9tica cardiacaIn the setting of the COVID-19 pandemic, approaches to CMR need to be adapted to allow for safe practices for urgent and semiurgent studies and appropriate deferral of elective examinations.", [["myocardial", "ANATOMY", 27, 37], ["myocardial necrosis", "DISEASE", 27, 46], ["myocardial", "MULTI-TISSUE_STRUCTURE", 27, 37], ["myocardial necrosis", "PROBLEM", 27, 46], ["Caracterizaci\u00f3n de la miocarditis", "TREATMENT", 100, 133], ["COVID", "TEST", 138, 143], ["the COVID", "TREATMENT", 203, 212], ["CMR", "TEST", 240, 243], ["urgent and semiurgent studies", "TEST", 295, 324], ["elective examinations", "TEST", 353, 374], ["degree", "OBSERVATION_MODIFIER", 17, 23], ["myocardial", "ANATOMY", 27, 37], ["necrosis", "OBSERVATION", 38, 46]]]], "e94ec2ec8b27ada764c24752fa77a3d18df73e3c": [["In this comparison of the RealStar\u00ae SARS-CoV-2 assay with the reference WHO assay, we observed a slightly better sensitivity of the RealStar\u00ae assay.", [["the RealStar\u00ae assay", "TEST", 128, 147]]], ["It provides a robust option for all molecular biology laboratories, with a strong real-life LoD and is compatible with various real-time PCR platforms.IntroductionThe novel coronavirus identified in China in December 2019 as the etiological agent of the COVID-19 disease has been declared as pandemic by the WHO the 11 th of March 2020 [1] .IntroductionThe etiological agent of this new infection is the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) [2] .", [["COVID-19 disease", "DISEASE", 254, 270], ["infection", "DISEASE", 387, 396], ["Acute Respiratory Syndrome coronavirus", "DISEASE", 411, 449], ["coronavirus", "ORGANISM", 173, 184], ["Severe Acute Respiratory Syndrome coronavirus", "SPECIES", 404, 449], ["SARS-CoV-2", "SPECIES", 453, 463], ["The novel coronavirus", "PROBLEM", 163, 184], ["the COVID-19 disease", "PROBLEM", 250, 270], ["this new infection", "PROBLEM", 378, 396], ["the Severe Acute Respiratory Syndrome coronavirus", "PROBLEM", 400, 449], ["SARS-CoV", "TEST", 453, 461], ["new", "OBSERVATION_MODIFIER", 383, 386], ["infection", "OBSERVATION", 387, 396], ["Severe", "OBSERVATION_MODIFIER", 404, 410], ["Acute", "OBSERVATION_MODIFIER", 411, 416], ["Respiratory Syndrome", "OBSERVATION", 417, 437]]], ["Availability and reliability of robust assays providing sensitive identification of infected individuals are the first steps allowing patient isolation, diagnosis and proper therapeutic measures.", [["patient", "ORGANISM", 134, 141], ["patient", "SPECIES", 134, 141], ["robust assays", "TEST", 32, 45], ["infected individuals", "PROBLEM", 84, 104], ["patient isolation", "TREATMENT", 134, 151], ["proper therapeutic measures", "TREATMENT", 167, 194], ["infected", "OBSERVATION", 84, 92]]], ["Several in-house and commercial RT-PCR assays have been quickly developed [3] but still require to be independently assessed and evaluated.", [["commercial RT-PCR assays", "TEST", 21, 45]]], ["The RealStare\u00ae SARS-CoV-2 RT-PCR kit (Altona) is a Research Usage Only (RUO) product providing the detection of SARS-CoV-2 and compatible with various real-time PCR platforms.", [["SARS-CoV", "SPECIES", 112, 120], ["The RealStare\u00ae SARS", "TEST", 0, 19], ["CoV", "TEST", 20, 23], ["SARS", "PROBLEM", 112, 116], ["CoV", "TEST", 117, 120]]], ["It allows detection and differentiation of lineage B-betacoronavirus (B-\u00dfCoV), by targeting the E gene from B-\u00dfCoV, and SARS-CoV-2 specific RNA, by targeting the S gene.", [["B-betacoronavirus", "GENE_OR_GENE_PRODUCT", 51, 68], ["B-\u00dfCoV", "ORGANISM", 70, 76], ["E", "GENE_OR_GENE_PRODUCT", 96, 97], ["B-\u00dfCoV", "GENE_OR_GENE_PRODUCT", 108, 114], ["SARS-CoV-2", "GENE_OR_GENE_PRODUCT", 120, 130], ["E gene", "DNA", 96, 102], ["B-\u00dfCoV, and SARS-CoV-2 specific RNA", "RNA", 108, 143], ["S gene", "DNA", 162, 168], ["B-\u00dfCoV", "SPECIES", 70, 76], ["B-\u00dfCoV", "SPECIES", 108, 114], ["SARS-CoV", "SPECIES", 120, 128], ["lineage B", "TEST", 43, 52], ["betacoronavirus", "TEST", 53, 68], ["SARS", "PROBLEM", 120, 124], ["CoV", "TEST", 125, 128]]], ["Evaluating the sensitivity of RT-PCR assays is an essential point as very low viral loads can be identified in patients nasopharyngeal swabs, especially in later disease stages [4, 5] .", [["nasopharyngeal swabs", "ANATOMY", 120, 140], ["patients", "ORGANISM", 111, 119], ["nasopharyngeal swabs", "ORGANISM_SUBSTANCE", 120, 140], ["patients", "SPECIES", 111, 119], ["RT-PCR assays", "TEST", 30, 43], ["very low viral loads", "PROBLEM", 69, 89], ["patients nasopharyngeal swabs", "PROBLEM", 111, 140], ["nasopharyngeal", "ANATOMY", 120, 134]]], ["To date, the RealStar\u00ae SARS-CoV-2 assay has been compared to several other commercial assay [6, 7] , however thorough limit of detection assessment and performances comparison with the currently WHO recommended assay have not been provided.J o u r n a l P r e -p r o o fHere, we report an independent validation of this new commercial PCR assay for SARS-CoV-2 detection, determining its limit of detection and comparing its performances on clinical samples with the currently WHO recommended RT-PCR assay [3] .Analytical sensitivity analysis of the RealStar\u00ae SARS-CoV-2 assayA preliminary sensitivity analysis was conducted using serial dilution of a SARS-CoV-2 positive nasopharyngeal sample.", [["samples", "ANATOMY", 449, 456], ["nasopharyngeal sample", "ANATOMY", 671, 692], ["nasopharyngeal sample", "CANCER", 671, 692], ["SARS-CoV", "SPECIES", 349, 357], ["SARS-CoV", "SPECIES", 651, 659], ["detection assessment", "TEST", 127, 147], ["this new commercial PCR assay", "TEST", 315, 344], ["SARS", "PROBLEM", 349, 353], ["CoV", "TEST", 354, 357], ["RT-PCR assay", "TEST", 492, 504], ["Analytical sensitivity analysis", "TEST", 510, 541], ["the RealStar\u00ae SARS", "TEST", 545, 563], ["CoV", "TEST", 564, 567], ["serial dilution", "TEST", 630, 645], ["a SARS", "TEST", 649, 655], ["CoV", "TEST", 656, 659], ["nasopharyngeal", "ANATOMY", 671, 685]]], ["This sample was serially diluted at 1:10 up to 1/100 000 before being serially diluted at 1:5 up to 1/12 500 000.", [["sample", "ANATOMY", 5, 11]]], ["All those dilutions were tested both with RealStar\u00ae SARS-CoV-2 and the currently WHO recommended RT-PCR assay (WHO-RT-PCR).", [["All those dilutions", "TEST", 0, 19], ["RT-PCR assay", "TEST", 97, 109]]], ["The same sample was quantified using a standardised RNA transcript control obtained from the European Virus Archive Program.", [["sample", "ANATOMY", 9, 15], ["a standardised RNA transcript control", "TREATMENT", 37, 74]]], ["The limit of detection (LoD) was then determined for the two assays by testing multiple replicates of serial two fold dilutions of the quantified sample around the expected LoD.", [["LoD", "PROTEIN", 173, 176], ["the two assays", "TEST", 53, 67], ["serial two fold dilutions", "TREATMENT", 102, 127]]], ["As recommended by the European Network of GMO Laboratories for LoD definition [8] , the LoD was defined as the concentration until obtaining 10 out of 10 positive replicates (10/10).", [["LoD definition", "TEST", 63, 77], ["the LoD", "TEST", 84, 91]]], ["All dilutions were done using Virocult transport medium and kept at +4\u00b0C before testing within 24h.Analytical sensitivity analysis of the RealStar\u00ae SARS-CoV-2 assayBriefly, for both assays the viral RNA was extracted from 200 \u00b5L of clinical samples with the MagNA Pure LC Total Nucleic Acid Isolation Kit -Large Volume (Roche Diagnostics) and eluted in 50 \u00b5L.", [["samples", "ANATOMY", 241, 248], ["SARS", "DISEASE", 148, 152], ["viral RNA", "RNA", 193, 202], ["All dilutions", "TREATMENT", 0, 13], ["Virocult transport medium", "TREATMENT", 30, 55], ["testing", "TEST", 80, 87], ["Analytical sensitivity analysis", "TEST", 99, 130], ["the RealStar\u00ae SARS", "TEST", 134, 152], ["CoV", "TEST", 153, 156], ["the viral RNA", "PROBLEM", 189, 202], ["the MagNA", "TREATMENT", 254, 263], ["Total Nucleic Acid Isolation", "TREATMENT", 272, 300], ["Large Volume (Roche Diagnostics)", "TREATMENT", 306, 338]]], ["The WHO RT-PCR, targeting E and Orf1 genes, was performed as described by Corman et al [3] and the RealStar\u00ae SARS-CoV-2 was performed according to the manufacturer recommendations.", [["E", "GENE_OR_GENE_PRODUCT", 26, 27], ["Orf1", "GENE_OR_GENE_PRODUCT", 32, 36], ["WHO RT-PCR", "DNA", 4, 14], ["E and Orf1 genes", "DNA", 26, 42], ["The WHO RT-PCR", "TEST", 0, 14], ["the RealStar\u00ae SARS", "TEST", 95, 113], ["CoV", "TEST", 114, 117]]], ["Both PCR assays were performed on an ABI 7500 plateform (Applied Biosystems\u00ae).", [["Both PCR assays", "TEST", 0, 15], ["an ABI", "TEST", 34, 40]]], ["For both assay, a signal with a cycle threshold (Ct) value above 40 was considered as negative.Evaluation of specificityTo assess the specificity of the RealStar\u00ae SARS-CoV-2 assay towards other coronaviruses we used using 2 pools of 3 positive samples for each of them (HKU1, NL63, OC43, 229E) obtained between October and December 2019.Performance comparison using clinical samplesWe included 83 nasopharyngeal swabs specimens from patients hospitalized in Bichat Claude Bernard teaching hospital, Paris, France.", [["samples", "ANATOMY", 244, 251], ["nasopharyngeal swabs specimens", "ANATOMY", 397, 427], ["coronaviruses", "ORGANISM", 194, 207], ["nasopharyngeal swabs specimens", "CANCER", 397, 427], ["patients", "ORGANISM", 433, 441], ["patients", "SPECIES", 433, 441], ["a cycle threshold (Ct) value", "TEST", 30, 58], ["Evaluation of specificity", "TEST", 95, 120], ["the RealStar\u00ae SARS", "TEST", 149, 167], ["CoV", "TEST", 168, 171], ["other coronaviruses", "PROBLEM", 188, 207], ["HKU1", "TEST", 270, 274], ["clinical samples", "TEST", 366, 382], ["nasopharyngeal swabs specimens", "TEST", 397, 427], ["negative", "OBSERVATION", 86, 94]]], ["These specimens were taken from patients suspected of COVID-19, collected in Virocult\u00ae viral transport media (Sigma).", [["specimens", "ANATOMY", 6, 15], ["specimens", "CANCER", 6, 15], ["patients", "ORGANISM", 32, 40], ["patients", "SPECIES", 32, 40], ["These specimens", "TEST", 0, 15], ["COVID", "TEST", 54, 59]]], ["Samples for the specificity evaluation were obtained for mPCR point of care evaluation approved by the Bichat Claude Bernard ethic committee (N2019-050).", [["N2019-050", "CHEMICAL", 142, 151], ["the specificity evaluation", "TEST", 12, 38], ["mPCR", "TEST", 57, 61], ["care evaluation", "TEST", 71, 86]]], ["All other hospitalized patients, included in this study, were included in the national French-COVID19 cohort and written consent was obtained for clinical and biological sub-studies.Analytical sensitivity analysis of the RealStar\u00ae SARS-CoV-2 assayAll results obtained from initial serial dilutions are depicted in Table 1 For the LoD assessment, all results obtained with the serial 1:2 dilutions around the expected LoD are depicted in table 2.", [["patients", "ORGANISM", 23, 31], ["LoD", "DNA", 417, 420], ["patients", "SPECIES", 23, 31], ["this study", "TEST", 45, 55], ["biological sub-studies", "TEST", 159, 181], ["Analytical sensitivity analysis", "TEST", 182, 213], ["the RealStar\u00ae SARS", "TEST", 217, 235], ["CoV", "TEST", 236, 239], ["initial serial dilutions", "TEST", 273, 297], ["the LoD assessment", "TEST", 326, 344], ["the serial 1:2 dilutions", "TREATMENT", 372, 396]]], ["The detection of 10/10 replicates by the WHO RT-PCR assay was achieved for the dilution containing 1250 copies/mL (i.e. for an input of 25 copies/PCR in our conditions) whereas it was achieved for the dilution containing 625 copies/mL with both E and S genes of the RealStar\u00ae SARS-CoV-2 assay (i.e. for an input of 13 copies/PCR).Evaluation of specificityNo cross-reaction was detected neither for human coronaviruses (229E, OC43, NL63 and HKU1, n=2 pools of three samples for each targets) nor other respiratory viruses (influenza A:H1N1, A:H3N2 and B, respiratory syncytial virus, rhinovirus, parainfluenza virus 1 and 4, and human metapneumovirus; n=1 pool for each).Performance comparison using clinical samplesAll results from this comparison are given in Figure 1DiscussionIn this work we assessed the performances and limit-of-detection on clinical samples of the RealStar\u00ae SARS-CoV-2 RT-PCR Kit RUO in comparison to the currently recommended WHO RT-PCR assay [3] .", [["samples", "ANATOMY", 465, 472], ["samples", "ANATOMY", 856, 863], ["respiratory viruses", "DISEASE", 501, 520], ["influenza A", "DISEASE", 522, 533], ["respiratory syncytial virus", "DISEASE", 554, 581], ["human metapneumovirus", "DISEASE", 628, 649], ["SARS", "DISEASE", 881, 885], ["human", "ORGANISM", 398, 403], ["samples", "CANCER", 465, 472], ["influenza A:H1N1, A:H3N2 and B, respiratory syncytial virus", "ORGANISM", 522, 581], ["rhinovirus", "ORGANISM", 583, 593], ["parainfluenza virus 1", "ORGANISM", 595, 616], ["human", "ORGANISM", 628, 633], ["metapneumovirus", "ORGANISM", 634, 649], ["Kit", "ORGANISM", 899, 902], ["E and S genes", "DNA", 245, 258], ["human", "SPECIES", 398, 403], ["respiratory syncytial virus", "SPECIES", 554, 581], ["parainfluenza virus 1", "SPECIES", 595, 616], ["human", "SPECIES", 628, 633], ["metapneumovirus", "SPECIES", 634, 649], ["human coronaviruses", "SPECIES", 398, 417], ["respiratory syncytial virus", "SPECIES", 554, 581], ["parainfluenza virus 1", "SPECIES", 595, 616], ["human metapneumovirus", "SPECIES", 628, 649], ["The detection", "TEST", 0, 13], ["the WHO RT-PCR assay", "TEST", 37, 57], ["copies/PCR", "TEST", 139, 149], ["the RealStar\u00ae SARS", "TEST", 262, 280], ["CoV", "TEST", 281, 284], ["an input", "TEST", 303, 311], ["copies/PCR", "TEST", 318, 328], ["Evaluation of specificity", "TEST", 330, 355], ["cross-reaction", "PROBLEM", 358, 372], ["human coronaviruses", "PROBLEM", 398, 417], ["OC43", "TEST", 425, 429], ["NL63", "TEST", 431, 435], ["HKU1", "TEST", 440, 444], ["each targets", "TEST", 477, 489], ["other respiratory viruses", "PROBLEM", 495, 520], ["influenza", "PROBLEM", 522, 531], ["H1N1", "PROBLEM", 534, 538], ["H3N2", "TEST", 542, 546], ["respiratory syncytial virus", "PROBLEM", 554, 581], ["rhinovirus", "PROBLEM", 583, 593], ["parainfluenza virus", "PROBLEM", 595, 614], ["human metapneumovirus", "PROBLEM", 628, 649], ["clinical samples", "TEST", 699, 715], ["clinical samples", "TEST", 847, 863], ["the RealStar\u00ae SARS", "TEST", 867, 885], ["CoV", "TEST", 886, 889], ["PCR Kit RUO", "TEST", 895, 906], ["WHO RT-PCR assay", "TEST", 950, 966], ["cross-reaction", "OBSERVATION", 358, 372], ["respiratory viruses", "OBSERVATION", 501, 520], ["respiratory syncytial", "ANATOMY", 554, 575]]], ["The LoD obtained for the E gene with the WHO RT-PCR assay, at 50 copies/PCR, was slightly higher than previously estimated in the initial description at 5 copies/PCR [3] .", [["E", "GENE_OR_GENE_PRODUCT", 25, 26], ["LoD", "DNA", 4, 7], ["E gene", "DNA", 25, 31], ["The LoD", "TEST", 0, 7], ["the WHO RT-PCR assay", "TEST", 37, 57], ["copies/PCR", "TEST", 65, 75], ["copies/PCR", "TEST", 155, 165]]], ["This may be explained in part by the use of SARS-CoV-2 clinical samples in the current work instead of transcript RNA and the use of different LoD estimation methods.DiscussionThe LoD of the RealStar\u00ae SARS-CoV-2 assay was in the same range and even slightly higher than the WHO assay in our work at 25 copies/PCR.", [["transcript RNA", "RNA", 103, 117], ["transcript RNA", "TREATMENT", 103, 117], ["different LoD estimation methods", "TREATMENT", 133, 165], ["the RealStar\u00ae SARS", "TEST", 187, 205], ["CoV-2 assay", "TEST", 206, 217]]], ["The poor sensitivity of the WHO assay for the RdRp gene has been previously evidenced in our previous works [9] and a recent prepublication comparing the performances of the main reference assays [10] .", [["RdRp gene", "DNA", 46, 55], ["the WHO assay", "TEST", 24, 37], ["the RdRp gene", "PROBLEM", 42, 55], ["a recent prepublication", "PROBLEM", 116, 139]]], ["The sensitivity and specificity of both the RealStar\u00ae SARS-CoV-2 RT-PCR RUO assay on clinical samples appears similar with 100% of concordance on 83 clinical nasopharyngeal samples.", [["samples", "ANATOMY", 94, 101], ["nasopharyngeal samples", "ANATOMY", 158, 180], ["nasopharyngeal samples", "CANCER", 158, 180], ["RealStar\u00ae SARS-CoV-2 RT-PCR RUO", "DNA", 44, 75], ["The sensitivity", "TEST", 0, 15], ["the RealStar\u00ae SARS", "TEST", 40, 58], ["CoV", "TEST", 59, 62], ["PCR RUO assay", "TEST", 68, 81], ["clinical samples", "TEST", 85, 101], ["clinical nasopharyngeal samples", "TEST", 149, 180], ["nasopharyngeal", "ANATOMY", 158, 172]]], ["Thus, the RealStar\u00ae SARS-CoV-2 RT-PCR RUO assay provides a promising commercial alternative for SARS-CoV-2 detection with a slightly better sensitivity than the WHO currently recommended assay.", [["SARS-CoV", "SPECIES", 96, 104], ["the RealStar\u00ae SARS", "TEST", 6, 24], ["CoV", "TEST", 25, 28], ["PCR RUO assay", "TEST", 34, 47], ["SARS", "PROBLEM", 96, 100]]], ["It can be used in most laboratories with various extraction and realtime PCR platforms.", [["various extraction", "TREATMENT", 41, 59], ["realtime PCR platforms", "TEST", 64, 86]]], ["To date, RT-PCR assays remain the methods of choice for COVID-19 diagnosis even if it can lack of sensitivity in swab samples from some patients, mostly presenting late stage diseases and for which chest CT or other respiratory samples can be of valuable help [11] [12] [13] .", [["swab samples", "ANATOMY", 113, 125], ["chest", "ANATOMY", 198, 203], ["respiratory samples", "ANATOMY", 216, 235], ["swab samples", "CANCER", 113, 125], ["patients", "ORGANISM", 136, 144], ["patients", "SPECIES", 136, 144], ["RT-PCR assays", "TEST", 9, 22], ["COVID", "TEST", 56, 61], ["sensitivity", "PROBLEM", 98, 109], ["swab samples", "TEST", 113, 125], ["late stage diseases", "PROBLEM", 164, 183], ["chest CT", "TEST", 198, 206], ["other respiratory samples", "TEST", 210, 235], ["late stage", "OBSERVATION_MODIFIER", 164, 174], ["diseases", "OBSERVATION", 175, 183], ["chest", "ANATOMY", 198, 203]]], ["This point also highlights the necessity of having highly sensitive PCR assays and the critical importance of checking and comparing their performances.", [["highly sensitive PCR assays", "PROBLEM", 51, 78]]], ["If the RealStar\u00ae SARS-CoV-2 assay will not fulfil all our needs, especially for high-throughput and highly automatized assays, it provides a robust, versatile and sensitive options for all molecular biology laboratories.", [["the RealStar\u00ae SARS", "TEST", 3, 21], ["CoV", "TEST", 22, 25]]]], "426480f16ca570349b07798d2fb36f14442ce79e": [["IntroductionTraditional machine learning algorithms assume that the number of instances belonging to problem classes is relatively similar.", [["Traditional machine learning algorithms", "TREATMENT", 12, 51], ["relatively", "OBSERVATION_MODIFIER", 120, 130], ["similar", "OBSERVATION_MODIFIER", 131, 138]]], ["However, it is worth noting that in many real problems the size of one class (majority class) may significantly exceed the size of the second one (minority class).", [["size", "OBSERVATION_MODIFIER", 59, 63], ["size", "OBSERVATION_MODIFIER", 123, 127]]], ["This makes the algorithms biased towards the majority class, although the correct recognition of less common class is often more important.", [["less common", "OBSERVATION_MODIFIER", 97, 108]]], ["This research trend is known as learning from imbalanced data [8] and it is still widely discussed in scientific works.IntroductionThere are three main approaches to dealing with the imbalanced data classification:Introduction-Data-level methods focusing on modifying the training set in such a way that it becomes suitable for classic learning algorithms (e.g., oversampling and undersampling).Introduction-Algorithm-level methods that modify existing classification algorithms to offset their bias towards the majority class. -Hybrid methods combining the strengths of the previously mentioned approaches.IntroductionMany works on imbalanced data classification employ classifier ensembles [16] .", [["modifying the training", "TREATMENT", 258, 280], ["classic learning algorithms", "TEST", 328, 355], ["Algorithm-level methods", "TREATMENT", 408, 431], ["Hybrid methods", "TREATMENT", 529, 543]]], ["This is based on the assumption that each of the base classifiers is an expert in a different region of the feature space.", [["base", "ANATOMY_MODIFIER", 49, 53], ["feature space", "OBSERVATION", 108, 121]]], ["The classification of each unknown sample by des involves three steps:Introduction-Definition of the region of competence; that is, how to define the local region surrounding the unknown sample, in which the competence level of the base models is estimated.", [["base", "ANATOMY_MODIFIER", 232, 236]]], ["This local region of competence is found in the dynamic selection dataset (dsel), which is usually part of the training set. -Defining the selection criterion later used to assess the competence of the base classifiers in the local region of competence (e.g., accuracy or diversity). -Determination of the selection mechanism deciding whether we choose a single classifier or an ensemble.IntroductionPrevious work related to the imbalanced data classification using classifier ensembles and des involves various approaches.", [["the selection criterion", "TEST", 135, 158], ["the base classifiers", "TREATMENT", 198, 218]]], ["Ksieniewicz in [9] proposed an Undersampled Majority Class Ensemble (umce) employing different combination methods and pruning, based on a k -fold division of the majority class to divide an imbalanced problem into many balanced ones.", [["different combination methods", "TREATMENT", 85, 114], ["a k -fold division", "TREATMENT", 137, 155], ["an imbalanced problem", "PROBLEM", 188, 209], ["imbalanced", "OBSERVATION", 191, 201]]], ["Chen et al. [4] presented the Dynamic Ensemble Selection Decision-making (desd) algorithm to select the most appropriate classifiers using a weighting mechanism to highlight the base models that are better suited for recognizing the minority class.", [["algorithm", "TREATMENT", 80, 89], ["a weighting mechanism", "TREATMENT", 139, 160]]], ["Zyblewski et al. in [17] proposed the Minority Driven Ensemble (mde) for highly imbalanced data streams classification and Roy et al. in [14] combined preprocessing with dynamic ensemble selection to classify both binary and multiclass stationary imbalanced datasets.IntroductionThe main contributions of this work are as follows:Introduction-The proposition of the new dynamic selection methods adapted for the classification of highly imbalanced data. -Experimental evaluation of the proposed algorithms based on a high number of diverse benchmark datasets and a detailed comparison with the state-of-art approaches.Dynamic Ensemble Selection Based on Imbalance Ratio and Euclidean DistanceThis paper proposes two algorithms for dynamic classifier selection for the imbalanced data classification problem.", [["combined preprocessing", "TREATMENT", 142, 164], ["dynamic ensemble selection", "TREATMENT", 170, 196], ["the new dynamic selection methods", "TREATMENT", 362, 395], ["Experimental evaluation", "TEST", 455, 478], ["the proposed algorithms", "TEST", 482, 505], ["Dynamic Ensemble Selection", "TREATMENT", 618, 644], ["dynamic classifier selection", "TREATMENT", 731, 759], ["the imbalanced data classification problem", "PROBLEM", 764, 806], ["main", "OBSERVATION_MODIFIER", 283, 287]]], ["These are respectively the Dynamic Ensemble Selection using Euclidean distance (dese) and the Dynamic Ensemble Selection using Imbalance Ratio and Euclidean distance (desire).", [["Imbalance Ratio", "TREATMENT", 127, 142]]], ["The generation of the classifier pool is based on the Bagging approach [2] , and more specifically on the Stratified Bagging, in which the samples are drawn with replacement from the minority and majority class separately in such a way that each bootstrap maintains the original training set class proportion.", [["the Bagging approach", "TREATMENT", 50, 70], ["the Stratified Bagging", "TREATMENT", 102, 124], ["the samples", "TEST", 135, 146], ["replacement", "TREATMENT", 162, 173]]], ["This is necessary due to the high imbalance, which in the case of standard bagging can lead to the generation of training sets containing only the majority class.Dynamic Ensemble Selection Based on Imbalance Ratio and Euclidean DistanceBoth proposed methods are derived in part from algorithms based on local oracles, and more specifically on knora-u [7] , which gives base classifiers weights based on the number of correctly classified instances in the local region of competence and then combines them by weighted majority voting.", [["the high imbalance", "PROBLEM", 25, 43], ["standard bagging", "TREATMENT", 66, 82], ["training sets", "TREATMENT", 113, 126], ["Dynamic Ensemble Selection", "TREATMENT", 162, 188], ["Imbalance Ratio", "TREATMENT", 198, 213], ["Euclidean DistanceBoth proposed methods", "TREATMENT", 218, 257], ["high", "OBSERVATION_MODIFIER", 29, 33], ["imbalance", "OBSERVATION", 34, 43]]], ["The computational cost in this type of method is mainly related to the size of the classifier pool and the dsel size, as the k -nearest neighbors technique is used to define local competence regions, which can be costly for large datasets.", [["the k -nearest neighbors technique", "TREATMENT", 121, 155], ["large datasets", "PROBLEM", 224, 238], ["computational", "OBSERVATION_MODIFIER", 4, 17], ["cost", "OBSERVATION", 18, 22], ["size", "OBSERVATION_MODIFIER", 71, 75], ["size", "OBSERVATION_MODIFIER", 112, 116]]], ["Instead of hard voting, dese and desire are based on the probabilities returned by the base models and they calculate weights for each classifier for both the minority and majority classes separately.Dynamic Ensemble Selection Based on Imbalance Ratio and Euclidean DistanceProposed methods come in two variants: Correct (denoted as C ), where weights are modified only in the case of correct classification, and All (denoted as A), where, in addition to correct decisions, weights are also affected by incorrect ones.", [["Dynamic Ensemble Selection", "TREATMENT", 200, 226], ["Imbalance Ratio", "TEST", 236, 251], ["Euclidean DistanceProposed methods", "TREATMENT", 256, 290]]], ["The exact way of weights calculation is presented in Algorithm 1.Dynamic Ensemble Selection Based on Imbalance Ratio and Euclidean DistanceFor each instance, the proposed algorithms perform the following steps:Dynamic Ensemble Selection Based on Imbalance Ratio and Euclidean Distance-In step 2, the k -nearest neighbors of a given instance are found in dsel, which form the local region of competence lrc. -In step 4, each classifier \u03a8 j from the pool classifies all samples belonging to lrc. -In steps 5-13, the classifier weights are modified separately for the minority and majority class, starting from the value of 0.", [["samples", "ANATOMY", 468, 475], ["lrc", "GENE_OR_GENE_PRODUCT", 402, 405], ["lrc", "GENE_OR_GENE_PRODUCT", 489, 492], ["lrc", "DNA", 402, 405], ["\u03a8 j", "DNA", 435, 438], ["lrc", "PROTEIN", 489, 492], ["weights calculation", "TEST", 17, 36], ["Dynamic Ensemble Selection", "TREATMENT", 65, 91], ["Imbalance Ratio", "TEST", 246, 261], ["Euclidean Distance", "TEST", 266, 284], ["lrc", "ANATOMY", 489, 492]]], ["In the case of dese, the modifications are based on the Euclidean distance between the classified sample and its neighbor from the local competence region, and in the case of desire, the Euclidean distance is additionally scaled by a percentage of the minority or majority class in such a way that more emphasis is placed on the minority class.Dynamic Ensemble Selection Based on Imbalance Ratio and Euclidean DistanceFinally, the weights obtained from dese or desire are normalized to the [0, 1] range and multiplied by the ensemble support matrix.", [["matrix", "CELLULAR_COMPONENT", 542, 548], ["Imbalance Ratio", "TEST", 380, 395], ["the weights", "TEST", 427, 438]]], ["The choice of this combination rule was dictated by a small number of instances in the datasets, which significantly reduces the risk of base classifiers overfitting.Dynamic Ensemble Selection Based on Imbalance Ratio and Euclidean DistanceAlgorithm 1: Pseudocode of the proposed weight calculation methods assuming that the minority class is positive and the majority class is negative.Experimental EvaluationThis section presents the details of the experimental study, the datasets used and the results that the proposed approaches have achieved compared to the state-of-art methods.Experimental Set-UpThe main goal of the following experiments was to compare the performance of proposed dynamic selection methods, designed specifically for the task of imbalanced data classification, with the state-of-art ensemble methods paired with preprocessing.", [["base classifiers overfitting", "PROBLEM", 137, 165], ["Imbalance Ratio", "TEST", 202, 217], ["Experimental Evaluation", "TEST", 387, 410], ["the experimental study", "TEST", 447, 469], ["small", "OBSERVATION_MODIFIER", 54, 59], ["base classifiers", "OBSERVATION", 137, 153], ["positive", "OBSERVATION", 343, 351], ["negative", "OBSERVATION", 378, 386], ["main", "OBSERVATION_MODIFIER", 608, 612]]], ["The evaluation in each of the experiments is based on 5 metrics commonly used to assess the quality of classification for imbalanced problems.", [["The evaluation", "TEST", 0, 14], ["imbalanced problems", "PROBLEM", 122, 141]]], ["These are F1 score [15] , precision and recall [13] , G-mean [11] and balanced accuracy score (bac) [3] according to the stream-learn [10] implementation.", [["G-mean", "TEST", 54, 60]]], ["All experiments have been implanted in Python and can be repeated using the code on Github 1 .Experimental Set-UpAs the base models three popular classifiers, according to the scikit-learn [12] implementation, were selected, i.e. Gaussian Naive Bayes (gnb), Classification and Regression Trees (cart) and k-Nearest Neighbors classifier (knn).", [["implanted", "OBSERVATION_MODIFIER", 26, 35]]], ["The fixed size of the classifier pool has been determined successively as 5, 15, 30 and 50 base models.", [["fixed", "OBSERVATION_MODIFIER", 4, 9], ["size", "OBSERVATION_MODIFIER", 10, 14], ["classifier pool", "OBSERVATION", 22, 37]]], ["The evaluation was carried out using 10 times repeated 5-fold crossvalidation.", [["The evaluation", "TEST", 0, 14]]], ["Due to the small number of instances in the datasets, dsel is defined as the entire training set.Experimental Set-UpThe experiments were carried out on 41 datasets from the keel repository [1] , which contain binary problems created through various combinations of class merging.", [["binary problems", "PROBLEM", 209, 224], ["small", "OBSERVATION_MODIFIER", 11, 16], ["number", "OBSERVATION_MODIFIER", 17, 23]]], ["All datasets have a high imbalance ratio of at least 9.", [["a high imbalance ratio", "PROBLEM", 18, 40]]], ["As a reference method, a single classifier, as well as stratified bagging and dynamic selection in the form of the knora-u algorithm were selected.Experimental Set-UpThe radar diagrams show the average global ranks achieved by each of the tested algorithms in terms of each of the 5 evaluation metrics, while the tables show the results of the Wilcoxon signed-rank (p = 0.05) statistical test for a pool size of 5 base classifiers.", [["Set-Up", "DNA", 160, 166], ["stratified bagging", "TREATMENT", 55, 73], ["dynamic selection", "TREATMENT", 78, 95], ["the knora-u algorithm", "TEST", 111, 132], ["The radar diagrams", "TEST", 166, 184], ["the tested algorithms", "TEST", 235, 256], ["the 5 evaluation metrics", "TEST", 277, 301], ["statistical test", "TEST", 376, 392], ["a pool size of 5 base classifiers", "TREATMENT", 397, 430]]], ["The numbers under the average rank of each method indicate the algorithms which are statistically significantly worse than the one in question.", [["numbers", "OBSERVATION_MODIFIER", 4, 11]]], ["The complete results for each of the 41 datasets and the full statistical analysis can be found on the Github 2 .Experiment 1 -Euclidean Distance-Based ApproachIn Fig. 1 we can see how the average ranks for dese and reference methods changed in terms of different metrics depending on the ensemble size.", [["the full statistical analysis", "TEST", 53, 82], ["size", "OBSERVATION_MODIFIER", 298, 302]]], ["We can see that the proposed methods (especially odese-c) for 5 base models achieve higher rankings in terms of each metric with an exception of recall.", [["odese-c", "GENE_OR_GENE_PRODUCT", 49, 56], ["5 base models", "TREATMENT", 62, 75]]], ["While the single classifier and bagging are preferring recall, odese-c and dese-c prefer precision.", [["odese-c", "GENE_OR_GENE_PRODUCT", 63, 70], ["dese-c", "GENE_OR_GENE_PRODUCT", 75, 81], ["odese", "DNA", 63, 68]]], ["As the number of base classifiers increases, bac and G-mean-based rankings deteriorate to knora-u level, while the F1 score remains high due to high precision.", [["base classifiers", "TEST", 17, 33], ["bac", "TEST", 45, 48], ["the F1 score", "TEST", 111, 123], ["base", "ANATOMY_MODIFIER", 17, 21]]], ["Table 2 presents the results of the statistical analysis, which shows that the odese-c method performs statistically significantly better than all reference methods in terms of each metric except for recall.Experiment 1 -Euclidean Distance-Based ApproachWhen the base classifier is cart, as seen in Fig. 2 , for the smallest pool, dese-c (both without and with oversampling) achieves higher ranks than the reference methods in terms of each of the five metrics.", [["dese-c", "GENE_OR_GENE_PRODUCT", 331, 337], ["odese", "DNA", 79, 84], ["the statistical analysis", "TEST", 32, 56], ["the smallest pool", "PROBLEM", 312, 329]]], ["Along with the increase in the number of classifiers, we can observe that while oknora-u and osb stand out in terms of precision, odese-c performs better in terms of other metrics, and odese-a, despite the low F1 score and precision, achieves the highest average ranks in terms of bac, G-mean and recall.", [["odese-c", "GENE_OR_GENE_PRODUCT", 130, 137], ["osb", "DNA", 93, 96], ["odese", "DNA", 130, 135], ["increase", "OBSERVATION_MODIFIER", 15, 23]]], ["Table 3 confirms that for the five base classifiers, odese-c is statistically significantly better than all reference methods, while odese-a performs statistically significantly better than odese-c in terms of recall, G-mean and bac.", [["odese-c", "GENE_OR_GENE_PRODUCT", 53, 60], ["odese-c", "GENE_OR_GENE_PRODUCT", 190, 197], ["odese-c", "DNA", 53, 60], ["odese", "PROTEIN", 190, 195]]], ["Together with the increase in the base classifier number, knora-u and osb achieve higher average ranks than odese-c and odese-a.Experiment 2 -Scaled Euclidean Distance-Based ApproachThe results below show the average ranks for the proposed desire method, which calculates weights based on Euclidean distances scaled by the percentages of the minority and majority classes in the training set.Experiment 2 -Scaled Euclidean Distance-Based ApproachIn the case of gnb as the base model (Fig. 4) , the odesire-c method achieves the best results compared to reference methods in terms of mean ranks based on F1 score, precision, G-mean and bac.", [["odese-c", "GENE_OR_GENE_PRODUCT", 108, 115], ["knora-u and osb", "DNA", 58, 73], ["odese", "DNA", 108, 113], ["odese", "DNA", 120, 125], ["gnb", "DNA", 461, 464], ["the odesire-c method", "TREATMENT", 494, 514], ["precision", "TEST", 613, 622], ["increase", "OBSERVATION_MODIFIER", 18, 26]]], ["When the ensemble size increases, the proposed method is equal to oknora-u in terms of bac and G-mean but retains the advantage in terms of F1 score and precision.", [["size", "OBSERVATION_MODIFIER", 18, 22], ["increases", "OBSERVATION_MODIFIER", 23, 32]]], ["Also, the more base classifiers the smaller the differences between desire using preprocessing and the version without it.", [["preprocessing and the version", "TREATMENT", 81, 110], ["base", "ANATOMY_MODIFIER", 15, 19], ["smaller", "OBSERVATION_MODIFIER", 36, 43]]], ["Table 5 presents the results of the statistical analysis, which shows that odesire-c is statistically better than all reference methods when the number of base classifiers is low.", [["odesire-c", "GENE_OR_GENE_PRODUCT", 75, 84], ["the statistical analysis", "TEST", 32, 56], ["low", "OBSERVATION_MODIFIER", 175, 178]]], ["Figure 5 shows that for a small classifier pool, odesire-c achieves higher ranks than reference methods in terms of each evaluation metric, and as the classifier number increases, it loses significantly in precision compared to osb and oknora-u. odesire-a has a high recall, which unfortunately is reflected by the lowest precision and F1 score.", [["odesire-c", "GENE_OR_GENE_PRODUCT", 49, 58], ["a small classifier pool", "PROBLEM", 24, 47], ["each evaluation", "TEST", 116, 131]]], ["In Table 6 we see that for 5 base classifiers, dsire-c both with and without preprocessing is statistically significantly better than reference methods in terms of all metrics except one, G-mean in the case desire-c and recall for odesire-c.Experiment 2 -Scaled Euclidean Distance-Based ApproachWhen the base classifier is knn (Fig. 6) , as in the case of dese, odesire-c is not statistically worse than osb and oknora-u (Table 7) and as the number of classifiers in the pool increases, the average global ranks significantly deteriorate compared to reference methods.Lessons LearnedThe presented results confirmed that dynamic selection methods adapted specifically for the imbalanced data classification can achieve statistically better results than state-of-art ensemble methods coupled with preprocessing, especially when the pool of base classifiers is relatively small.", [["dsire-c", "GENE_OR_GENE_PRODUCT", 47, 54], ["odesire-c", "GENE_OR_GENE_PRODUCT", 231, 240], ["odesire-c", "GENE_OR_GENE_PRODUCT", 362, 371], ["odesire", "PROTEIN", 231, 238], ["5 base classifiers", "TREATMENT", 27, 45], ["dynamic selection methods", "TREATMENT", 620, 645], ["preprocessing", "TREATMENT", 795, 808], ["relatively", "OBSERVATION_MODIFIER", 858, 868], ["small", "OBSERVATION_MODIFIER", 869, 874]]], ["This may be due to the fact that bagging has not yet stabilized, while the proposed method chooses the best single classifier.", [["bagging", "TREATMENT", 33, 40], ["may be due to", "UNCERTAINTY", 5, 18], ["bagging", "OBSERVATION", 33, 40]]], ["The Correct approach in which the weights of the models were changed only if the instances belonging to the local competence region were correctly classified, proved to be more balanced in terms of all 5 evaluation measures.", [["all 5 evaluation measures", "TEST", 198, 223]]], ["This may indicate too high weight penalties with incorrect classification in the All approach.", [["too high weight penalties", "PROBLEM", 18, 43]]], ["When knn is used as the base classifier, with a small pool the proposed methods performed statistically similar to knora-u, and with a larger number of classifiers, achieved statistically inferior rank compared to the reference methods.", [["knn", "DNA", 5, 8], ["knora-u", "CELL_LINE", 115, 122]]], ["This may be probably due to the support calculation method in the knn, which is not suitable for the algorithms proposed in this work.", [["may be probably due to", "UNCERTAINTY", 5, 27]]], ["For gnb and cart, dese-c and desire-c achieved results which are statistically better than or similar to the reference methods, often without the use of preprocessing, since it has a built-in mechanism to deal with the imbalance.ConclusionsThe main purpose of this work was to propose a novel solution based on dynamic classifier selection for imbalanced data classification problem.", [["dese-c", "GENE_OR_GENE_PRODUCT", 18, 24], ["gnb", "PROBLEM", 4, 7], ["preprocessing", "TREATMENT", 153, 166], ["the imbalance", "PROBLEM", 215, 228], ["a novel solution", "TREATMENT", 285, 301], ["dynamic classifier selection", "TREATMENT", 311, 339], ["imbalanced data classification problem", "PROBLEM", 344, 382], ["imbalance", "OBSERVATION", 219, 228], ["main", "OBSERVATION_MODIFIER", 244, 248]]], ["Research conducted on benchmark datasets and statistical analysis confirmed the usefulness of proposed methods, especially when there is a need to maintain a relatively low number of classifiers.", [["benchmark datasets", "TEST", 22, 40], ["statistical analysis", "TEST", 45, 65]]], ["Future work may involve the exploration of different approaches to the base classifiers' weighting, as well as using different combination methods and the use of proposed methods for the imbalanced data stream classification.", [["the exploration", "TEST", 24, 39], ["different combination methods", "TREATMENT", 117, 146], ["proposed methods", "TREATMENT", 162, 178]]]], "PMC6027237": [], "PMC6499054": [["IntroductionPorcine epidemic diarrhea virus (PEDV) contributes to enteropathogenic diarrhea, especially among suckling piglets, and causes significant economic loss to the swine industry worldwide (Choudhury et al., 2016; Jung & Saif, 2015).", [["IntroductionPorcine epidemic diarrhea", "DISEASE", 0, 37], ["enteropathogenic diarrhea", "DISEASE", 66, 91], ["IntroductionPorcine epidemic diarrhea virus", "ORGANISM", 0, 43], ["piglets", "ORGANISM", 119, 126], ["diarrhea virus", "SPECIES", 29, 43], ["piglets", "SPECIES", 119, 126], ["swine", "SPECIES", 172, 177], ["IntroductionPorcine epidemic diarrhea virus", "SPECIES", 0, 43], ["PEDV", "SPECIES", 45, 49], ["swine", "SPECIES", 172, 177], ["IntroductionPorcine epidemic diarrhea virus", "PROBLEM", 0, 43], ["PEDV", "PROBLEM", 45, 49], ["enteropathogenic diarrhea", "PROBLEM", 66, 91], ["significant economic loss", "PROBLEM", 139, 164], ["enteropathogenic", "OBSERVATION_MODIFIER", 66, 82], ["diarrhea", "OBSERVATION", 83, 91], ["significant", "OBSERVATION_MODIFIER", 139, 150], ["economic loss", "OBSERVATION", 151, 164]]], ["PEDV-infected pigs experience watery diarrhea, vomiting and severe dehydration, which leads to 50\u201390% mortality among susceptible piglets (Madson et al., 2014; Shibata et al., 2000).", [["PEDV", "CHEMICAL", 0, 4], ["watery diarrhea", "DISEASE", 30, 45], ["vomiting", "DISEASE", 47, 55], ["dehydration", "DISEASE", 67, 78], ["PEDV", "ORGANISM", 0, 4], ["pigs", "ORGANISM", 14, 18], ["piglets", "ORGANISM", 130, 137], ["pigs", "SPECIES", 14, 18], ["piglets", "SPECIES", 130, 137], ["PEDV", "SPECIES", 0, 4], ["pigs", "SPECIES", 14, 18], ["PEDV", "PROBLEM", 0, 4], ["watery diarrhea", "PROBLEM", 30, 45], ["vomiting", "PROBLEM", 47, 55], ["severe dehydration", "PROBLEM", 60, 78], ["infected", "OBSERVATION_MODIFIER", 5, 13], ["severe", "OBSERVATION_MODIFIER", 60, 66], ["dehydration", "OBSERVATION", 67, 78]]], ["Transmission is frequently fecal-oral, but infections via airborne and fomites have been documented (Alonso et al., 2014; Lowe et al., 2014; Sasaki et al., 2016).IntroductionPorcine epidemic diarrhea virus is a single-stranded positive-sense RNA virus belonging to the family Coronaviridae and the genus Alphacoronavirus (Lin et al., 2016).", [["oral", "ANATOMY", 33, 37], ["infections", "DISEASE", 43, 53], ["diarrhea", "DISEASE", 191, 199], ["fecal", "ORGANISM_SUBDIVISION", 27, 32], ["oral", "ORGANISM_SUBDIVISION", 33, 37], ["IntroductionPorcine epidemic diarrhea virus", "ORGANISM", 162, 205], ["Coronaviridae", "GENE_OR_GENE_PRODUCT", 276, 289], ["epidemic diarrhea virus", "SPECIES", 182, 205], ["IntroductionPorcine epidemic diarrhea virus", "SPECIES", 162, 205], ["infections", "PROBLEM", 43, 53], ["IntroductionPorcine epidemic diarrhea virus", "PROBLEM", 162, 205], ["a single-stranded positive-sense RNA virus", "PROBLEM", 209, 251], ["infections", "OBSERVATION", 43, 53], ["diarrhea virus", "OBSERVATION", 191, 205], ["genus Alphacoronavirus", "ANATOMY", 298, 320]]], ["PEDV genome encodes the replicase polyprotein 1a and 1b (processed into 16 non-structural proteins nsp1\u2013nsp16), spike (S), open reading frame 3 (ORF3), envelope (E), membrane (M), and nucleocapsid (N) (Song & Park, 2012).", [["membrane", "ANATOMY", 166, 174], ["replicase polyprotein 1a", "GENE_OR_GENE_PRODUCT", 24, 48], ["1b", "GENE_OR_GENE_PRODUCT", 53, 55], ["nsp1\u2013nsp16", "GENE_OR_GENE_PRODUCT", 99, 109], ["open reading frame 3", "GENE_OR_GENE_PRODUCT", 123, 143], ["ORF3", "GENE_OR_GENE_PRODUCT", 145, 149], ["envelope (E)", "GENE_OR_GENE_PRODUCT", 152, 164], ["membrane", "CELLULAR_COMPONENT", 166, 174], ["PEDV genome", "DNA", 0, 11], ["replicase polyprotein 1a and 1b", "PROTEIN", 24, 55], ["structural proteins", "PROTEIN", 79, 98], ["nsp1\u2013nsp16", "PROTEIN", 99, 109], ["spike (S)", "PROTEIN", 112, 121], ["open reading frame 3", "DNA", 123, 143], ["ORF3", "DNA", 145, 149], ["PEDV", "SPECIES", 0, 4], ["structural proteins nsp1\u2013nsp", "TEST", 79, 107], ["spike (S)", "PROBLEM", 112, 121], ["open reading frame", "TEST", 123, 141]]], ["The most widely-accepted classification of PEDV is based on the S gene sequence, which categorizes PEDV genotypes into two genogroups (G1 and G2).", [["PEDV", "CANCER", 43, 47], ["PEDV", "GENE_OR_GENE_PRODUCT", 99, 103], ["PEDV", "DNA", 43, 47], ["S gene sequence", "DNA", 64, 79], ["PEDV", "PROBLEM", 43, 47], ["most widely", "OBSERVATION_MODIFIER", 4, 15], ["PEDV", "OBSERVATION", 43, 47]]], ["Each genogroup is further sub-divided into subgroups (G1a, G1b, G2a, and G2b).", [["G1b", "GENE_OR_GENE_PRODUCT", 59, 62], ["G2a", "GENE_OR_GENE_PRODUCT", 64, 67], ["G2b", "GENE_OR_GENE_PRODUCT", 73, 76], ["further sub", "PROBLEM", 18, 29]]], ["Classical strains are designated G1a, while the new variant strains (S INDEL) strains belong to G1b.", [["G1a", "GENE_OR_GENE_PRODUCT", 33, 36], ["G1b", "GENE_OR_GENE_PRODUCT", 96, 99], ["G1a", "DNA", 33, 36], ["G1b", "DNA", 96, 99], ["Classical strains", "PROBLEM", 0, 17], ["the new variant strains (S INDEL) strains", "PROBLEM", 44, 85], ["strains", "OBSERVATION", 10, 17]]], ["The highly virulent Asian and North American strains are designated G2a and G2b, respectively (Lin et al., 2016).", [["highly", "OBSERVATION_MODIFIER", 4, 10], ["virulent", "OBSERVATION_MODIFIER", 11, 19]]], ["The original PEDV (represented by the prototypic CV777 strain) was first reported in the 1970s in Europe and was associated with high morbidity and mortality among infected pigs (Pensaert & De Bouck, 1978).IntroductionThe S INDEL strains were first reported in the U.S. in 2014 and were subsequently introduced to Asia and Europe.", [["pigs", "ORGANISM", 173, 177], ["pigs", "SPECIES", 173, 177], ["pigs", "SPECIES", 173, 177], ["high morbidity", "PROBLEM", 129, 143], ["The S INDEL strains", "PROBLEM", 218, 237], ["PEDV", "OBSERVATION", 13, 17]]], ["These strains contain insertions and deletions in the N-terminal region of the S protein (S1 region) compared to the prototype CV777.", [["N", "CHEMICAL", 54, 55], ["N-terminal region", "DNA", 54, 71], ["S protein", "PROTEIN", 79, 88], ["S1 region", "PROTEIN", 90, 99], ["CV777", "PROTEIN", 127, 132], ["These strains contain insertions and deletions", "PROBLEM", 0, 46], ["insertions", "OBSERVATION_MODIFIER", 22, 32], ["terminal", "ANATOMY_MODIFIER", 56, 64], ["region", "ANATOMY_MODIFIER", 65, 71], ["S protein", "ANATOMY_MODIFIER", 79, 88], ["S1", "ANATOMY", 90, 92], ["region", "ANATOMY_MODIFIER", 93, 99]]], ["One-third of the S gene among the new variants G1b shared greater than 95% identity to the classical G1a strain, while the remaining two-thirds possessed greater than 99% similarity to highly virulent G2 strains.", [["G1b", "GENE_OR_GENE_PRODUCT", 47, 50], ["G1a", "GENE_OR_GENE_PRODUCT", 101, 104], ["S gene", "DNA", 17, 23], ["G1b", "DNA", 47, 50], ["highly virulent G2 strains", "PROBLEM", 185, 211], ["new", "OBSERVATION_MODIFIER", 34, 37], ["virulent", "OBSERVATION_MODIFIER", 192, 200], ["G2 strains", "OBSERVATION", 201, 211]]], ["Therefore, S INDEL variants resemble recombination strains between G1a and G2 (Huang et al., 2013; Wang et al., 2014).", [["S INDEL", "GENE_OR_GENE_PRODUCT", 11, 18], ["S INDEL variants", "DNA", 11, 27]]], ["Infection by some S-INDEL variants was reported to produce decreased symptom severity including moderate diarrhea, lower titers of viral shedding, and reduced mortality (Murakami et al., 2015; Vlasova et al., 2014).", [["diarrhea", "DISEASE", 105, 113], ["Infection", "PROBLEM", 0, 9], ["some S-INDEL variants", "PROBLEM", 13, 34], ["decreased symptom severity", "PROBLEM", 59, 85], ["moderate diarrhea", "PROBLEM", 96, 113], ["lower titers of viral shedding", "PROBLEM", 115, 145], ["reduced mortality", "PROBLEM", 151, 168], ["INDEL variants", "OBSERVATION", 20, 34], ["decreased", "OBSERVATION_MODIFIER", 59, 68], ["moderate", "OBSERVATION_MODIFIER", 96, 104], ["diarrhea", "OBSERVATION", 105, 113], ["lower titers", "OBSERVATION_MODIFIER", 115, 127]]], ["The highly virulent G2 strains caused an epidemic in Asia and have been identified in North America and elsewhere around the world (Lee, 2015).IntroductionThailand has a major pork production industry in Southeast Asia.", [["pork", "ORGANISM_SUBDIVISION", 176, 180], ["The highly virulent G2 strains", "PROBLEM", 0, 30], ["highly", "OBSERVATION_MODIFIER", 4, 10], ["virulent", "OBSERVATION_MODIFIER", 11, 19], ["G2 strains", "OBSERVATION", 20, 30], ["epidemic", "OBSERVATION_MODIFIER", 41, 49]]], ["Despite improved animal husbandry, farm management, vaccination, and boosting of lactogenic immunity, PEDV outbreaks continue to occur on Thai swine farms.", [["swine", "SPECIES", 143, 148], ["PEDV", "SPECIES", 102, 106], ["Thai swine", "SPECIES", 138, 148], ["farm management", "TREATMENT", 35, 50], ["vaccination", "TREATMENT", 52, 63], ["lactogenic immunity", "TREATMENT", 81, 100], ["PEDV outbreaks", "PROBLEM", 102, 116]]], ["Loss of piglets due to PEDV infection necessitates constant epidemiological surveillance to effectively monitor transmission.", [["PEDV", "CHEMICAL", 23, 27], ["infection", "DISEASE", 28, 37], ["piglets", "ORGANISM", 8, 15], ["piglets", "SPECIES", 8, 15], ["PEDV", "SPECIES", 23, 27], ["Loss of piglets", "PROBLEM", 0, 15], ["PEDV infection", "PROBLEM", 23, 37], ["constant epidemiological surveillance", "TEST", 51, 88], ["PEDV", "OBSERVATION_MODIFIER", 23, 27], ["infection", "OBSERVATION", 28, 37]]], ["To determine the genetic relationship among the current and past PEDV strains in Thailand compared to the global strains, we characterized the S, ORF3, and N genes and evaluated the deduced amino acid sequence variations in 95 PEDV strains from commercial swine farms throughout the country.Samples ::: Materials and MethodsA total of 769 samples were submitted to the Livestock Animal Hospital of the Faculty of Veterinary Science, Chulalongkorn University in Nakhon Pathom province between May 2011 and August 2016.", [["samples", "ANATOMY", 339, 346], ["amino acid", "CHEMICAL", 190, 200], ["amino acid", "CHEMICAL", 190, 200], ["ORF3", "GENE_OR_GENE_PRODUCT", 146, 150], ["amino acid", "AMINO_ACID", 190, 200], ["samples", "CANCER", 339, 346], ["S, ORF3, and N genes", "DNA", 143, 163], ["swine", "SPECIES", 256, 261], ["PEDV", "SPECIES", 227, 231], ["swine", "SPECIES", 256, 261], ["past PEDV strains", "PROBLEM", 60, 77], ["ORF3", "TEST", 146, 150], ["the deduced amino acid sequence variations", "PROBLEM", 178, 220], ["PEDV strains", "PROBLEM", 227, 239]]], ["These represent archived and convenient samples from 123 commercial pig farms located throughout Thailand (Fig. S1).", [["samples", "ANATOMY", 40, 47], ["pig", "ORGANISM", 68, 71], ["S1", "GENE_OR_GENE_PRODUCT", 112, 114], ["S1", "PROTEIN", 112, 114], ["pig", "SPECIES", 68, 71], ["pig", "SPECIES", 68, 71], ["convenient samples", "TEST", 29, 47], ["commercial pig farms", "TREATMENT", 57, 77]]], ["Most of the samples were primarily submitted from the central part of Thailand where the majority of swine farms are located.", [["samples", "ANATOMY", 12, 19], ["swine", "ORGANISM", 101, 106], ["farms", "ORGANISM_SUBDIVISION", 107, 112], ["swine", "SPECIES", 101, 106], ["swine", "SPECIES", 101, 106], ["the samples", "TEST", 8, 19], ["central", "ANATOMY_MODIFIER", 54, 61], ["swine farms", "OBSERVATION", 101, 112]]], ["Samples were from western provinces (Kanchanaburi, Prachuap Khiri Khan, Phetchaburi, and Ratchaburi; n = 316), central provinces (Lop Buri, Samut Songkhram, Suphan Buri, Saraburi, Phra Nakhon Si Ayutthaya, and Nakhon Pathom; n = 173), eastern provinces (Chon Buri and Chachoengsao, n = 109), northeastern provinces (Ubon Ratchathani, Udon Thani, and Nakhon Ratchasima, n = 80), southern provinces (Trang and Nakhon Si Thammarat, n = 26), and from unspecified locations (n = 65).Samples ::: Materials and MethodsFeces (n = 509) and small intestinal content (intestinal mucosa of the duodenum and upper part of jejunum from tissues scraping, n = 260) from diarrheic pigs were prepared as 10% (w/v) suspension in sterile phosphate buffered saline.", [["intestinal", "ANATOMY", 537, 547], ["intestinal mucosa", "ANATOMY", 557, 574], ["duodenum", "ANATOMY", 582, 590], ["upper part", "ANATOMY", 595, 605], ["jejunum", "ANATOMY", 609, 616], ["tissues", "ANATOMY", 622, 629], ["phosphate", "CHEMICAL", 718, 727], ["phosphate", "CHEMICAL", 718, 727], ["intestinal", "ORGAN", 537, 547], ["intestinal mucosa", "MULTI-TISSUE_STRUCTURE", 557, 574], ["duodenum", "MULTI-TISSUE_STRUCTURE", 582, 590], ["upper part", "ORGANISM_SUBDIVISION", 595, 605], ["jejunum", "MULTI-TISSUE_STRUCTURE", 609, 616], ["tissues", "TISSUE", 622, 629], ["pigs", "ORGANISM", 664, 668], ["phosphate buffered saline", "SIMPLE_CHEMICAL", 718, 743], ["pigs", "SPECIES", 664, 668], ["pigs", "SPECIES", 664, 668], ["central provinces (Lop Buri", "TREATMENT", 111, 138], ["Samut Songkhram", "TREATMENT", 140, 155], ["Suphan Buri", "TREATMENT", 157, 168], ["Saraburi", "TREATMENT", 170, 178], ["Samples", "TEST", 478, 485], ["MethodsFeces", "TEST", 504, 516], ["small intestinal content", "PROBLEM", 531, 555], ["diarrheic pigs", "TREATMENT", 654, 668], ["sterile phosphate buffered saline", "TREATMENT", 710, 743], ["small", "OBSERVATION_MODIFIER", 531, 536], ["intestinal content", "OBSERVATION", 537, 555], ["intestinal mucosa", "ANATOMY", 557, 574], ["duodenum", "ANATOMY", 582, 590], ["upper", "ANATOMY_MODIFIER", 595, 600], ["jejunum", "ANATOMY", 609, 616], ["tissues", "ANATOMY", 622, 629]]], ["Clarified filtrates were collected after centrifugation at 3,000\u00d7g for 20 min.", [["filtrates", "ANATOMY", 10, 19], ["centrifugation", "TREATMENT", 41, 55], ["filtrates", "OBSERVATION", 10, 19]]], ["The Institutional Animal Care and Use Committee (IACUC number 1731020) and the Institutional Biosafety Committee (IBC number 1731008) of Chulalongkorn University approved this study.Reverse-transcription polymerase chain reaction ::: Materials and MethodsViral RNA was extracted using Ribospin vRD II viral RNA purification Kit (GeneAll, Seoul, Korea) according to manufacturer\u2019s instructions.", [["MethodsViral RNA", "RNA", 248, 264], ["this study", "TEST", 171, 181], ["MethodsViral RNA", "TREATMENT", 248, 264], ["Ribospin", "TREATMENT", 285, 293]]], ["Partial S gene was amplified by RT-PCR using SuperScript III One-Step RT-PCR with Platinum Taq DNA polymerase (Invitrogen, Carlsbad, CA, USA) as previously described (Kim, Song & Park, 2001).", [["DNA", "CELLULAR_COMPONENT", 95, 98], ["S gene", "DNA", 8, 14], ["Platinum Taq DNA polymerase", "PROTEIN", 82, 109], ["PCR", "TEST", 35, 38], ["SuperScript III", "TEST", 45, 60], ["PCR", "TEST", 73, 76], ["Platinum Taq DNA polymerase", "TEST", 82, 109], ["Invitrogen", "TEST", 111, 121]]], ["PCR cycling parameters were initial denaturation at 95 \u00b0C for 2 min, followed by 30 cycles of denaturation at 94 \u00b0C for 30 s, annealing at 55 \u00b0C for 1 min, extension at 72 \u00b0C for 1 min, and a final extension at 72 \u00b0C for 5 min.", [["PCR cycling parameters", "TEST", 0, 22], ["initial denaturation", "PROBLEM", 28, 48], ["denaturation", "TREATMENT", 94, 106]]], ["Samples tested positive for the S gene were subjected to the amplification of ORF3 and the N gene using annealing temperatures of 51 \u00b0C and 55 \u00b0C, respectively (Table S1).", [["Samples", "ANATOMY", 0, 7], ["ORF3", "GENE_OR_GENE_PRODUCT", 78, 82], ["S gene", "DNA", 32, 38], ["ORF3", "DNA", 78, 82], ["N gene", "DNA", 91, 97], ["Samples", "TEST", 0, 7], ["the S gene", "PROBLEM", 28, 38], ["ORF3", "TREATMENT", 78, 82], ["annealing temperatures", "TEST", 104, 126]]], ["Amplicons were purified using agarose gel electrophoresis and subjected to Sanger sequencing.", [["agarose", "SIMPLE_CHEMICAL", 30, 37], ["Amplicons", "TREATMENT", 0, 9], ["agarose gel electrophoresis", "TREATMENT", 30, 57], ["Sanger sequencing", "TEST", 75, 92]]], ["Nucleotide sequences of the Thai strains obtained from this study were deposited in the GenBank database (accession numbers are in Table S2; raw sequence data are in Datasets S1\u2013S3).Nucleotide and amino acid sequence analyses ::: Materials and MethodsNucleotide sequences were assembled and edited using SeqMan II and aligned using BioEdit and ClustralX.", [["amino acid", "CHEMICAL", 197, 207], ["amino acid", "CHEMICAL", 197, 207], ["amino acid", "AMINO_ACID", 197, 207], ["SeqMan II", "DNA", 304, 313], ["ClustralX", "DNA", 344, 353], ["Nucleotide sequences", "TEST", 0, 20], ["the Thai strains", "TEST", 24, 40], ["this study", "TEST", 55, 65], ["raw sequence data", "TEST", 141, 158], ["Nucleotide and amino acid sequence analyses", "TEST", 182, 225], ["MethodsNucleotide sequences", "TEST", 244, 271], ["BioEdit", "TREATMENT", 332, 339], ["ClustralX", "TREATMENT", 344, 353]]], ["Genetic relatedness among the Thai PEDV strains from this study (n = 95) was compared to previously identified Thai strains, global strains, and PEDV vaccine strains.", [["Thai PEDV", "SPECIES", 30, 39], ["PEDV", "SPECIES", 145, 149], ["Genetic relatedness", "PROBLEM", 0, 19], ["the Thai PEDV strains", "PROBLEM", 26, 47], ["this study", "TEST", 53, 63], ["Thai strains", "PROBLEM", 111, 123], ["global strains", "PROBLEM", 125, 139], ["PEDV vaccine strains", "TREATMENT", 145, 165]]], ["Phylogenetic trees were constructed using the maximum likelihood method and 1,000 bootstrap replicates implemented in MEGA6 (Tamura et al., 2013).", [["Phylogenetic trees", "PROBLEM", 0, 18], ["the maximum likelihood method", "TREATMENT", 42, 71]]], ["Best model fitting was automatically calculated for genetic distances (HKY+G model for S gene, T93+G model for ORF3, and K2+G model for N gene).", [["T93+G", "GENE_OR_GENE_PRODUCT", 95, 100], ["K2+G", "GENE_OR_GENE_PRODUCT", 121, 125], ["S gene", "DNA", 87, 93], ["T93", "DNA", 95, 98], ["ORF3", "DNA", 111, 115], ["K2", "DNA", 121, 123], ["N gene", "DNA", 136, 142], ["genetic distances", "PROBLEM", 52, 69], ["HKY", "TEST", 71, 74], ["T93", "TEST", 95, 98], ["ORF3", "TEST", 111, 115], ["K2+G model", "TREATMENT", 121, 131]]], ["Bootstrap values \u226580% were considered significant.", [["Bootstrap values", "TEST", 0, 16]]], ["Vaccine strains in which sequences were available for inclusion in all three phylogenetic trees were CV777 (Belgian strain), attenuated DR13 (Korean strain), and 96P4-C6 (Japanese strain).", [["96P4-C6", "CELL", 162, 169], ["Vaccine strains", "TREATMENT", 0, 15], ["Belgian strain", "TEST", 108, 122], ["attenuated DR13 (Korean strain), and 96P4-C6 (Japanese strain)", "PROBLEM", 125, 187]]], ["Deduced amino acid sequences of the Thai strains were also compared to those of the vaccine strains and reported as amino acid identity unless otherwise stated.", [["amino acid", "CHEMICAL", 8, 18], ["amino acid", "CHEMICAL", 116, 126], ["amino acid", "CHEMICAL", 8, 18], ["amino acid", "CHEMICAL", 116, 126], ["amino acid", "AMINO_ACID", 8, 18], ["amino acid", "AMINO_ACID", 116, 126], ["Deduced amino acid sequences", "TEST", 0, 28], ["the Thai strains", "PROBLEM", 32, 48], ["the vaccine strains", "TREATMENT", 80, 99], ["amino acid identity", "PROBLEM", 116, 135]]], ["Residue position numbering was based on CV777.Analysis of the S gene ::: ResultsBased on genetic analysis, the S sequences clustered into two major groups (Fig. 1).", [["S gene", "DNA", 62, 68], ["S sequences", "DNA", 111, 122], ["Residue position numbering", "PROBLEM", 0, 26], ["genetic analysis", "TEST", 89, 105], ["the S sequences", "TEST", 107, 122], ["position", "OBSERVATION_MODIFIER", 8, 16]]], ["While the historical CV777 strain was assigned in the G1-1 group, the majority (92/95) of the Thai PEDV strains in this study either clustered with previously identified Thai strains or with some of the common vaccine strains such as KPEDV-9 and attenuated DR13 in the G1-3 group.", [["KPEDV-9", "CHEMICAL", 234, 241], ["DR13", "CHEMICAL", 257, 261], ["CV777 strain", "ORGANISM", 21, 33], ["KPEDV-9", "CELL", 234, 241], ["KPEDV-9", "DNA", 234, 241], ["DR13", "DNA", 257, 261], ["PEDV", "SPECIES", 99, 103], ["the Thai PEDV strains", "PROBLEM", 90, 111], ["this study", "TEST", 115, 125], ["Thai strains", "PROBLEM", 170, 182], ["the common vaccine strains", "TREATMENT", 199, 225], ["KPEDV", "TEST", 234, 239]]], ["Three Thai PEDV strains (NP-68/12, NP-65/14, and RB38/15) were genetically distinct from others and formed a G1-2 cluster with Thai PEDV strains AGPED0609_1, AGPED0609_2 previously identified in 2011.Analysis of the S gene ::: ResultsThe deduced amino acid residues of the S protein showed that Thai PEDV strains consistently shared amino acid sequence identity to the PEDV strains reported on swine farms in Vietnam (92.3\u201399.4% identity), Japan (93.8\u201398.7% identity), China (92.8\u201399.2% identity), Korea (91.9\u201399.4% identity), and the U.S. (93.6\u201398.7% identity).", [["amino acid", "CHEMICAL", 246, 256], ["amino acid", "CHEMICAL", 333, 343], ["amino acid", "CHEMICAL", 246, 256], ["amino acid", "CHEMICAL", 333, 343], ["NP-68/12", "CELL", 25, 33], ["NP-65/14", "CELL", 35, 43], ["RB38/15", "CELL", 49, 56], ["amino acid", "AMINO_ACID", 246, 256], ["amino acid", "AMINO_ACID", 333, 343], ["S gene", "DNA", 216, 222], ["S protein", "PROTEIN", 273, 282], ["swine", "SPECIES", 394, 399], ["swine", "SPECIES", 394, 399], ["Three Thai PEDV strains", "TEST", 0, 23], ["NP", "TEST", 25, 27], ["NP", "TEST", 35, 37], ["Thai PEDV strains", "TEST", 127, 144], ["The deduced amino acid residues", "TEST", 234, 265], ["the S protein", "TEST", 269, 282], ["Thai PEDV strains", "PROBLEM", 295, 312], ["amino acid sequence", "TREATMENT", 333, 352], ["the PEDV strains", "PROBLEM", 365, 381], ["Japan", "TEST", 440, 445], ["China", "TEST", 469, 474], ["Korea", "TEST", 498, 503], ["the U.S.", "TEST", 531, 539], ["amino acid residues", "OBSERVATION", 246, 265]]], ["Moreover, the Thai strains shared 92.8\u201396.6% identity to the prototypic strain CV777 and 93.7\u201398.5% identity to other vaccine strains (Table S4).", [["the Thai strains", "TEST", 10, 26], ["the prototypic strain", "TEST", 57, 78], ["other vaccine strains", "PROBLEM", 112, 133]]], ["We note that one Thai PEDV strain designated RB-468.2/12 shared 100% identity to Thai strains from other studies (08RB05, 08CC01, 08CB03, 07NP01, SBPED0211_1, and NPPED0108_1), all of which were previously identified in or before 2011.Analysis of the S gene ::: ResultsAlignment of amino acid sequences encompassing positions 507\u2013689 revealed that all 95 Thai strains differed from CV777 at residues S523G, V527I, and I635V.", [["amino acid", "CHEMICAL", 282, 292], ["amino acid", "CHEMICAL", 282, 292], ["RB-468.2/12", "CELL", 45, 56], ["amino acid", "AMINO_ACID", 282, 292], ["\u2013689", "AMINO_ACID", 329, 333], ["RB", "PROTEIN", 45, 47], ["S gene", "DNA", 251, 257], ["Thai PEDV strain designated RB-468.2/12", "SPECIES", 17, 56], ["RB", "TEST", 45, 47], ["Thai strains", "TEST", 81, 93], ["other studies", "TEST", 99, 112], ["08RB05", "TEST", 114, 120], ["SBPED0211_1", "TEST", 146, 157], ["amino acid sequences", "TEST", 282, 302], ["Thai strains", "TEST", 355, 367]]], ["Additionally, all 92 Thai strains from the G1-3 group shared G594S, most of which also possessed A517S, L521H, T549S, L612F, and I667F.", [["G594S", "GENE_OR_GENE_PRODUCT", 61, 66], ["A517S", "GENE_OR_GENE_PRODUCT", 97, 102], ["T549S", "TEST", 111, 116]]], ["The three G1-2 Thai strains were primarily characterized by S567G and M641I, of which NP-68/12 differed most from CV777 at 14 residues over this region (Figs.", [["CV777", "CHEMICAL", 114, 119], ["Thai strains", "PROBLEM", 15, 27], ["NP", "TEST", 86, 88]]], ["S3A\u2013S3D).Analysis of the ORF3 gene ::: ResultsThe ORF3 gene was phylogenetically divided into two groups.", [["S3A", "GENE_OR_GENE_PRODUCT", 0, 3], ["ORF3", "GENE_OR_GENE_PRODUCT", 25, 29], ["ORF3", "GENE_OR_GENE_PRODUCT", 50, 54], ["S3A", "PROTEIN", 0, 3], ["S3D", "PROTEIN", 4, 7], ["ORF3 gene", "DNA", 25, 34], ["ORF3 gene", "DNA", 50, 59], ["The ORF3 gene", "TREATMENT", 46, 59]]], ["A number of the Thai PEDV strains (12/95) belonged to the G1 group with CV777 and the attenuated DR13 strain (Fig. 2).", [["Thai", "ORGANISM", 16, 20], ["PEDV strains", "ORGANISM", 21, 33], ["the Thai PEDV strains", "PROBLEM", 12, 33], ["the attenuated DR13 strain", "PROBLEM", 82, 108]]], ["The majority of the Thai strains (83/95) were more closely related to the previous Thai strains than to the vaccine strains and were grouped in G2.", [["Thai strains", "PROBLEM", 83, 95], ["the vaccine strains", "TREATMENT", 104, 123], ["majority", "OBSERVATION_MODIFIER", 4, 12]]], ["The S-INDEL strains were also in this group.", [["The S-INDEL strains", "PROBLEM", 0, 19]]], ["Deduced amino acid sequences showed that the Thai PEDV strains shared 94.4\u2013100% amino acid identity with each other, 95.8\u201397% identity to CV777, and 95\u201398.1% identity to the other vaccine strains.", [["amino acid", "CHEMICAL", 8, 18], ["amino acid", "CHEMICAL", 80, 90], ["amino acid", "CHEMICAL", 8, 18], ["amino acid", "CHEMICAL", 80, 90], ["amino acid", "AMINO_ACID", 8, 18], ["amino acid", "AMINO_ACID", 80, 90], ["Deduced amino acid sequences", "TEST", 0, 28], ["the Thai PEDV strains", "TEST", 41, 62], ["amino acid identity", "TEST", 80, 99]]], ["In particular, Thai G1 strains in this study shared 99.7\u201399.8% identity to a Chinese YC/2013 strain from 2013, and 98.8\u201399.1% identity to a previous Thai strain CBR1 identified in 2014.", [["Chinese YC/2013 strain", "SPECIES", 77, 99], ["Thai G1 strains", "TEST", 15, 30], ["this study", "TEST", 34, 44], ["Thai strain CBR1", "TEST", 149, 165]]], ["Meanwhile, the Thai G2 strains in this study shared 95.8\u2013100% identity to previous Thai strains from 2008 to 2012.", [["the Thai G2 strains", "TEST", 11, 30], ["this study", "TEST", 34, 44], ["previous Thai strains", "PROBLEM", 74, 95]]], ["All Thai strains were similar to CV777 in their absence of deletions of residues 82\u201399 and 138\u2013139 in the ORF3 protein compared to other vaccine strains (Table S5).Analysis of the N gene ::: ResultsWhile CV777 and other vaccine strains clustered within the G1 group, all Thai PEDV strains in this study appeared to have diverged and branched off as a separate group (Fig. 3).", [["CV777", "CHEMICAL", 204, 209], ["ORF3", "GENE_OR_GENE_PRODUCT", 106, 110], ["PEDV strains", "ORGANISM", 276, 288], ["ORF3 protein", "PROTEIN", 106, 118], ["N gene", "DNA", 180, 186], ["PEDV", "SPECIES", 276, 280], ["All Thai strains", "PROBLEM", 0, 16], ["deletions of residues", "PROBLEM", 59, 80], ["the ORF3 protein", "TEST", 102, 118], ["other vaccine strains", "PROBLEM", 131, 152], ["other vaccine strains", "TREATMENT", 214, 235], ["this study", "TEST", 292, 302]]], ["Although they shared 96\u2013100% amino acid identity, the Thai strains belonging to G3-1 (83/95) are genetically close to the reference strains previously identified in the U.S. (OH851) and China (CH/ZMDZY/11) (97.1\u201399.7% amino acid identity).", [["amino acid", "CHEMICAL", 29, 39], ["amino acid", "CHEMICAL", 218, 228], ["amino acid", "CHEMICAL", 29, 39], ["amino acid", "CHEMICAL", 218, 228], ["amino acid", "AMINO_ACID", 29, 39], ["G3-1", "ORGANISM", 80, 84], ["amino acid", "AMINO_ACID", 218, 228], ["China (CH/ZMDZY/11", "SPECIES", 186, 204], ["amino acid identity", "TEST", 29, 48], ["ZMDZY", "TEST", 196, 201], ["amino acid identity", "TEST", 218, 237]]], ["In the G3-2 group, the Thai strains TH/NP1-1/15 and TH/CB74/15 showed identical nucleotide sequences to the Vietnamese strain CT3.", [["nucleotide", "CHEMICAL", 80, 90], ["nucleotide", "CHEMICAL", 80, 90], ["G3-2", "CELL", 7, 11], ["TH", "GENE_OR_GENE_PRODUCT", 36, 38], ["NP1", "GENE_OR_GENE_PRODUCT", 39, 42], ["TH", "GENE_OR_GENE_PRODUCT", 52, 54], ["CB74/15", "GENE_OR_GENE_PRODUCT", 55, 62], ["NP1", "PROTEIN", 39, 42], ["TH", "PROTEIN", 52, 54], ["CB74/15", "PROTEIN", 55, 62], ["Thai strains TH/NP1-1/15", "SPECIES", 23, 47], ["the Thai strains", "TEST", 19, 35], ["NP1", "TEST", 39, 42], ["identical nucleotide sequences", "PROBLEM", 70, 100]]], ["We next analyzed the deduced amino acid sequences of the N protein from the Thai strains, which spanned residues 13\u2013406 (out of 441 residues).", [["amino acid", "CHEMICAL", 29, 39], ["amino acid", "CHEMICAL", 29, 39], ["amino acid", "AMINO_ACID", 29, 39], ["N protein", "PROTEIN", 57, 66], ["the deduced amino acid sequences", "TEST", 17, 49], ["the Thai strains", "PROBLEM", 72, 88]]], ["Sequence alignment with CV777 showed that eight Thai strains possessed several residue deletions in the middle of the N protein encompassing positions 241\u2013251 in addition to several residue differences (Fig. S4).", [["CV777", "DNA", 24, 29], ["N protein", "PROTEIN", 118, 127], ["Sequence alignment", "TEST", 0, 18], ["CV777", "TEST", 24, 29], ["Thai strains", "PROBLEM", 48, 60], ["several residue deletions", "PROBLEM", 71, 96], ["several residue differences", "PROBLEM", 174, 201], ["several", "OBSERVATION_MODIFIER", 71, 78], ["residue deletions", "OBSERVATION", 79, 96], ["middle", "ANATOMY_MODIFIER", 104, 110]]], ["Four Thai strains (TH/UD-1010.1/11, TH/UD-1010.2/11, TH/UD-1010.3/11, TH/UD-1010.4/11) were missing residues R241 and H242.", [["UD", "TEST", 22, 24], ["UD", "TEST", 39, 41], ["UD", "TEST", 56, 58], ["UD", "TEST", 73, 75]]], ["Three Thai strains (TH/RB160/16, TH/RB161/16, and TH/RB-838/14) were missing residues K243 and Q244.", [["K243", "CHEMICAL", 86, 90], ["Q244", "CHEMICAL", 95, 99], ["TH", "GENE_OR_GENE_PRODUCT", 33, 35], ["TH", "GENE_OR_GENE_PRODUCT", 50, 52], ["RB", "PROTEIN", 53, 55], ["Three Thai strains", "TEST", 0, 18], ["TH/RB", "TEST", 50, 55], ["missing residues K243", "PROBLEM", 69, 90]]], ["Finally, residue E251 was absent in TH/NP-68/12.DiscussionImprovement in the molecular epidemiology of PEDV has advanced the understanding of viral transmission and spread.", [["PEDV", "CHEMICAL", 103, 107], ["TH", "GENE_OR_GENE_PRODUCT", 36, 38], ["PEDV", "CANCER", 103, 107], ["PEDV", "SPECIES", 103, 107], ["residue E251", "TEST", 9, 21], ["PEDV", "PROBLEM", 103, 107], ["viral transmission", "OBSERVATION", 142, 160]]], ["Most studies now involve the characterization of multiple gene sequences, namely S, M, ORF3, and even full-length genome analysis (Cheun-Arom et al., 2016; Puranaveja et al., 2009; Stott et al., 2017; Temeeyasen et al., 2014).", [["ORF3", "GENE_OR_GENE_PRODUCT", 87, 91], ["multiple gene sequences", "DNA", 49, 72], ["ORF3", "DNA", 87, 91], ["Most studies", "TEST", 0, 12], ["multiple gene sequences", "TEST", 49, 72], ["ORF3", "TEST", 87, 91]]], ["The analysis of the S sequence from strains in the U.S. between 2016 and 2017 has identified three new emergent strains (termed S1 NTD-del PEDV variants).", [["S sequence", "DNA", 20, 30], ["S1 NTD-del PEDV variants", "DNA", 128, 152], ["The analysis", "TEST", 0, 12], ["the S sequence", "TEST", 16, 30], ["new emergent strains (termed S1 NTD", "PROBLEM", 99, 134], ["del PEDV variants", "PROBLEM", 135, 152]]], ["These variants possessed several large deletions within S1 N-terminal domain and differed from the original U.S. S INDEL (Su et al., 2018).", [["N", "CHEMICAL", 59, 60], ["S1 N-terminal domain", "DNA", 56, 76], ["several large deletions", "PROBLEM", 25, 48], ["several", "OBSERVATION_MODIFIER", 25, 32], ["large", "OBSERVATION_MODIFIER", 33, 38], ["deletions", "OBSERVATION", 39, 48]]], ["High variation region on the antigenic COE domain seen in the Thai PEDV strains identified between 2011 and 2016 showed that PEDV in Thailand continue to evolve.", [["PEDV", "CHEMICAL", 125, 129], ["antigenic COE domain", "PROTEIN", 29, 49], ["Thai PEDV", "SPECIES", 62, 71], ["PEDV", "SPECIES", 125, 129], ["High variation region", "PROBLEM", 0, 21], ["the Thai PEDV strains", "PROBLEM", 58, 79], ["PEDV", "PROBLEM", 125, 129], ["variation", "OBSERVATION_MODIFIER", 5, 14], ["region", "OBSERVATION_MODIFIER", 15, 21], ["Thai PEDV", "ANATOMY", 62, 71], ["PEDV", "OBSERVATION", 125, 129]]], ["The COE domain was first identified in the transmissible gastroenteritis virus and is a known PEDV neutralizing epitope (Chang et al., 2002; Hou et al., 2017).", [["gastroenteritis", "DISEASE", 57, 72], ["COE domain", "PROTEIN", 4, 14], ["PEDV neutralizing epitope", "PROTEIN", 94, 119], ["transmissible gastroenteritis virus", "SPECIES", 43, 78], ["the transmissible gastroenteritis virus", "PROBLEM", 39, 78], ["transmissible", "OBSERVATION_MODIFIER", 43, 56], ["gastroenteritis virus", "OBSERVATION", 57, 78], ["PEDV", "OBSERVATION_MODIFIER", 94, 98], ["neutralizing", "OBSERVATION_MODIFIER", 99, 111]]], ["As this region is under immune pressure from the host, sequence variations are often found throughout this most distal region of the S protein.", [["S protein", "PROTEIN", 133, 142], ["sequence variations", "TEST", 55, 74], ["immune pressure", "OBSERVATION", 24, 39]]], ["It was not surprising that distinct groups of Thai strains (namely G1-2 and G1-3) were circulating on Thai farms, both of which varied from the vaccine strains.", [["G1-2", "CELL", 67, 71], ["G1-3", "CELL", 76, 80], ["Thai strains", "TEST", 46, 58], ["G1", "TEST", 67, 69], ["the vaccine strains", "TREATMENT", 140, 159], ["distinct", "OBSERVATION_MODIFIER", 27, 35]]], ["As a result, variations on the epitope region seen in circulating PEDV strains may affect viral neutralization and vaccine escapes.", [["PEDV strains", "ORGANISM", 66, 78], ["epitope region", "PROTEIN", 31, 45], ["PEDV", "SPECIES", 66, 70], ["the epitope region", "TREATMENT", 27, 45], ["circulating PEDV strains", "PROBLEM", 54, 78], ["viral neutralization", "TREATMENT", 90, 110], ["vaccine escapes", "TREATMENT", 115, 130], ["viral neutralization", "OBSERVATION", 90, 110]]], ["Our observation that the vaccine strains are phylogenetically distant from the majority of the circulating PEDV strains might reflects the relatively low vaccine efficacy afforded by some of the current vaccine strains, of which CV777, 83P-5, SM98, and DR13 have been used in attenuated vaccines in Asia (Gerdts & Zakhartchouk, 2017; Song, Moon & Kang, 2015).", [["CV777", "CHEMICAL", 229, 234], ["83P-5, SM98", "CHEMICAL", 236, 247], ["DR13", "CHEMICAL", 253, 257], ["PEDV strains", "ORGANISM", 107, 119], ["83P-5", "ORGANISM", 236, 241], ["SM98", "GENE_OR_GENE_PRODUCT", 243, 247], ["DR13", "GENE_OR_GENE_PRODUCT", 253, 257], ["PEDV", "SPECIES", 107, 111], ["Our observation", "TEST", 0, 15], ["the vaccine strains", "TREATMENT", 21, 40], ["the circulating PEDV strains", "PROBLEM", 91, 119], ["the current vaccine strains", "TREATMENT", 191, 218], ["attenuated vaccines", "TREATMENT", 276, 295]]], ["However, prediction of viral antigenicity should not rely solely on the variations on the COE antigenic epitopes, but should also depend on the other epitope region variations, serological assays, and/or animal experiment studies.DiscussionOpen reading frame 3 is a 224 amino acid accessory and a transmembrane protein, which possesses a potassium ion channel function (Teeravechyan et al., 2016).", [["transmembrane", "ANATOMY", 297, 310], ["amino acid", "CHEMICAL", 270, 280], ["potassium", "CHEMICAL", 338, 347], ["amino acid", "CHEMICAL", 270, 280], ["potassium", "CHEMICAL", 338, 347], ["amino acid", "AMINO_ACID", 270, 280], ["transmembrane", "CELLULAR_COMPONENT", 297, 310], ["potassium", "SIMPLE_CHEMICAL", 338, 347], ["COE antigenic epitopes", "PROTEIN", 90, 112], ["DiscussionOpen reading frame 3", "DNA", 230, 260], ["transmembrane protein", "PROTEIN", 297, 318], ["viral antigenicity", "PROBLEM", 23, 41], ["the COE antigenic epitopes", "TREATMENT", 86, 112], ["the other epitope region variations", "PROBLEM", 140, 175], ["serological assays", "TEST", 177, 195], ["animal experiment studies", "TEST", 204, 229], ["a transmembrane protein", "TEST", 295, 318], ["viral antigenicity", "OBSERVATION", 23, 41]]], ["It is known that the ORF3 gene product is not required for viability as PEDV generated from cDNA clones lacking the ORF3 is infectious (Jengarn et al., 2015).", [["ORF3", "GENE_OR_GENE_PRODUCT", 21, 25], ["PEDV", "GENE_OR_GENE_PRODUCT", 72, 76], ["ORF3", "GENE_OR_GENE_PRODUCT", 116, 120], ["ORF3 gene product", "PROTEIN", 21, 38], ["PEDV", "PROTEIN", 72, 76], ["cDNA clones", "DNA", 92, 103], ["ORF3", "DNA", 116, 120], ["PEDV", "SPECIES", 72, 76], ["the ORF3 gene product", "TREATMENT", 17, 38], ["viability", "PROBLEM", 59, 68], ["PEDV", "PROBLEM", 72, 76], ["cDNA clones", "PROBLEM", 92, 103], ["infectious", "OBSERVATION_MODIFIER", 124, 134]]], ["Our analysis of the entire ORF3 gene showed that Thai strains clustered with the vaccine strains.", [["ORF3", "GENE_OR_GENE_PRODUCT", 27, 31], ["ORF3 gene", "DNA", 27, 36], ["Our analysis", "TEST", 0, 12], ["the entire ORF3 gene", "TEST", 16, 36], ["Thai strains", "PROBLEM", 49, 61], ["the vaccine strains", "TREATMENT", 77, 96]]], ["In contrast to the field strains, several vaccine strains including the attenuated DR13, KPEDV-9, and P-5V have a 51 nucleotide deletion between position 245 and 295 in their ORF3 gene (Li et al., 2014).", [["KPEDV-9", "CHEMICAL", 89, 96], ["KPEDV-9", "ORGANISM", 89, 96], ["P-5V", "ORGANISM", 102, 106], ["ORF3", "GENE_OR_GENE_PRODUCT", 175, 179], ["DR13, KPEDV-9", "DNA", 83, 96], ["P-5V", "DNA", 102, 106], ["51 nucleotide deletion", "DNA", 114, 136], ["ORF3 gene", "DNA", 175, 184], ["KPEDV-9", "SPECIES", 89, 96], ["P-5V", "SPECIES", 102, 106], ["several vaccine strains", "TREATMENT", 34, 57], ["KPEDV", "TEST", 89, 94], ["a 51 nucleotide deletion", "PROBLEM", 112, 136]]], ["This notable sequence difference may have contributed to the clustering of the phylogenetic tree of ORF3 into two groups.DiscussionPrevious reports of molecular surveillance of PEDV on Thai swine farms have mainly examined the genetic diversity of the S, M, and ORF3 genes.", [["PEDV", "CHEMICAL", 177, 181], ["ORF3", "GENE_OR_GENE_PRODUCT", 100, 104], ["PEDV", "ORGANISM", 177, 181], ["ORF3", "GENE_OR_GENE_PRODUCT", 262, 266], ["ORF3", "DNA", 100, 104], ["S, M, and ORF3 genes", "DNA", 252, 272], ["swine", "SPECIES", 190, 195], ["PEDV", "SPECIES", 177, 181], ["Thai swine", "SPECIES", 185, 195], ["PEDV", "PROBLEM", 177, 181], ["phylogenetic tree", "OBSERVATION", 79, 96]]], ["Less frequently examined is the N gene because its crucial function in binding viral RNA genome partially constrains changes in its sequence (Puranaveja et al., 2009; Temeeyasen et al., 2014).", [["N gene", "DNA", 32, 38], ["binding viral RNA genome", "DNA", 71, 95], ["binding viral RNA genome", "PROBLEM", 71, 95], ["viral RNA genome", "OBSERVATION", 79, 95]]], ["The N protein is abundantly expressed during the early stages of PEDV infection and is therefore a preferred target for PEDV detection.", [["infection", "DISEASE", 70, 79], ["PEDV", "ORGANISM", 65, 69], ["PEDV", "SIMPLE_CHEMICAL", 120, 124], ["N protein", "PROTEIN", 4, 13], ["PEDV", "SPECIES", 65, 69], ["PEDV", "SPECIES", 120, 124], ["PEDV infection", "PROBLEM", 65, 79], ["PEDV detection", "TEST", 120, 134], ["early stages", "OBSERVATION_MODIFIER", 49, 61], ["PEDV", "OBSERVATION_MODIFIER", 65, 69], ["infection", "OBSERVATION", 70, 79]]], ["Sequence variations on the N gene could also be used to evaluate PEDV genetic diversity and relationship among circulating PEDV strains.", [["PEDV strains", "ORGANISM", 123, 135], ["N gene", "DNA", 27, 33], ["PEDV", "SPECIES", 123, 127], ["Sequence variations", "TEST", 0, 19], ["the N gene", "TREATMENT", 23, 33], ["PEDV genetic diversity", "PROBLEM", 65, 87], ["circulating PEDV strains", "PROBLEM", 111, 135]]], ["Our phylogenetic analysis of the near-complete N gene showed that the Thai strains genetically grouped with the recent PEDV strains from the U.S. and China.", [["N gene", "DNA", 47, 53], ["Our phylogenetic analysis", "TEST", 0, 25], ["the Thai strains", "PROBLEM", 66, 82], ["the recent PEDV strains", "PROBLEM", 108, 131], ["PEDV", "OBSERVATION", 119, 123]]], ["Meanwhile, the vaccine strains were more genetically distant compared to the current field strains in circulation.", [["the vaccine strains", "TREATMENT", 11, 30]]], ["Interestingly, eight Thai PEDV strains demonstrated up to two residue deletions in the middle of the N protein.", [["N protein", "PROTEIN", 101, 110], ["PEDV", "SPECIES", 26, 30], ["Thai PEDV strains", "PROBLEM", 21, 38], ["two residue deletions", "PROBLEM", 58, 79], ["residue deletions", "OBSERVATION", 62, 79], ["middle", "ANATOMY_MODIFIER", 87, 93]]], ["These missing residues encompassing position 241\u2013251 have not been previously characterized in other PEDV or alphacoronaviruses even though the N gene has the greatest sequence similarities to TGEV and human coronaviruses (HCV 229E and HCV NL63) (Bridgen et al., 1993; Lin et al., 2015).", [["PEDV", "GENE_OR_GENE_PRODUCT", 101, 105], ["alphacoronaviruses", "GENE_OR_GENE_PRODUCT", 109, 127], ["TGEV", "ORGANISM", 193, 197], ["human", "ORGANISM", 202, 207], ["coronaviruses", "ORGANISM", 208, 221], ["HCV 229E", "ORGANISM", 223, 231], ["HCV NL63", "ORGANISM", 236, 244], ["N gene", "DNA", 144, 150], ["TGEV", "SPECIES", 193, 197], ["human", "SPECIES", 202, 207], ["PEDV", "SPECIES", 101, 105], ["TGEV", "SPECIES", 193, 197], ["human coronaviruses", "SPECIES", 202, 221], ["HCV", "SPECIES", 223, 226], ["HCV", "SPECIES", 236, 239], ["These missing residues", "PROBLEM", 0, 22], ["alphacoronaviruses", "PROBLEM", 109, 127], ["human coronaviruses", "PROBLEM", 202, 221], ["HCV", "TEST", 223, 226]]], ["This observation was reproducible by repeating the RNA extraction of samples, amplification, and sequencing.", [["samples", "ANATOMY", 69, 76], ["the RNA extraction", "TREATMENT", 47, 65], ["sequencing", "TEST", 97, 107]]], ["In addition, samples came from different farms and provinces, and therefore are unlikely to be due to artifacts or contamination.", [["samples", "ANATOMY", 13, 20], ["samples", "TEST", 13, 20], ["artifacts", "PROBLEM", 102, 111], ["contamination", "PROBLEM", 115, 128], ["unlikely to be due to", "UNCERTAINTY", 80, 101], ["artifacts", "OBSERVATION", 102, 111], ["contamination", "OBSERVATION", 115, 128]]], ["These deletions involved residues located within the immunodominant region of the N protein between residues 136 and 289 previously shown to be associated with NF-\u0138B activation pathway (Cao et al., 2015).", [["NF-\u0138B", "GENE_OR_GENE_PRODUCT", 160, 165], ["immunodominant region", "PROTEIN", 53, 74], ["N protein", "PROTEIN", 82, 91], ["NF-\u0138B", "PROTEIN", 160, 165], ["These deletions involved residues", "PROBLEM", 0, 33]]], ["Residue deletions in this region observed in some Thai PEDV strains, therefore, may indicate an evolving flexible domain with no major functional significance.", [["Thai PEDV", "SPECIES", 50, 59], ["Residue deletions in this region", "PROBLEM", 0, 32], ["some Thai PEDV strains", "PROBLEM", 45, 67], ["an evolving flexible domain", "PROBLEM", 93, 120], ["deletions", "OBSERVATION", 8, 17], ["flexible domain", "OBSERVATION", 105, 120], ["no major", "UNCERTAINTY", 126, 134]]], ["Nevertheless, pathological relevance of this deletion requires further examination and will benefit from reverse genetic studies.DiscussionIn this study, several Thai PEDV strains from animals of different age, herd, and year of collection had identical amino acid sequences and belonged to the same subtypes (Table S6).", [["amino acid", "CHEMICAL", 254, 264], ["amino acid", "CHEMICAL", 254, 264], ["amino acid", "AMINO_ACID", 254, 264], ["S6", "PROTEIN", 316, 318], ["this deletion", "PROBLEM", 40, 53], ["further examination", "TEST", 63, 82], ["reverse genetic studies", "TEST", 105, 128], ["this study", "TEST", 142, 152], ["identical amino acid sequences", "PROBLEM", 244, 274]]], ["This observation is consistent with the potential transmission of PEDV from farm to farm due to animal transportation and trade (Beam et al., 2015; Puranaveja et al., 2009).", [["PEDV", "CHEMICAL", 66, 70], ["PEDV", "ORGANISM", 66, 70], ["PEDV", "SPECIES", 66, 70], ["PEDV", "PROBLEM", 66, 70], ["consistent with", "UNCERTAINTY", 20, 35]]], ["The recurrent PEDV outbreaks on Thai farms were also likely due to circulation and re-emergence within the swine herds as a result of the common practice of restocking new susceptible pigs with improper gilt acclimatization, insufficient colostrum intake in newborn piglets, and insufficient immunization of pregnant sow.", [["colostrum", "ANATOMY", 238, 247], ["pigs", "ORGANISM", 184, 188], ["gilt", "ORGANISM_SUBDIVISION", 203, 207], ["colostrum", "ORGANISM_SUBDIVISION", 238, 247], ["piglets", "ORGANISM", 266, 273], ["sow", "ORGANISM_SUBDIVISION", 317, 320], ["swine", "SPECIES", 107, 112], ["pigs", "SPECIES", 184, 188], ["piglets", "SPECIES", 266, 273], ["PEDV", "SPECIES", 14, 18], ["swine", "SPECIES", 107, 112], ["pigs", "SPECIES", 184, 188], ["The recurrent PEDV outbreaks", "PROBLEM", 0, 28], ["circulation", "PROBLEM", 67, 78], ["restocking new susceptible pigs", "TREATMENT", 157, 188], ["improper gilt acclimatization", "TREATMENT", 194, 223], ["recurrent", "OBSERVATION_MODIFIER", 4, 13], ["PEDV", "OBSERVATION", 14, 18], ["likely due to", "UNCERTAINTY", 53, 66], ["improper gilt acclimatization", "OBSERVATION", 194, 223]]], ["Alternatively, older pigs with asymptomatic PEDV infection may serve as a reservoir and spread the infection sub-clinically.", [["PEDV infection", "DISEASE", 44, 58], ["infection", "DISEASE", 99, 108], ["pigs", "ORGANISM", 21, 25], ["pigs", "SPECIES", 21, 25], ["pigs", "SPECIES", 21, 25], ["PEDV", "SPECIES", 44, 48], ["asymptomatic PEDV infection", "PROBLEM", 31, 58], ["a reservoir", "TREATMENT", 72, 83], ["the infection sub", "PROBLEM", 95, 112], ["asymptomatic", "OBSERVATION_MODIFIER", 31, 43], ["PEDV", "OBSERVATION_MODIFIER", 44, 48], ["infection", "OBSERVATION", 49, 58], ["infection", "OBSERVATION", 99, 108]]], ["Vertical transmission is also possible as PEDV RNA has been detected in the milk of infected lactating sows (Li et al., 2012; Sun et al., 2012).DiscussionBased on the phylogenetic analysis of the partial S gene, most of the Thai strains in this study belonged to the high virulent G2a lineage.", [["milk", "ANATOMY", 76, 80], ["G2a lineage", "ANATOMY", 281, 292], ["PEDV", "GENE_OR_GENE_PRODUCT", 42, 46], ["milk", "ORGANISM_SUBSTANCE", 76, 80], ["sows", "ORGANISM", 103, 107], ["G2a lineage", "CELL", 281, 292], ["PEDV RNA", "RNA", 42, 50], ["S gene", "DNA", 204, 210], ["G2a lineage", "CELL_TYPE", 281, 292], ["PEDV", "SPECIES", 42, 46], ["PEDV RNA", "PROBLEM", 42, 50], ["the phylogenetic analysis", "TEST", 163, 188], ["the Thai strains", "PROBLEM", 220, 236], ["this study", "TEST", 240, 250], ["also possible", "UNCERTAINTY", 25, 38], ["infected", "OBSERVATION_MODIFIER", 84, 92], ["virulent G2a lineage", "OBSERVATION", 272, 292]]], ["Several Thai strains (23/95), especially those from 2013 to 2015, were genetically related to the new variant G2b strains (Chinese-like strains and U.S.-like strains).", [["G2b", "GENE_OR_GENE_PRODUCT", 110, 113], ["Chinese-like strains", "ORGANISM", 123, 143], ["Several Thai strains", "PROBLEM", 0, 20], ["the new variant G2b strains", "PROBLEM", 94, 121], ["Chinese-like strains", "PROBLEM", 123, 143], ["strains", "OBSERVATION_MODIFIER", 13, 20]]], ["We found that the circulating PEDV strains in Thailand continue to diverge from the classical vaccine strains such as the attenuated DR13, CV777, and 96P4-C6.", [["PEDV", "GENE_OR_GENE_PRODUCT", 30, 34], ["96P4-C6", "CELL", 150, 157], ["PEDV", "SPECIES", 30, 34], ["the circulating PEDV strains", "PROBLEM", 14, 42], ["the classical vaccine strains", "PROBLEM", 80, 109], ["C6", "ANATOMY_MODIFIER", 155, 157]]], ["This underscores a major obstacle in the control of disease transmission.", [["major", "OBSERVATION_MODIFIER", 19, 24], ["obstacle", "OBSERVATION_MODIFIER", 25, 33], ["disease", "OBSERVATION", 52, 59]]], ["Although some vaccines are derived from high-passaged laboratory cultivated viral stocks and are administered orally or intramuscularly to pregnant sows, there is rarely a complete protection among nursing piglets from subsequent PEDV infection (Jung & Saif, 2015).", [["infection", "DISEASE", 235, 244], ["piglets", "ORGANISM", 206, 213], ["piglets", "SPECIES", 206, 213], ["PEDV", "SPECIES", 230, 234], ["some vaccines", "TREATMENT", 9, 22], ["viral stocks", "TREATMENT", 76, 88], ["nursing piglets", "TREATMENT", 198, 213], ["subsequent PEDV infection", "PROBLEM", 219, 244], ["viral stocks", "OBSERVATION", 76, 88], ["PEDV", "OBSERVATION_MODIFIER", 230, 234], ["infection", "OBSERVATION", 235, 244]]], ["Furthermore, induction of immunity among lactating sows from ingestion of fecal slurry or homogenized intestines of infected neonatal piglets presents the risk of unintended transmission of other enteric pathogens.DiscussionThis study has several limitations.", [["fecal slurry", "ANATOMY", 74, 86], ["intestines", "ANATOMY", 102, 112], ["sows", "ORGANISM", 51, 55], ["fecal", "ORGANISM_SUBSTANCE", 74, 79], ["intestines", "ORGAN", 102, 112], ["piglets", "ORGANISM", 134, 141], ["piglets", "SPECIES", 134, 141], ["immunity among lactating sows", "TREATMENT", 26, 55], ["fecal slurry", "PROBLEM", 74, 86], ["homogenized intestines", "PROBLEM", 90, 112], ["infected neonatal piglets", "PROBLEM", 116, 141], ["other enteric pathogens", "PROBLEM", 190, 213], ["This study", "TEST", 224, 234], ["fecal slurry", "OBSERVATION_MODIFIER", 74, 86], ["intestines", "ANATOMY", 102, 112], ["infected", "OBSERVATION_MODIFIER", 116, 124], ["neonatal piglets", "OBSERVATION", 125, 141], ["enteric", "ANATOMY", 196, 203], ["pathogens", "OBSERVATION", 204, 213]]], ["We did not include in our analysis the PEDV strains with missing S, ORF3 or N gene sequences, which could have revealed additional diversity of PEDV strains circulating in Thailand.", [["ORF3", "GENE_OR_GENE_PRODUCT", 68, 72], ["PEDV strains", "ORGANISM", 144, 156], ["S, ORF3 or N gene sequences", "DNA", 65, 92], ["PEDV", "SPECIES", 144, 148], ["the PEDV strains", "PROBLEM", 35, 51], ["ORF3 or N gene sequences", "TEST", 68, 92], ["PEDV strains", "PROBLEM", 144, 156], ["PEDV strains", "OBSERVATION", 144, 156]]], ["Samples in our study were primarily submitted from pigs in central Thailand where the majority of swine farms are located, therefore surveillance of farms in other parts of the country was incomplete.", [["pigs", "ORGANISM", 51, 55], ["swine", "ORGANISM", 98, 103], ["pigs", "SPECIES", 51, 55], ["swine", "SPECIES", 98, 103], ["pigs", "SPECIES", 51, 55], ["swine", "SPECIES", 98, 103], ["our study", "TEST", 11, 20], ["swine farms", "OBSERVATION", 98, 109]]], ["Nevertheless, our multi-year study provides additional knowledge regarding the diversity of PEDV in this region and may assist in determining suitable PEDV strains for future vaccine development.ConclusionAssessing the diversity of PEDV on Thai swine farms was facilitated by the analysis of the S gene in combination with ORF3 and the N genes.", [["PEDV", "CHEMICAL", 232, 236], ["PEDV", "GENE_OR_GENE_PRODUCT", 92, 96], ["PEDV strains", "ORGANISM", 151, 163], ["PEDV", "GENE_OR_GENE_PRODUCT", 232, 236], ["ORF3", "GENE_OR_GENE_PRODUCT", 323, 327], ["PEDV", "DNA", 92, 96], ["S gene", "DNA", 296, 302], ["ORF3", "DNA", 323, 327], ["N genes", "DNA", 336, 343], ["swine", "SPECIES", 245, 250], ["PEDV", "SPECIES", 92, 96], ["PEDV", "SPECIES", 151, 155], ["PEDV", "SPECIES", 232, 236], ["Thai swine", "SPECIES", 240, 250], ["our multi-year study", "TEST", 14, 34], ["PEDV", "PROBLEM", 92, 96], ["suitable PEDV strains", "TREATMENT", 142, 163], ["future vaccine development", "TREATMENT", 168, 194], ["PEDV", "PROBLEM", 232, 236], ["Thai swine farms", "TREATMENT", 240, 256], ["the analysis", "TEST", 276, 288], ["ORF3", "TREATMENT", 323, 327]]], ["Circulating PEDV strains differed significantly from the vaccine strains, which may explain vaccine failure in the field.", [["PEDV", "GENE_OR_GENE_PRODUCT", 12, 16], ["Circulating PEDV strains", "PROBLEM", 0, 24], ["the vaccine strains", "TREATMENT", 53, 72], ["vaccine failure in the field", "PROBLEM", 92, 120], ["may explain", "UNCERTAINTY", 80, 91], ["vaccine failure", "OBSERVATION", 92, 107]]], ["Continued molecular epidemiology and surveillance will be important in monitoring PEDV transmission.", [["PEDV", "CANCER", 82, 86], ["PEDV", "SPECIES", 82, 86]]]], "fd0573c82149c4294e97b04a8f74eabf43ec4056": [["Introduction :The novel coronavirus-2 (nCoV-2) responsible for causing the Coronavirus disease 19 pandemic has created worldwide chaos and panic.", [["Coronavirus disease", "DISEASE", 75, 94], ["pandemic", "DISEASE", 98, 106], ["panic", "DISEASE", 139, 144], ["coronavirus-2", "ORGANISM", 24, 37], ["nCoV-2", "ORGANISM", 39, 45], ["The novel coronavirus", "TEST", 14, 35], ["the Coronavirus disease", "PROBLEM", 71, 94], ["panic", "PROBLEM", 139, 144], ["Coronavirus disease", "OBSERVATION", 75, 94]]], ["1 The most severe spectrum of this pandemic is being seen in the elderly and in adults with co-morbidities.", [["co-morbidities", "PROBLEM", 92, 106], ["most severe", "OBSERVATION_MODIFIER", 6, 17]]], ["2 In the largest cohort of patients from China, children and adolescents comprised to less than 2% of the affected patients with no mortality recorded in children younger than 9 years of age.", [["patients", "ORGANISM", 27, 35], ["children", "ORGANISM", 48, 56], ["patients", "ORGANISM", 115, 123], ["children", "ORGANISM", 154, 162], ["patients", "SPECIES", 27, 35], ["children", "SPECIES", 48, 56], ["adolescents", "SPECIES", 61, 72], ["patients", "SPECIES", 115, 123], ["children", "SPECIES", 154, 162], ["largest", "OBSERVATION_MODIFIER", 9, 16]]], ["3 Since nCoV-2 does not have an established therapy currently and there isn't a vaccine available for prevention, the only way to control its spread is by avoiding contact with infected persons.", [["nCoV-2", "GENE_OR_GENE_PRODUCT", 8, 14], ["persons", "ORGANISM", 186, 193], ["persons", "SPECIES", 186, 193], ["an established therapy", "TREATMENT", 29, 51], ["a vaccine", "TREATMENT", 78, 87], ["prevention", "TREATMENT", 102, 112]]], ["4, 5 This concept of social distancing in which individuals have to maintain atleast one meter distance from each other, is being widely publicized by the World Health Organisation (WHO), Centre for disease control (CDC) and Indian Council of Medical Research (ICMR) for preventing spread of the virus.Introduction :While there are only a handful of case reports to date regarding COVID-19 infection in posttransplant patients.", [["infection", "DISEASE", 390, 399], ["individuals", "ORGANISM", 48, 59], ["COVID-19", "ORGANISM", 381, 389], ["patients", "ORGANISM", 418, 426], ["patients", "SPECIES", 418, 426], ["COVID-19", "SPECIES", 381, 389], ["Medical Research (ICMR)", "TREATMENT", 243, 266], ["the virus", "PROBLEM", 292, 301], ["COVID-19 infection", "PROBLEM", 381, 399], ["virus", "OBSERVATION", 296, 301], ["infection", "OBSERVATION", 390, 399]]], ["Any infection in this cohort including COVID-19 is a major concern because of their immunocompromised status.", [["infection", "DISEASE", 4, 13], ["COVID-19", "CHEMICAL", 39, 47], ["Any infection", "PROBLEM", 0, 13], ["COVID", "TEST", 39, 44], ["their immunocompromised status", "PROBLEM", 78, 108], ["infection", "OBSERVATION", 4, 13], ["immunocompromised", "OBSERVATION", 84, 101]]], ["Pediatric liver transplant recipients form a special group due to their continued association with their treating teams as these patients require periodic follow up for clinical evaluation and also for investigations including liver functions, immunosuppression levels and abdominal imaging.", [["liver", "ANATOMY", 10, 15], ["liver", "ANATOMY", 227, 232], ["abdominal", "ANATOMY", 273, 282], ["liver", "ORGAN", 10, 15], ["patients", "ORGANISM", 129, 137], ["liver", "ORGAN", 227, 232], ["abdominal", "ORGANISM_SUBDIVISION", 273, 282], ["patients", "SPECIES", 129, 137], ["Pediatric liver transplant recipients", "TREATMENT", 0, 37], ["clinical evaluation", "TEST", 169, 188], ["investigations", "TEST", 202, 216], ["liver functions", "TEST", 227, 242], ["immunosuppression levels", "TEST", 244, 268], ["abdominal imaging", "TEST", 273, 290], ["liver", "ANATOMY", 10, 15], ["transplant", "OBSERVATION", 16, 26], ["liver", "ANATOMY", 227, 232], ["abdominal", "ANATOMY", 273, 282]]], ["There is evidence that the responsibility of caring for these Accepted Article children also increases stress levels in the family leading to increased levels of anxiety in their carers .", [["anxiety", "DISEASE", 162, 169], ["children", "ORGANISM", 79, 87], ["children", "SPECIES", 79, 87], ["stress levels", "PROBLEM", 103, 116], ["anxiety", "PROBLEM", 162, 169]]], ["6 Clear guidance and reassurance is necessary for these families during this period.", [["reassurance", "TREATMENT", 21, 32]]], ["A questionnaire based study was conducted to assess the level of awareness amongst parents of pediatric liver transplant recepients and also identify their main areas of concerns so that effective and targeted education can be provided.Materials and Methods :The study was conducted at Dr Rela Institute and medical centre, which is a large volume quaternary liver transplant hospital.", [["liver", "ANATOMY", 104, 109], ["liver", "ANATOMY", 359, 364], ["liver", "ORGAN", 104, 109], ["liver", "ORGAN", 359, 364], ["A questionnaire based study", "TEST", 0, 27], ["pediatric liver transplant recepients", "TREATMENT", 94, 131], ["The study", "TEST", 259, 268], ["a large volume quaternary liver transplant", "TREATMENT", 333, 375], ["liver", "ANATOMY", 104, 109], ["large", "OBSERVATION_MODIFIER", 335, 340], ["liver", "ANATOMY", 359, 364], ["transplant", "OBSERVATION", 365, 375]]], ["A cross-sectional online survey was sent to the primary caregivers of 172 pediatric liver transplant recipients whom we had transplanted in the last 5 years.", [["liver", "ANATOMY", 84, 89], ["liver", "ORGAN", 84, 89], ["recipients", "ORGANISM", 101, 111], ["pediatric liver transplant recipients", "TREATMENT", 74, 111], ["liver", "ANATOMY", 84, 89], ["transplant", "OBSERVATION", 90, 100]]], ["In total, 230 children were transplanted in our centre over the last 5 years, of which 58 were excluded from the survey, as these were children were being followed up by the pediatric hepatologist in their own native places and we couldn't contact them.", [["children", "ORGANISM", 14, 22], ["children", "ORGANISM", 135, 143], ["children", "SPECIES", 14, 22], ["children", "SPECIES", 135, 143]]], ["The survey was conducted between the dates 21 March 2020 to 26 March 2020.The 19-point questionnaire was distributed through the 'google-forms' online software through email and a reminder email was sent after 72 hours.", [["19-", "OBSERVATION_MODIFIER", 78, 81]]], ["The questionnaire was designed based on queries that we received from a crosssection of our patient carers following initial reports of cases of COVID-19 in India and the WHO declaration of it as a pandemic.", [["patient", "ORGANISM", 92, 99], ["patient", "SPECIES", 92, 99], ["COVID", "TEST", 145, 150], ["a pandemic", "PROBLEM", 196, 206]]], ["Queries were structured under the following headings:Materials and Methods :-Awareness of COVID-19 epidemiology : Parents were asked about the symptomatology of COVID-19, its modes of transmission, the possibility of an asymptomatic person infecting others and also impact on COVID-19 on their child who is a liver recepient.Materials and Methods :-Preventive & protective measures against infection : Parents were asked about the current available means for preventing COVID-19, any precautions they would take to minimise the contact of their child with others individuals and the methods they would use for disinfection in case of contact with a contaminated surface.", [["liver", "ANATOMY", 309, 314], ["surface", "ANATOMY", 662, 669], ["COVID", "DISEASE", 161, 166], ["liver recepient", "DISEASE", 309, 324], ["infection", "DISEASE", 390, 399], ["child", "ORGANISM", 294, 299], ["liver", "ORGAN", 309, 314], ["surface", "CELLULAR_COMPONENT", 662, 669], ["person", "SPECIES", 233, 239], ["COVID", "TEST", 90, 95], ["COVID", "TEST", 161, 166], ["Methods", "TREATMENT", 339, 346], ["Preventive & protective measures", "TREATMENT", 349, 381], ["infection", "PROBLEM", 390, 399], ["COVID", "TREATMENT", 470, 475], ["any precautions", "TREATMENT", 480, 495], ["disinfection", "TREATMENT", 610, 622], ["liver", "ANATOMY", 309, 314]]], ["We also wanted to know how they would act if their child develops any symptoms of flu, if they are worried on that and what they would do with the administration of immunosuppressive medications in such a scenario.", [["flu", "DISEASE", 82, 85], ["any symptoms", "PROBLEM", 66, 78], ["flu", "PROBLEM", 82, 85], ["immunosuppressive medications", "TREATMENT", 165, 194]]], ["We also ellicited their awareness on the class of medicines to be avoided (like NSAIDs) in case of a flu and also their thoughts on deferring the routine clinical and/or lab visits as these children can have potential exposure at these places.Accepted ArticleThis article is protected by copyright.", [["flu", "DISEASE", 101, 104], ["children", "ORGANISM", 190, 198], ["children", "SPECIES", 190, 198], ["medicines", "TREATMENT", 50, 59], ["NSAIDs", "TREATMENT", 80, 86], ["a flu", "PROBLEM", 99, 104]]], ["All rights reserved -Sources of information regarding COVID-19 : We wanted to know the commonest sources the parents would depend upon for getting general information on COVID-19 and also on the sources they would rely on for information regarding precautions and preventive measures to be followed during the ongoing pandemic.Accepted Article-Areas of concerns related to the pandemic : We asked the parents of pediatric liver transplant recepients to list up to five concerns that they wished the medical team to clarify regarding COVID-19 and they were classified into general querries, information on COVID-19Accepted Articlewhich are yet to have scientific basis, concerns regarding prevention and cure, concerns due to lack of access and lockdown, and others.Accepted ArticleData was collected and tabulated in an excel spreadsheet.", [["liver", "ANATOMY", 422, 427], ["liver", "ORGAN", 422, 427], ["precautions", "TREATMENT", 248, 259], ["preventive measures", "TREATMENT", 264, 283], ["liver", "ANATOMY", 422, 427]]], ["The parental response was considered as the consent for participation in the study.Results :There were 106 responses among 172 carers.(62% response rate).", [["the study", "TEST", 73, 82], ["response rate", "TEST", 139, 152]]], ["There were no incomplete submissions.", [["no", "UNCERTAINTY", 11, 13]]], ["The median post-transplant duration of the recipients was 31 (12-52) months.The responses were categorised under the following headings( Table 1) .Awareness of COVID-19 epidemiologyMost parents had a good awareness of the symptoms of COVID-19.", [["COVID", "DISEASE", 234, 239], ["COVID-19", "CHEMICAL", 234, 242], ["recipients", "ORGANISM", 43, 53], ["COVID", "TEST", 160, 165], ["the symptoms", "PROBLEM", 218, 230], ["COVID", "TEST", 234, 239], ["transplant", "OBSERVATION", 16, 26]]], ["A majority recognised fever and its respiratory symptomatology (fever-94% cough-90%, and breathlessness-86%.", [["respiratory", "ANATOMY", 36, 47], ["fever", "DISEASE", 22, 27], ["respiratory symptomatology", "DISEASE", 36, 62], ["fever", "DISEASE", 64, 69], ["cough", "DISEASE", 74, 79], ["breathlessness", "DISEASE", 89, 103], ["fever", "PROBLEM", 22, 27], ["its respiratory symptomatology", "PROBLEM", 32, 62], ["fever", "PROBLEM", 64, 69], ["cough", "TEST", 74, 79], ["breathlessness", "TEST", 89, 103], ["fever", "OBSERVATION", 22, 27], ["respiratory", "ANATOMY", 36, 47]]], ["Only 34 % of parents knew that diarrhea is a common symptom in COVID-19 infection.", [["diarrhea", "DISEASE", 31, 39], ["infection", "DISEASE", 72, 81], ["COVID-19", "ORGANISM", 63, 71], ["COVID-19", "SPECIES", 63, 71], ["diarrhea", "PROBLEM", 31, 39], ["a common symptom in COVID-19 infection", "PROBLEM", 43, 81], ["infection", "OBSERVATION", 72, 81]]], ["70% of the parents were aware that asymptomatic individuals including children can spread the infection.18% of the caregivers were not sure whether asymptomatic individuals can transmit the virus and 12% felt asymptomatic individuals can never spread infection.", [["infection", "DISEASE", 94, 103], ["infection", "DISEASE", 251, 260], ["individuals", "ORGANISM", 48, 59], ["children", "ORGANISM", 70, 78], ["individuals", "ORGANISM", 161, 172], ["individuals", "ORGANISM", 222, 233], ["children", "SPECIES", 70, 78], ["asymptomatic individuals", "PROBLEM", 35, 59], ["the infection", "PROBLEM", 90, 103], ["asymptomatic individuals", "PROBLEM", 148, 172], ["the virus", "PROBLEM", 186, 195], ["asymptomatic individuals", "PROBLEM", 209, 233], ["infection", "PROBLEM", 251, 260], ["infection", "OBSERVATION", 94, 103], ["spread", "OBSERVATION_MODIFIER", 244, 250], ["infection", "OBSERVATION", 251, 260]]], ["Parents were aware of the main modes of disease transmission including droplet spread through coughing or sneezing (93%), and fomites (94%).", [["disease transmission", "PROBLEM", 40, 60], ["droplet spread", "PROBLEM", 71, 85], ["coughing", "PROBLEM", 94, 102], ["sneezing", "PROBLEM", 106, 114], ["disease", "OBSERVATION", 40, 47]]], ["74% were also aware that virus is potentially transmissible by kissing.", [["virus", "PROBLEM", 25, 30]]], ["Only 27% were aware that feco-oral transmission is possible.", [["feco-oral transmission", "PROBLEM", 25, 47]]], ["86% also felt that COVID-19 infection can be severe in the post-liver transplant patients, as they are immunocompromised.Preventive & protective measures against infection11% of parents were not concerned of the COVID-19 and 3% felt it never affects children.", [["post-liver transplant", "ANATOMY", 59, 80], ["COVID-19", "CHEMICAL", 19, 27], ["infection", "DISEASE", 28, 37], ["COVID-19", "ORGANISM", 19, 27], ["patients", "ORGANISM", 81, 89], ["infection11", "ORGANISM", 162, 173], ["children", "ORGANISM", 250, 258], ["patients", "SPECIES", 81, 89], ["children", "SPECIES", 250, 258], ["COVID-19 infection", "PROBLEM", 19, 37], ["immunocompromised", "PROBLEM", 103, 120], ["Preventive & protective measures", "TREATMENT", 121, 153], ["infection", "OBSERVATION", 28, 37], ["severe", "OBSERVATION_MODIFIER", 45, 51], ["post-liver", "ANATOMY", 59, 69], ["transplant", "OBSERVATION", 70, 80], ["immunocompromised", "OBSERVATION", 103, 120]]], ["All rights reserved infection.", [["infection", "DISEASE", 20, 29], ["infection", "PROBLEM", 20, 29], ["rights", "OBSERVATION_MODIFIER", 4, 10], ["reserved", "OBSERVATION_MODIFIER", 11, 19], ["infection", "OBSERVATION", 20, 29]]], ["70%Accepted Articlewere aware that either washing with soap water or with alcohol rub can disinfect the contaminated hands.", [["alcohol", "CHEMICAL", 74, 81], ["alcohol", "CHEMICAL", 74, 81], ["alcohol", "SIMPLE_CHEMICAL", 74, 81], ["hands", "ORGANISM_SUBDIVISION", 117, 122], ["soap water", "TREATMENT", 55, 65], ["the contaminated hands", "PROBLEM", 100, 122]]], ["87% would contact the child specialist or the transplant unit if their child displayed flu-like symptoms.", [["flu-like symptoms", "DISEASE", 87, 104], ["flu-like symptoms", "PROBLEM", 87, 104]]], ["Within the last four weeks, 7(7%) children had some respiratory problem which worried the parents due to the ongoing pandemic.", [["respiratory problem", "DISEASE", 52, 71], ["children", "ORGANISM", 34, 42], ["children", "SPECIES", 34, 42], ["some respiratory problem", "PROBLEM", 47, 71], ["pandemic", "PROBLEM", 117, 125], ["respiratory", "ANATOMY", 52, 63], ["problem", "OBSERVATION", 64, 71]]], ["98% would never modify their immunosuppressive agents including stopping or reducing the dose if there is a flu-like illness in their child and would rather talk to the transplant team for advice.", [["flu-like illness", "DISEASE", 108, 124], ["their immunosuppressive agents", "TREATMENT", 23, 53]]], ["Majority (65%) would also avoid non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen, aspirin and diclofenac (8) .Accepted Article80% of responding parents understood the risk of travelling outside including for clinic appointments and blood tests and would contact the transplant team for guidance.", [["non-steroidal", "ANATOMY", 32, 45], ["blood", "ANATOMY", 245, 250], ["ibuprofen", "CHEMICAL", 84, 93], ["aspirin", "CHEMICAL", 95, 102], ["diclofenac", "CHEMICAL", 107, 117], ["ibuprofen", "CHEMICAL", 84, 93], ["aspirin", "CHEMICAL", 95, 102], ["diclofenac", "CHEMICAL", 107, 117], ["non-steroidal anti-inflammatory drugs", "SIMPLE_CHEMICAL", 32, 69], ["NSAIDs", "SIMPLE_CHEMICAL", 71, 77], ["ibuprofen", "SIMPLE_CHEMICAL", 84, 93], ["aspirin", "SIMPLE_CHEMICAL", 95, 102], ["diclofenac", "SIMPLE_CHEMICAL", 107, 117], ["blood", "ORGANISM_SUBSTANCE", 245, 250], ["non-steroidal anti-inflammatory drugs", "TREATMENT", 32, 69], ["NSAIDs)", "TREATMENT", 71, 78], ["ibuprofen", "TREATMENT", 84, 93], ["aspirin", "TREATMENT", 95, 102], ["diclofenac", "TREATMENT", 107, 117], ["blood tests", "TEST", 245, 256]]], ["10%Accepted Articlerespondents were not worried about visiting the hospital, and 10% wanted to defer the visit or blood test because of the risk of infection.Sources of information regarding COVID-1985% of respondents depended on television and 55 % depended on newspapers to get information regarding the pandemic and safety precautions to be observed( Figure 1 ).Sources of information regarding COVID-19Interestingly social media such as Whatsapp and Facebook appeared to be an important source of COVID-19 related information amongst the respondents with over 40% stating they would rely on these sources for advice about safety measures.Areas of concerns related to the pandemic68% of respondents conveyed their concerns through the questionnaire ( Table 2 ).", [["blood", "ANATOMY", 114, 119], ["infection", "DISEASE", 148, 157], ["blood", "ORGANISM_SUBSTANCE", 114, 119], ["blood test", "TEST", 114, 124], ["infection", "PROBLEM", 148, 157], ["safety precautions", "TREATMENT", 319, 337], ["safety measures", "TREATMENT", 626, 641], ["infection", "OBSERVATION", 148, 157]]], ["The queries were primarily concerned about early recognition of symptoms, questions related to homeremedies and unconventional treatments circulating over social media and concerns regarding treatment options, follow-up visits and supply of medications during the period of lockdown.Discussion :Since COVID-19 was declared as a pandemic by the WHO, over 850000 individuals have been affected by the virus.", [["individuals", "ORGANISM", 361, 372], ["symptoms", "PROBLEM", 64, 72], ["homeremedies", "TREATMENT", 95, 107], ["unconventional treatments", "TREATMENT", 112, 137], ["treatment options", "TREATMENT", 191, 208], ["medications", "TREATMENT", 241, 252], ["the virus", "PROBLEM", 395, 404], ["virus", "OBSERVATION", 399, 404]]], ["4 To date, there are only a few case reports of COVID-19 infection in solid organ transplant recipients.", [["solid organ transplant", "ANATOMY", 70, 92], ["COVID-19", "CHEMICAL", 48, 56], ["infection", "DISEASE", 57, 66], ["COVID-19", "ORGANISM", 48, 56], ["solid", "CANCER", 70, 75], ["organ", "ORGAN", 76, 81], ["COVID-19 infection", "PROBLEM", 48, 66], ["solid organ transplant recipients", "TREATMENT", 70, 103], ["infection", "OBSERVATION", 57, 66], ["solid organ", "ANATOMY", 70, 81], ["transplant recipients", "OBSERVATION", 82, 103]]], ["7, 8 In a previous review on the effect of common respiratory virus inAccepted ArticleThis article is protected by copyright.", [["common respiratory virus", "PROBLEM", 43, 67], ["respiratory virus", "OBSERVATION", 50, 67]]], ["All rights reserved recipients of solid organ transplantation, it was reported that transplant recipients were more prone to develop lower respiratory tract infection which can progress more rapidly when compared to the normal population.", [["organ", "ANATOMY", 40, 45], ["lower respiratory tract", "ANATOMY", 133, 156], ["respiratory tract infection", "DISEASE", 139, 166], ["recipients", "ORGANISM", 20, 30], ["organ", "ORGAN", 40, 45], ["recipients", "ORGANISM", 95, 105], ["lower", "ORGANISM_SUBDIVISION", 133, 138], ["respiratory tract", "ORGANISM_SUBDIVISION", 139, 156], ["solid organ transplantation", "TREATMENT", 34, 61], ["transplant recipients", "TREATMENT", 84, 105], ["lower respiratory tract infection", "PROBLEM", 133, 166], ["solid organ transplantation", "OBSERVATION", 34, 61], ["lower", "ANATOMY_MODIFIER", 133, 138], ["respiratory tract", "ANATOMY", 139, 156], ["infection", "OBSERVATION", 157, 166], ["normal", "OBSERVATION", 220, 226]]], ["These patients also have higher viral loads, prolonged shedding of the viruses, and increased morbidity and mortality from respiratory failure.", [["respiratory", "ANATOMY", 123, 134], ["respiratory failure", "DISEASE", 123, 142], ["patients", "ORGANISM", 6, 14], ["patients", "SPECIES", 6, 14], ["higher viral loads", "PROBLEM", 25, 43], ["prolonged shedding of the viruses", "PROBLEM", 45, 78], ["increased morbidity", "PROBLEM", 84, 103], ["respiratory failure", "PROBLEM", 123, 142], ["higher", "OBSERVATION_MODIFIER", 25, 31], ["viral loads", "OBSERVATION", 32, 43], ["viruses", "OBSERVATION", 71, 78], ["increased", "OBSERVATION_MODIFIER", 84, 93], ["morbidity", "OBSERVATION", 94, 103], ["respiratory failure", "OBSERVATION", 123, 142]]], ["9 It is also known that the corona group of viruses can themselves worsen the outcome in transplant recipients.", [["recipients", "ORGANISM", 100, 110], ["the corona group of viruses", "PROBLEM", 24, 51], ["transplant recipients", "TREATMENT", 89, 110], ["corona", "OBSERVATION_MODIFIER", 28, 34], ["viruses", "OBSERVATION", 44, 51]]], ["10,11 Hence, the impact of the COVOID-19 pandemic on the health of transplant recipients cannot be under-estimated.Accepted ArticleAnother factor of significance is the explosion of information on social media platforms which is creating a 'pandemic of panic'.", [["panic", "DISEASE", 253, 258], ["recipients", "ORGANISM", 78, 88], ["ArticleAnother factor", "PROTEIN", 124, 145], ["the COVOID", "TREATMENT", 27, 37], ["transplant recipients", "TREATMENT", 67, 88], ["panic'", "PROBLEM", 253, 259]]], ["12 In a recent study looking at the awareness of general public on COVID-19 done across USA and UK, a number of misconceptions regarding this viral infection and the increasing ability of social media to influence beliefs were identified.", [["viral infection", "DISEASE", 142, 157], ["a recent study", "TEST", 6, 20], ["COVID", "TEST", 67, 72], ["this viral infection", "PROBLEM", 137, 157], ["viral", "OBSERVATION_MODIFIER", 142, 147], ["infection", "OBSERVATION", 148, 157]]], ["13 The WHO has also identified this as a major safety concern and published a 'myth-buster' list related to the COVID-19 pandemic.", [["the COVID", "TEST", 108, 117], ["pandemic", "PROBLEM", 121, 129]]], ["14 We conducted this survey to assess the extent of awareness amongst carers of our pediatric recipients as we expected them to be concerned More than the general population.", [["recipients", "ORGANISM", 94, 104], ["this survey", "TEST", 16, 27]]], ["It was also a concern that excessive reliance on social media could lead to them making health-care decisions and interventions which may be unsafe for the child and the graft.Accepted ArticleThe results of our study are encouraging and suggests that the parents are quite clued-in regarding the current COVID-19 scenario.", [["graft", "TISSUE", 170, 175], ["interventions", "TREATMENT", 114, 127], ["the graft", "TREATMENT", 166, 175], ["our study", "TEST", 207, 216], ["graft", "OBSERVATION", 170, 175]]], ["Majority were aware of the symptomatology, mode of spread of infection and most recognised the increased risk for their child due to the immunosuppression.", [["infection", "DISEASE", 61, 70], ["the symptomatology", "PROBLEM", 23, 41], ["infection", "PROBLEM", 61, 70], ["the immunosuppression", "TREATMENT", 133, 154], ["infection", "OBSERVATION", 61, 70], ["immunosuppression", "OBSERVATION", 137, 154]]], ["30% of the parents were either not sure or were unaware about the fact that asymptomatic carriers can transmit the infection.Accepted ArticleIt was also reassuring that parents were more likely to get their information from traditional media such as television and newspaper which are considered more trustworthy and less likely to provide unsubstantiated information.", [["infection", "DISEASE", 115, 124], ["asymptomatic carriers", "PROBLEM", 76, 97], ["the infection", "PROBLEM", 111, 124], ["infection", "OBSERVATION", 115, 124]]], ["12% of parents however went to the extreme of suggesting the need for strict isolation to a room.", [["strict isolation", "TREATMENT", 70, 86]]], ["All rights reserved home visitors and the basics of hygiene are practised, isolation is not needed unless the child shows some symptoms of flu.", [["flu", "DISEASE", 139, 142], ["isolation", "TREATMENT", 75, 84], ["some symptoms", "PROBLEM", 122, 135], ["flu", "PROBLEM", 139, 142], ["flu", "OBSERVATION", 139, 142]]], ["Such isolation is a definite stressor for a child and can lead to mental problems like anxiety and post-traumatic stress disorder.", [["anxiety", "DISEASE", 87, 94], ["post-traumatic stress disorder", "DISEASE", 99, 129], ["mental problems", "PROBLEM", 66, 81], ["anxiety", "PROBLEM", 87, 94], ["post-traumatic stress disorder", "PROBLEM", 99, 129], ["post-traumatic stress", "OBSERVATION", 99, 120]]], ["16 In children of appropriate mental age, it is recommended that parents discuss the seriousness of the current scenario in simple terms and should not induce panic.Accepted ArticleMajority of the respondents appeared to have a healthy belief in the healthcare system and would contact the medical team in case of any worrying signs.", [["panic", "DISEASE", 159, 164], ["children", "ORGANISM", 6, 14], ["children", "SPECIES", 6, 14], ["panic", "PROBLEM", 159, 164]]], ["98% of the participants responded that that they will not alter the immunosuppression without discussing with the primary physician.", [["participants", "ORGANISM", 11, 23], ["participants", "SPECIES", 11, 23], ["the immunosuppression", "TREATMENT", 64, 85]]], ["They also understood the need for minimising exposure for the child on clinic appointments and were happy to interact with the medical team on the phone.Accepted ArticleFrom this survey, we have used inputs from the parental responses along with the most common querries they had to modify our patient care protocols during this period and a detailed parentfriendly information brochure on COVID-19 was prepared and circulated through emails to the parents of liver transplant recepients.", [["liver", "ANATOMY", 460, 465], ["COVID-19", "CHEMICAL", 390, 398], ["patient", "ORGANISM", 294, 301], ["liver", "ORGAN", 460, 465], ["patient", "SPECIES", 294, 301], ["liver transplant recepients", "TREATMENT", 460, 487], ["liver", "ANATOMY", 460, 465], ["transplant", "OBSERVATION", 466, 476]]], ["We also have initiated home visits for routine blood sample collection to minimise hospital visit.", [["blood sample", "ANATOMY", 47, 59], ["blood", "ORGANISM_SUBSTANCE", 47, 52], ["routine blood sample collection", "TREATMENT", 39, 70]]], ["As the knowledge regarding COVID-19 continues to increase exponentially, we have tried to provide the most updated information to the parents of our pediatric liver transplant recepients and also rectified any misinformation they had through the above mentioned services.Accepted ArticleWe had a response rate of 62 % which is appreciable for on an online survey.", [["liver", "ANATOMY", 159, 164], ["liver", "ORGAN", 159, 164], ["COVID", "TEST", 27, 32], ["a response rate", "TEST", 294, 309], ["liver", "ANATOMY", 159, 164]]], ["Our medium for long term contact with the patient's family is usually through emails and we had conducted this survey through emails.", [["patient", "ORGANISM", 42, 49], ["patient", "SPECIES", 42, 49]]], ["These factors probably helped in getting a good response to this survey.Accepted ArticleThe main limitations of the study are that it is a single centre study and the questionnaire used is specific for COVID-19 and hence by its very nature not validated.", [["the study", "TEST", 112, 121], ["a single centre study", "TEST", 137, 158], ["COVID", "TEST", 202, 207], ["main", "OBSERVATION_MODIFIER", 92, 96]]], ["It is also possible that the concerns regarding the influence of social media may not be constant across all countries or societies.", [["social media", "TREATMENT", 65, 77], ["also possible", "UNCERTAINTY", 6, 19]]], ["However, we believe that the results of the survey can guide pediatric liver transplant teams across the globe in addressing common concerns of parents and ensuring that they get accurate and reliable information.Accepted ArticleThis article is protected by copyright.", [["liver", "ANATOMY", 71, 76], ["liver", "ORGAN", 71, 76], ["liver", "ANATOMY", 71, 76], ["globe", "ANATOMY", 105, 110]]], ["All rights reservedWhat is the impact of Coronavirus infection (COVID-19) on your child?It has no effect on my child No, we don't feel there is a risk and routine tests can be done There is a definite risk and I want to defer the labs There is a risk, so will contact the transplant centre for advice 10(10) 11(10)Accepted ArticleThis article is protected by copyright.", [["infection", "DISEASE", 53, 62], ["Coronavirus", "ORGANISM", 41, 52], ["Coronavirus infection", "PROBLEM", 41, 62], ["routine tests", "TEST", 155, 168], ["the labs", "TEST", 226, 234], ["Coronavirus", "OBSERVATION_MODIFIER", 41, 52], ["infection", "OBSERVATION", 53, 62], ["no", "UNCERTAINTY", 95, 97], ["effect", "OBSERVATION_MODIFIER", 98, 104]]], ["All rights reserved current COVID19 scenario which you believe are important", [["current COVID19 scenario", "TREATMENT", 20, 44]]]], "3130b0c01369b316081719e48857bae1ede5683a": [["Additionally, morphological and particle analyses of T. gondii cysts were applied to gain further insight into the cyst 73 shape uniformity, as well as to a possible correlation between the cyst size and the number of parasites.", [["cyst", "ANATOMY", 115, 119], ["cyst", "ANATOMY", 190, 194], ["T. gondii", "ORGANISM", 53, 62], ["cyst", "CANCER", 190, 194], ["T. gondii", "SPECIES", 53, 62], ["T. gondii", "SPECIES", 53, 62], ["T. gondii cysts", "PROBLEM", 53, 68], ["the cyst size", "PROBLEM", 186, 199], ["particle", "OBSERVATION_MODIFIER", 32, 40], ["gondii cysts", "OBSERVATION", 56, 68], ["cyst", "OBSERVATION", 115, 119], ["shape", "OBSERVATION_MODIFIER", 123, 128], ["uniformity", "OBSERVATION_MODIFIER", 129, 139], ["cyst", "OBSERVATION", 190, 194], ["size", "OBSERVATION_MODIFIER", 195, 199], ["number", "OBSERVATION_MODIFIER", 208, 214], ["parasites", "OBSERVATION", 218, 227]]], ["Perimeter Area y Circularit \uf0b4 \uf03d circularity values close to 1.0, whereas elongated shapes have very low circularity (close to 0.0).", [["circularity values", "TEST", 32, 50], ["very low circularity", "PROBLEM", 95, 115], ["circularity", "OBSERVATION_MODIFIER", 32, 43], ["very", "OBSERVATION_MODIFIER", 95, 99], ["low circularity", "OBSERVATION_MODIFIER", 100, 115]]], ["Cysts were transferred to black background images for subsequent particle analysis.124For particle analysis, images were first enhanced using histogram equalization.", [["Cysts", "ANATOMY", 0, 5], ["Cysts", "PROBLEM", 0, 5], ["black background images", "TEST", 26, 49], ["subsequent particle analysis", "TEST", 54, 82], ["particle analysis", "TEST", 90, 107], ["images", "TEST", 109, 115], ["histogram equalization", "TEST", 142, 164]]], ["During this relative particle count (RPC) was determined following the local Bernsen auto-thresholding, watershed further segmented by a watershed algorithm for two reasons: a) it seems that, due to a low local border clearly separated particle areas.", [["this relative particle count", "TEST", 7, 35], ["the local Bernsen auto-thresholding", "TREATMENT", 67, 102], ["a watershed algorithm", "TEST", 135, 156], ["a low local border clearly separated particle areas", "PROBLEM", 199, 250], ["separated", "OBSERVATION_MODIFIER", 226, 235], ["particle", "OBSERVATION_MODIFIER", 236, 244]]], ["In that manner, all of the cyst cross-section images were subjected to an 148 automated processing and the obtained particle numbers, N p , were expected to be proportional to the Fig 2C.", [["cyst", "ANATOMY", 27, 31], ["the cyst cross-section images", "TEST", 23, 52], ["cyst", "OBSERVATION", 27, 31]]], ["The FD was obtained as a negative slope of the best-fit regression line:124Each FD calculation is accompanied by the correlation coefficient, , describing a goodness of 2 r 193 fit of the regression line, in a particular case.194In the cumulative mass method, a probability of finding a certain pixel number within a given194Lacunarity of a fractal set represents the ratio of the second-order moment (variance) to the194In addition to the mentioned parameters, we defined another parameter measuring the 207 percentage of space covered by bradyzoites, and termed it 'packing density' (PD).", [["PD", "DISEASE", 586, 588], ["the regression line", "TREATMENT", 184, 203], ["bradyzoites", "PROBLEM", 540, 551], ["it 'packing density' (PD", "TREATMENT", 564, 588], ["regression line", "OBSERVATION", 188, 203], ["mass", "OBSERVATION", 247, 251], ["packing density", "OBSERVATION", 568, 583]]], ["The two-dimensional 208 analysis was performed on the cyst cross-sectional areas captured on microscope.", [["cyst", "ANATOMY", 54, 58], ["The two-dimensional 208 analysis", "TEST", 0, 32], ["microscope", "TEST", 93, 103], ["cyst", "OBSERVATION", 54, 58]]], ["Both particle analysis 209 and fractal analysis provided the number of black pixels in a considered cross section, N B .", [["Both particle analysis", "TEST", 0, 22], ["fractal analysis", "TEST", 31, 47], ["black pixels", "PROBLEM", 71, 83], ["particle", "OBSERVATION_MODIFIER", 5, 13]]], ["The total number of pixels in a cross section, N T , was known in all cases, which allowed the packing density 211 estimation as 212 .194(7)194The 3A; Fig 4A,B) .", [["a cross section", "TREATMENT", 30, 45], ["total", "OBSERVATION_MODIFIER", 4, 9]]], ["Lacunarity, on the other hand, differed among the strains, in that it was significantly lower 265 in the BGD1 strain in comparison to the three other ones (p\u22640.001), as well as in BGD14 and BGD26 vs.266Me49 (Tukey p=0.044 and p=0.033, respectively), but not between BGD14 and BGD26 (p=0.99) (Fig 3B) .291In an attempt to improve the understanding of the nature of the tissue cyst structural The analyzed cysts widely differed in diameter, with the cysts obtained from the experiment 299 being smaller, albeit not significantly, compared to historical (archived) cysts.", [["tissue cyst", "ANATOMY", 368, 379], ["cysts", "ANATOMY", 404, 409], ["cysts", "ANATOMY", 448, 453], ["cysts", "ANATOMY", 562, 567], ["Lacunarity", "DISEASE", 0, 10], ["BGD1", "GENE_OR_GENE_PRODUCT", 105, 109], ["BGD14", "GENE_OR_GENE_PRODUCT", 180, 185], ["tissue cyst", "MULTI-TISSUE_STRUCTURE", 368, 379], ["cysts", "CANCER", 404, 409], ["cysts", "PATHOLOGICAL_FORMATION", 448, 453], ["cysts", "PATHOLOGICAL_FORMATION", 562, 567], ["BGD14", "PROTEIN", 266, 271], ["Lacunarity", "PROBLEM", 0, 10], ["the BGD1 strain", "PROBLEM", 101, 116], ["BGD26", "TEST", 190, 195], ["Tukey p", "TEST", 208, 215], ["p", "TEST", 226, 227], ["BGD14", "TEST", 266, 271], ["BGD26", "TEST", 276, 281], ["the tissue cyst", "PROBLEM", 364, 379], ["The analyzed cysts", "PROBLEM", 391, 409], ["the cysts", "PROBLEM", 444, 453], ["historical (archived) cysts", "PROBLEM", 540, 567], ["tissue", "ANATOMY", 368, 374], ["cyst", "OBSERVATION", 375, 379], ["cysts", "OBSERVATION", 404, 409], ["widely", "OBSERVATION_MODIFIER", 410, 416], ["differed", "OBSERVATION_MODIFIER", 417, 425], ["diameter", "OBSERVATION_MODIFIER", 429, 437], ["cysts", "OBSERVATION", 448, 453], ["smaller", "OBSERVATION_MODIFIER", 493, 500], ["significantly", "OBSERVATION_MODIFIER", 513, 526], ["cysts", "OBSERVATION", 562, 567]]], ["This may be due to a bias 300 towards larger, more interesting cysts kept in a laboratory photo archive.", [["cysts", "ANATOMY", 63, 68], ["more interesting cysts", "PROBLEM", 46, 68], ["may be due to", "UNCERTAINTY", 5, 18], ["larger", "OBSERVATION_MODIFIER", 38, 44], ["more interesting", "OBSERVATION_MODIFIER", 46, 62], ["cysts", "OBSERVATION", 63, 68]]]], "8104d7b95efed70e16c8d453024fb99756e7ebe9": [["BackgroundStevens-Johnson Syndrome (SJS) is an acute mucocutaneous eruption with blisters of the skin and haemorrhagic erosions of mucous membranes.", [["blisters", "ANATOMY", 81, 89], ["skin", "ANATOMY", 97, 101], ["mucous membranes", "ANATOMY", 131, 147], ["BackgroundStevens-Johnson Syndrome", "DISEASE", 0, 34], ["SJS", "DISEASE", 36, 39], ["erosions", "DISEASE", 119, 127], ["skin", "ORGAN", 97, 101], ["mucous membranes", "MULTI-TISSUE_STRUCTURE", 131, 147], ["BackgroundStevens-Johnson Syndrome (SJS)", "SPECIES", 0, 40], ["Johnson Syndrome", "PROBLEM", 18, 34], ["an acute mucocutaneous eruption", "PROBLEM", 44, 75], ["blisters of the skin", "PROBLEM", 81, 101], ["haemorrhagic erosions of mucous membranes", "PROBLEM", 106, 147], ["Johnson Syndrome", "OBSERVATION", 18, 34], ["acute", "OBSERVATION_MODIFIER", 47, 52], ["mucocutaneous eruption", "OBSERVATION", 53, 75], ["blisters", "OBSERVATION", 81, 89], ["skin", "ANATOMY", 97, 101], ["haemorrhagic", "OBSERVATION_MODIFIER", 106, 118], ["erosions", "OBSERVATION", 119, 127], ["mucous membranes", "OBSERVATION", 131, 147]]], ["This report describes air-leak syndrome and obstructive uropathy occurring early in the disease course of a teenage patient affected by SJS.", [["air-leak syndrome", "DISEASE", 22, 39], ["obstructive uropathy", "DISEASE", 44, 64], ["SJS", "DISEASE", 136, 139], ["patient", "ORGANISM", 116, 123], ["patient", "SPECIES", 116, 123], ["air-leak syndrome", "PROBLEM", 22, 39], ["obstructive uropathy", "PROBLEM", 44, 64], ["air-leak syndrome", "OBSERVATION", 22, 39], ["obstructive", "OBSERVATION_MODIFIER", 44, 55], ["uropathy", "OBSERVATION", 56, 64], ["SJS", "OBSERVATION", 136, 139]]], ["The importance is that it is the first report in the medical literature describing these two complications occurring simultaneously in an affected patient.", [["patient", "ORGANISM", 147, 154], ["patient", "SPECIES", 147, 154], ["these two complications", "PROBLEM", 83, 106]]], ["We describe the events during our patient's stay on the intensive care unit (ICU), provide a literature review of these rare complications, and derive clinically important learning points from our experience.Case presentationA 17-year-old Malay female with no significant past medical history presented with rashes over the neck and trunk and swollen lips.", [["neck", "ANATOMY", 324, 328], ["trunk", "ANATOMY", 333, 338], ["lips", "ANATOMY", 351, 355], ["rashes", "DISEASE", 308, 314], ["patient", "ORGANISM", 34, 41], ["female", "ORGANISM", 245, 251], ["neck", "ORGANISM_SUBDIVISION", 324, 328], ["trunk", "ORGANISM_SUBDIVISION", 333, 338], ["lips", "ORGANISM_SUBDIVISION", 351, 355], ["patient", "SPECIES", 34, 41], ["these rare complications", "PROBLEM", 114, 138], ["rashes over the neck and trunk and swollen lips", "PROBLEM", 308, 355], ["no", "UNCERTAINTY", 257, 259], ["significant", "OBSERVATION_MODIFIER", 260, 271], ["rashes", "OBSERVATION", 308, 314], ["neck", "ANATOMY", 324, 328], ["trunk", "ANATOMY", 333, 338], ["swollen lips", "ANATOMY", 343, 355]]], ["She had been unwell for 2 days prior to hospital attendance with symptoms of fever, sore throat, and running nose and red itchy eyes.", [["nose", "ANATOMY", 109, 113], ["eyes", "ANATOMY", 128, 132], ["fever", "DISEASE", 77, 82], ["sore throat", "DISEASE", 84, 95], ["itchy", "DISEASE", 122, 127], ["nose", "ORGANISM_SUBDIVISION", 109, 113], ["eyes", "ORGAN", 128, 132], ["unwell", "PROBLEM", 13, 19], ["symptoms", "PROBLEM", 65, 73], ["fever", "PROBLEM", 77, 82], ["sore throat", "PROBLEM", 84, 95], ["running nose and red itchy eyes", "PROBLEM", 101, 132], ["fever", "OBSERVATION", 77, 82], ["sore throat", "ANATOMY", 84, 95], ["nose", "ANATOMY", 109, 113], ["itchy eyes", "OBSERVATION", 122, 132]]], ["She had attended her family physician 1 day before presentation to hospital and had been prescribed paracetamol, dequalinium lozenges, loratidine/pseudoephrine nasal spray, and co-amoxiclav tablets, of which she had taken two doses.Case presentationInspection of the patient's skin revealed scattered dusky, flaccid blisters demonstrating positive Nikolsky's sign (Fig. 1 ).", [["nasal", "ANATOMY", 160, 165], ["skin", "ANATOMY", 277, 281], ["blisters", "ANATOMY", 316, 324], ["paracetamol", "CHEMICAL", 100, 111], ["dequalinium lozenges", "CHEMICAL", 113, 133], ["loratidine", "CHEMICAL", 135, 145], ["pseudoephrine", "CHEMICAL", 146, 159], ["flaccid blisters", "DISEASE", 308, 324], ["paracetamol", "CHEMICAL", 100, 111], ["dequalinium lozenges", "CHEMICAL", 113, 133], ["loratidine", "CHEMICAL", 135, 145], ["paracetamol", "SIMPLE_CHEMICAL", 100, 111], ["dequalinium lozenges", "SIMPLE_CHEMICAL", 113, 133], ["loratidine", "SIMPLE_CHEMICAL", 135, 145], ["pseudoephrine", "SIMPLE_CHEMICAL", 146, 159], ["co-amoxiclav", "SIMPLE_CHEMICAL", 177, 189], ["patient", "ORGANISM", 267, 274], ["skin", "ORGAN", 277, 281], ["dusky", "ORGANISM_SUBDIVISION", 301, 306], ["patient", "SPECIES", 267, 274], ["paracetamol", "TREATMENT", 100, 111], ["dequalinium lozenges", "TREATMENT", 113, 133], ["loratidine", "TREATMENT", 135, 145], ["pseudoephrine nasal spray", "TREATMENT", 146, 171], ["co-amoxiclav tablets", "TREATMENT", 177, 197], ["the patient's skin", "TEST", 263, 281], ["scattered dusky", "PROBLEM", 291, 306], ["flaccid blisters", "PROBLEM", 308, 324], ["positive Nikolsky's sign", "PROBLEM", 339, 363], ["skin", "ANATOMY", 277, 281], ["scattered", "OBSERVATION_MODIFIER", 291, 300], ["dusky", "OBSERVATION_MODIFIER", 301, 306], ["flaccid", "OBSERVATION_MODIFIER", 308, 315], ["blisters", "OBSERVATION", 316, 324], ["positive", "OBSERVATION_MODIFIER", 339, 347]]], ["These were distributed over the face (including hairline and scalp), neck, anterior trunk, and back (Fig. 2) .", [["face", "ANATOMY", 32, 36], ["hairline", "ANATOMY", 48, 56], ["scalp", "ANATOMY", 61, 66], ["neck", "ANATOMY", 69, 73], ["anterior trunk", "ANATOMY", 75, 89], ["back", "ANATOMY", 95, 99], ["hairline", "ORGANISM_SUBDIVISION", 48, 56], ["scalp", "ORGAN", 61, 66], ["neck", "ORGANISM_SUBDIVISION", 69, 73], ["anterior trunk", "MULTI-TISSUE_STRUCTURE", 75, 89], ["back", "ORGANISM_SUBDIVISION", 95, 99], ["hairline and scalp), neck, anterior trunk, and back (Fig", "PROBLEM", 48, 104], ["face", "ANATOMY", 32, 36], ["hairline", "ANATOMY", 48, 56], ["scalp", "ANATOMY", 61, 66], ["neck", "ANATOMY", 69, 73], ["anterior", "ANATOMY_MODIFIER", 75, 83], ["trunk", "ANATOMY", 84, 89], ["back", "ANATOMY", 95, 99]]], ["Most of her arms and all of her legs were spared.", [["legs", "ANATOMY", 32, 36], ["legs", "ORGANISM_SUBDIVISION", 32, 36], ["arms", "ANATOMY", 12, 16], ["legs", "ANATOMY", 32, 36]]], ["There was no evidence of secondary cutaneous infection.", [["cutaneous", "ANATOMY", 35, 44], ["infection", "DISEASE", 45, 54], ["cutaneous", "ORGANISM_SUBDIVISION", 35, 44], ["secondary cutaneous infection", "PROBLEM", 25, 54], ["no evidence of", "UNCERTAINTY", 10, 24], ["secondary", "OBSERVATION_MODIFIER", 25, 34], ["cutaneous", "OBSERVATION_MODIFIER", 35, 44], ["infection", "OBSERVATION", 45, 54]]], ["Mucosa erosions were seen on the lips as well as the labial surfaces.", [["Mucosa", "ANATOMY", 0, 6], ["lips", "ANATOMY", 33, 37], ["labial surfaces", "ANATOMY", 53, 68], ["erosions", "DISEASE", 7, 15], ["Mucosa erosions", "PATHOLOGICAL_FORMATION", 0, 15], ["lips", "ORGANISM_SUBDIVISION", 33, 37], ["labial surfaces", "MULTI-TISSUE_STRUCTURE", 53, 68], ["Mucosa erosions", "PROBLEM", 0, 15], ["erosions", "OBSERVATION", 7, 15], ["lips", "ANATOMY", 33, 37], ["labial", "ANATOMY", 53, 59], ["surfaces", "ANATOMY_MODIFIER", 60, 68]]], ["Opthalmic examination demonstrated injected conjunctiva with pseudomembranes of the upper and lower palpebral conjunctiva.", [["conjunctiva", "ANATOMY", 44, 55], ["pseudomembranes", "ANATOMY", 61, 76], ["upper", "ANATOMY", 84, 89], ["lower palpebral conjunctiva", "ANATOMY", 94, 121], ["conjunctiva", "ORGAN", 44, 55], ["upper", "ORGANISM_SUBDIVISION", 84, 89], ["palpebral conjunctiva", "ORGAN", 100, 121], ["Opthalmic examination", "TEST", 0, 21], ["pseudomembranes of the upper and lower palpebral conjunctiva", "PROBLEM", 61, 121], ["injected conjunctiva", "OBSERVATION", 35, 55], ["upper", "ANATOMY_MODIFIER", 84, 89], ["lower", "ANATOMY_MODIFIER", 94, 99], ["palpebral conjunctiva", "ANATOMY", 100, 121]]], ["Corneal examination showed a 6-mm epithelial defect on the right side.", [["Corneal", "ANATOMY", 0, 7], ["epithelial", "ANATOMY", 34, 44], ["epithelial", "TISSUE", 34, 44], ["Corneal examination", "TEST", 0, 19], ["a 6-mm epithelial defect on the right side", "PROBLEM", 27, 69], ["6-mm", "OBSERVATION_MODIFIER", 29, 33], ["epithelial", "ANATOMY_MODIFIER", 34, 44], ["defect", "OBSERVATION", 45, 51], ["right", "ANATOMY_MODIFIER", 59, 64]]], ["Skin punch biopsy demonstrated sub-epidermal splitting, necrotic keratinocytes in the epidermis, and apoptotic debris (Fig. 3a, b) .", [["Skin", "ANATOMY", 0, 4], ["epidermal", "ANATOMY", 35, 44], ["necrotic keratinocytes", "ANATOMY", 56, 78], ["epidermis", "ANATOMY", 86, 95], ["necrotic", "DISEASE", 56, 64], ["Skin punch", "MULTI-TISSUE_STRUCTURE", 0, 10], ["necrotic keratinocytes", "CELL", 56, 78], ["epidermis", "TISSUE", 86, 95], ["necrotic keratinocytes", "CELL_TYPE", 56, 78], ["Skin punch biopsy", "TEST", 0, 17], ["sub-epidermal splitting", "PROBLEM", 31, 54], ["necrotic keratinocytes in the epidermis", "PROBLEM", 56, 95], ["apoptotic debris", "PROBLEM", 101, 117], ["sub-", "OBSERVATION_MODIFIER", 31, 35], ["epidermal splitting", "OBSERVATION", 35, 54], ["necrotic", "OBSERVATION_MODIFIER", 56, 64], ["keratinocytes", "OBSERVATION", 65, 78], ["epidermis", "ANATOMY", 86, 95], ["apoptotic debris", "OBSERVATION", 101, 117]]], ["These clinical and histological findings were consistent with a diagnosis of Stevens-Johnson Syndrome.", [["Stevens-Johnson Syndrome", "DISEASE", 77, 101], ["Johnson Syndrome", "PROBLEM", 85, 101], ["consistent with", "UNCERTAINTY", 46, 61], ["Johnson Syndrome", "OBSERVATION", 85, 101]]], ["Severity of illness score for toxic epidermal necrolysis (SCORTEN score) on admission was 2.", [["epidermal", "ANATOMY", 36, 45], ["illness", "DISEASE", 12, 19], ["toxic epidermal necrolysis", "DISEASE", 30, 56], ["epidermal", "ORGAN", 36, 45], ["illness score", "PROBLEM", 12, 25], ["toxic epidermal necrolysis", "PROBLEM", 30, 56], ["SCORTEN score", "TEST", 58, 71], ["necrolysis", "OBSERVATION", 46, 56]]], ["The trigger for her SJS remains uncertain.", [["SJS", "DISEASE", 20, 23], ["her SJS", "PROBLEM", 16, 23], ["SJS", "OBSERVATION", 20, 23]]], ["ALDEN scoring for all drugs was \u2212 3; onset of red eye symptom was taken as probable index day [1] .", [["red eye", "ANATOMY", 46, 53], ["eye", "ORGAN", 50, 53], ["all drugs", "TREATMENT", 18, 27], ["red eye symptom", "PROBLEM", 46, 61], ["eye", "ANATOMY", 50, 53]]], ["Infectious screening for human immunodeficiency virus, respiratory viral panel (influenza A and B, respiratory syncytial viruses A and B, coronaviruses), Mycoplasma (Acute titre), and Epstein-Barr virus serology were negative.", [["human immunodeficiency virus", "DISEASE", 25, 53], ["respiratory viral panel", "DISEASE", 55, 78], ["influenza A and B", "DISEASE", 80, 97], ["respiratory syncytial viruses", "DISEASE", 99, 128], ["human immunodeficiency virus", "ORGANISM", 25, 53], ["influenza A and B, respiratory syncytial viruses A", "ORGANISM", 80, 130], ["B", "CANCER", 135, 136], ["coronaviruses", "ORGANISM", 138, 151], ["Epstein-Barr virus", "ORGANISM", 184, 202], ["human", "SPECIES", 25, 30], ["immunodeficiency virus", "SPECIES", 31, 53], ["human immunodeficiency virus", "SPECIES", 25, 53], ["Epstein-Barr virus", "SPECIES", 184, 202], ["Infectious screening", "TEST", 0, 20], ["human immunodeficiency virus", "PROBLEM", 25, 53], ["respiratory viral panel", "TEST", 55, 78], ["influenza A", "TEST", 80, 91], ["respiratory syncytial viruses", "PROBLEM", 99, 128], ["coronaviruses", "PROBLEM", 138, 151], ["Mycoplasma", "PROBLEM", 154, 164], ["Acute titre)", "PROBLEM", 166, 178], ["Epstein-Barr virus serology", "TEST", 184, 211], ["respiratory syncytial", "ANATOMY", 99, 120], ["Barr virus", "OBSERVATION", 192, 202]]], ["Serum herpes simplex virus (HSV) IgM was positive, but nasopharyngeal HSV 1 and 2 cultures were negative.Case presentationThe patient was admitted to our ICU with tachycardia and tachypnoea, although blood pressure and peripheral oxygen saturation were within normal limits at the time of admission.", [["blood", "ANATOMY", 200, 205], ["herpes simplex virus", "DISEASE", 6, 26], ["tachycardia", "DISEASE", 163, 174], ["tachypnoea", "DISEASE", 179, 189], ["oxygen", "CHEMICAL", 230, 236], ["oxygen", "CHEMICAL", 230, 236], ["Serum", "ORGANISM_SUBSTANCE", 0, 5], ["herpes simplex virus", "ORGANISM", 6, 26], ["HSV", "ORGANISM", 28, 31], ["IgM", "GENE_OR_GENE_PRODUCT", 33, 36], ["nasopharyngeal HSV 1", "ORGANISM", 55, 75], ["patient", "ORGANISM", 126, 133], ["blood", "ORGANISM_SUBSTANCE", 200, 205], ["oxygen", "SIMPLE_CHEMICAL", 230, 236], ["IgM", "PROTEIN", 33, 36], ["herpes simplex virus", "SPECIES", 6, 26], ["patient", "SPECIES", 126, 133], ["herpes simplex virus", "SPECIES", 6, 26], ["HSV", "SPECIES", 28, 31], ["HSV 1", "SPECIES", 70, 75], ["Serum herpes simplex virus (HSV) IgM", "TEST", 0, 36], ["nasopharyngeal HSV", "TEST", 55, 73], ["2 cultures", "TEST", 80, 90], ["tachycardia", "PROBLEM", 163, 174], ["tachypnoea", "PROBLEM", 179, 189], ["blood pressure", "TEST", 200, 214], ["peripheral oxygen saturation", "TEST", 219, 247], ["herpes simplex virus", "OBSERVATION", 6, 26], ["nasopharyngeal", "ANATOMY", 55, 69], ["tachycardia", "OBSERVATION", 163, 174], ["tachypnoea", "OBSERVATION", 179, 189], ["peripheral", "ANATOMY_MODIFIER", 219, 229], ["oxygen saturation", "OBSERVATION", 230, 247], ["normal limits", "OBSERVATION", 260, 273]]], ["The patient subsequently developed significant pulmonary and renal complications which are described below.", [["pulmonary", "ANATOMY", 47, 56], ["renal", "ANATOMY", 61, 66], ["pulmonary and renal complications", "DISEASE", 47, 80], ["patient", "ORGANISM", 4, 11], ["pulmonary", "ORGAN", 47, 56], ["renal", "ORGAN", 61, 66], ["patient", "SPECIES", 4, 11], ["significant pulmonary and renal complications", "PROBLEM", 35, 80], ["significant", "OBSERVATION_MODIFIER", 35, 46], ["pulmonary", "ANATOMY", 47, 56], ["renal", "ANATOMY", 61, 66], ["complications", "OBSERVATION", 67, 80]]], ["A timeline of significant events and trend of renal function is outlined in Fig. 4 .Urology complicationsBlood tests on admission showed acute kidney injury (creatinine 104 mmol/L).", [["renal", "ANATOMY", 46, 51], ["Blood", "ANATOMY", 105, 110], ["kidney", "ANATOMY", 143, 149], ["acute kidney injury", "DISEASE", 137, 156], ["creatinine", "CHEMICAL", 158, 168], ["creatinine", "CHEMICAL", 158, 168], ["renal", "ORGAN", 46, 51], ["Blood", "ORGANISM_SUBSTANCE", 105, 110], ["kidney", "ORGAN", 143, 149], ["significant events", "PROBLEM", 14, 32], ["Urology complications", "PROBLEM", 84, 105], ["Blood tests", "TEST", 105, 116], ["acute kidney injury", "PROBLEM", 137, 156], ["creatinine", "TEST", 158, 168], ["significant", "OBSERVATION_MODIFIER", 14, 25], ["renal", "ANATOMY", 46, 51], ["function", "OBSERVATION", 52, 60], ["complications", "OBSERVATION", 92, 105], ["acute", "OBSERVATION_MODIFIER", 137, 142], ["kidney", "ANATOMY", 143, 149], ["injury", "OBSERVATION", 150, 156]]], ["Our patient's serum creatinine continued to worsen during admission despite adequate fluid replacement.", [["serum", "ANATOMY", 14, 19], ["fluid", "ANATOMY", 85, 90], ["creatinine", "CHEMICAL", 20, 30], ["creatinine", "CHEMICAL", 20, 30], ["patient", "ORGANISM", 4, 11], ["serum", "ORGANISM_SUBSTANCE", 14, 19], ["creatinine", "SIMPLE_CHEMICAL", 20, 30], ["fluid", "ORGANISM_SUBSTANCE", 85, 90], ["patient", "SPECIES", 4, 11], ["Our patient's serum creatinine", "TEST", 0, 30], ["adequate fluid replacement", "TREATMENT", 76, 102], ["fluid replacement", "OBSERVATION", 85, 102]]], ["Gross haematuria was noted from urinary catheter on the third day of admission.", [["urinary", "ANATOMY", 32, 39], ["haematuria", "DISEASE", 6, 16], ["urinary", "ORGANISM_SUBDIVISION", 32, 39], ["Gross haematuria", "PROBLEM", 0, 16], ["urinary catheter", "TREATMENT", 32, 48], ["haematuria", "OBSERVATION", 6, 16], ["urinary", "ANATOMY", 32, 39], ["catheter", "OBSERVATION", 40, 48]]], ["Urine analysis was negative for casts with 90% isomorphic red blood cells, suggesting urological origin of haematuria.", [["Urine", "ANATOMY", 0, 5], ["red blood cells", "ANATOMY", 58, 73], ["haematuria", "DISEASE", 107, 117], ["Urine", "ORGANISM_SUBSTANCE", 0, 5], ["red blood cells", "CELL", 58, 73], ["red blood cells", "CELL_TYPE", 58, 73], ["Urine analysis", "TEST", 0, 14], ["casts", "TEST", 32, 37], ["red blood cells", "TEST", 58, 73], ["haematuria", "PROBLEM", 107, 117], ["blood cells", "OBSERVATION", 62, 73], ["urological origin", "OBSERVATION_MODIFIER", 86, 103], ["haematuria", "OBSERVATION", 107, 117]]], ["On the fifth day of admission, her urine output dropped significantly.", [["urine", "ANATOMY", 35, 40], ["urine", "ORGANISM_SUBSTANCE", 35, 40], ["her urine output", "TEST", 31, 47]]], ["Bedside ultrasound revealed bilaterally enlarged collecting system, and subsequent CT-KUB confirmed bilateral hydronephrosis and mild hydro-ureters with the presence of dependent debris in pelvicalyceal system and ureters (Fig. 5 , right).", [["collecting system", "ANATOMY", 49, 66], ["pelvicalyceal system", "ANATOMY", 189, 209], ["ureters", "ANATOMY", 214, 221], ["hydronephrosis", "DISEASE", 110, 124], ["hydro-ureters", "DISEASE", 134, 147], ["ureters", "ORGAN", 214, 221], ["Bedside ultrasound", "TEST", 0, 18], ["bilaterally enlarged collecting system", "PROBLEM", 28, 66], ["subsequent CT", "TEST", 72, 85], ["KUB", "TEST", 86, 89], ["bilateral hydronephrosis", "PROBLEM", 100, 124], ["mild hydro-ureters", "PROBLEM", 129, 147], ["dependent debris in pelvicalyceal system", "PROBLEM", 169, 209], ["bilaterally", "ANATOMY_MODIFIER", 28, 39], ["enlarged", "OBSERVATION", 40, 48], ["collecting system", "ANATOMY", 49, 66], ["bilateral", "ANATOMY_MODIFIER", 100, 109], ["hydronephrosis", "OBSERVATION", 110, 124], ["mild", "OBSERVATION_MODIFIER", 129, 133], ["hydro-ureters", "OBSERVATION", 134, 147], ["dependent", "OBSERVATION_MODIFIER", 169, 178], ["debris", "OBSERVATION", 179, 185], ["pelvicalyceal system", "ANATOMY", 189, 209], ["ureters", "ANATOMY", 214, 221], ["right", "ANATOMY_MODIFIER", 232, 237]]], ["Rigid cystoscopy showed normal urethra, but bleeding from both ureteric openings and clots in the collecting system.", [["urethra", "ANATOMY", 31, 38], ["ureteric", "ANATOMY", 63, 71], ["clots", "ANATOMY", 85, 90], ["bleeding", "DISEASE", 44, 52], ["urethra", "MULTI-TISSUE_STRUCTURE", 31, 38], ["ureteric", "PATHOLOGICAL_FORMATION", 63, 71], ["clots", "ORGANISM_SUBSTANCE", 85, 90], ["Rigid cystoscopy", "TEST", 0, 16], ["bleeding from both ureteric openings", "PROBLEM", 44, 80], ["clots in the collecting system", "PROBLEM", 85, 115], ["normal", "OBSERVATION", 24, 30], ["urethra", "ANATOMY", 31, 38], ["bleeding", "OBSERVATION", 44, 52], ["both", "ANATOMY_MODIFIER", 58, 62], ["ureteric", "ANATOMY", 63, 71], ["openings", "OBSERVATION", 72, 80], ["clots", "OBSERVATION", 85, 90], ["collecting system", "ANATOMY", 98, 115]]], ["Fluoroscopy confirmed filling defects (Fig. 5 , left).", [["Fluoroscopy", "TEST", 0, 11], ["filling defects", "PROBLEM", 22, 37], ["filling defects", "OBSERVATION", 22, 37], ["left", "ANATOMY_MODIFIER", 48, 52]]], ["Bilateral ureteric stents were deployed intra-operatively.", [["ureteric", "ANATOMY", 10, 18], ["ureteric stents", "MULTI-TISSUE_STRUCTURE", 10, 25], ["Bilateral ureteric stents", "TREATMENT", 0, 25], ["ureteric", "ANATOMY", 10, 18], ["stents", "OBSERVATION", 19, 25]]], ["Subsequently, her urine output improved dramatically with immediate improvement in creatinine and resolution to baseline within a few days of stenting.Pulmonary complicationOur patient had respiratory distress on admission, and nasoendoscopy revealed mild arytenoid and supraglottic swelling.", [["urine", "ANATOMY", 18, 23], ["Pulmonary", "ANATOMY", 151, 160], ["respiratory", "ANATOMY", 189, 200], ["arytenoid", "ANATOMY", 256, 265], ["supraglottic", "ANATOMY", 270, 282], ["creatinine", "CHEMICAL", 83, 93], ["respiratory distress", "DISEASE", 189, 209], ["supraglottic swelling", "DISEASE", 270, 291], ["creatinine", "CHEMICAL", 83, 93], ["urine", "ORGANISM_SUBSTANCE", 18, 23], ["creatinine", "SIMPLE_CHEMICAL", 83, 93], ["Pulmonary", "ORGAN", 151, 160], ["patient", "ORGANISM", 177, 184], ["arytenoid", "ORGAN", 256, 265], ["patient", "SPECIES", 177, 184], ["her urine output", "TEST", 14, 30], ["creatinine", "TEST", 83, 93], ["stenting", "TREATMENT", 142, 150], ["respiratory distress", "PROBLEM", 189, 209], ["nasoendoscopy", "TEST", 228, 241], ["mild arytenoid", "PROBLEM", 251, 265], ["supraglottic swelling", "PROBLEM", 270, 291], ["urine output", "OBSERVATION", 18, 30], ["improvement", "OBSERVATION_MODIFIER", 68, 79], ["stenting", "OBSERVATION", 142, 150], ["respiratory distress", "OBSERVATION", 189, 209], ["mild", "OBSERVATION_MODIFIER", 251, 255], ["arytenoid", "ANATOMY", 256, 265], ["supraglottic", "ANATOMY", 270, 282], ["swelling", "OBSERVATION", 283, 291]]], ["Respiratory condition worsened on day 2 of admission; the patient became progressively more tachypnoeic with increasing secretion load and required supplemental oxygen.", [["tachypnoeic", "DISEASE", 92, 103], ["oxygen", "CHEMICAL", 161, 167], ["oxygen", "CHEMICAL", 161, 167], ["patient", "ORGANISM", 58, 65], ["oxygen", "SIMPLE_CHEMICAL", 161, 167], ["patient", "SPECIES", 58, 65], ["Respiratory condition", "PROBLEM", 0, 21], ["progressively more tachypnoeic", "PROBLEM", 73, 103], ["increasing secretion load", "PROBLEM", 109, 134], ["supplemental oxygen", "TREATMENT", 148, 167], ["worsened", "OBSERVATION", 22, 30], ["increasing", "OBSERVATION_MODIFIER", 109, 119], ["secretion load", "OBSERVATION", 120, 134]]], ["Due to work of breathing, she was initially trialled on non-invasive ventilation (NIV) which was soon switched to high-flow nasal cannula (Fi02 0.3, flow rate 30 L/min) in view of inability to clear secretions whilst on NIV.", [["nasal", "ANATOMY", 124, 129], ["secretions", "ANATOMY", 199, 209], ["secretions", "ORGANISM_SUBSTANCE", 199, 209], ["work of breathing", "PROBLEM", 7, 24], ["non-invasive ventilation", "TREATMENT", 56, 80], ["NIV", "TREATMENT", 82, 85], ["high-flow nasal cannula", "TREATMENT", 114, 137], ["Fi02", "TREATMENT", 139, 143], ["flow rate", "TREATMENT", 149, 158], ["inability to clear secretions", "PROBLEM", 180, 209], ["NIV", "TREATMENT", 220, 223], ["secretions", "OBSERVATION", 199, 209]]], ["Twenty-four hours later, at the end of day 3 of admission, she developed sudden onset severe respiratory distress with desaturation and required intubation and mechanical ventilation.", [["respiratory", "ANATOMY", 93, 104], ["respiratory distress", "DISEASE", 93, 113], ["desaturation", "DISEASE", 119, 131], ["sudden onset severe respiratory distress", "PROBLEM", 73, 113], ["desaturation", "PROBLEM", 119, 131], ["intubation", "TREATMENT", 145, 155], ["mechanical ventilation", "TREATMENT", 160, 182], ["severe", "OBSERVATION_MODIFIER", 86, 92], ["respiratory distress", "OBSERVATION", 93, 113], ["desaturation", "OBSERVATION", 119, 131], ["mechanical ventilation", "OBSERVATION", 160, 182]]], ["Clinical examination demonstrated extensive subcutaneous emphysema.", [["subcutaneous emphysema", "ANATOMY", 44, 66], ["emphysema", "DISEASE", 57, 66], ["Clinical examination", "TEST", 0, 20], ["extensive subcutaneous emphysema", "PROBLEM", 34, 66], ["extensive", "OBSERVATION_MODIFIER", 34, 43], ["subcutaneous", "ANATOMY", 44, 56], ["emphysema", "OBSERVATION", 57, 66]]], ["Chest X-ray confirmed presence of right-sided pneumothorax, small left-sided pneumothorax, and pneumomediastinum (Fig. 6, left) .", [["pneumothorax", "DISEASE", 46, 58], ["left-sided pneumothorax", "DISEASE", 66, 89], ["pneumomediastinum", "DISEASE", 95, 112], ["Chest X-ray", "TEST", 0, 11], ["right-sided pneumothorax", "PROBLEM", 34, 58], ["small left-sided pneumothorax", "PROBLEM", 60, 89], ["pneumomediastinum", "PROBLEM", 95, 112], ["right", "ANATOMY_MODIFIER", 34, 39], ["sided", "ANATOMY_MODIFIER", 40, 45], ["pneumothorax", "OBSERVATION", 46, 58], ["small", "OBSERVATION_MODIFIER", 60, 65], ["left", "ANATOMY_MODIFIER", 66, 70], ["sided", "ANATOMY_MODIFIER", 71, 76], ["pneumothorax", "OBSERVATION", 77, 89], ["pneumomediastinum", "OBSERVATION", 95, 112], ["left", "ANATOMY_MODIFIER", 122, 126]]], ["A chest tube was inserted for the right-sided pneumothorax.", [["chest tube", "ANATOMY", 2, 12], ["pneumothorax", "DISEASE", 46, 58], ["chest tube", "TISSUE", 2, 12], ["A chest tube", "TREATMENT", 0, 12], ["the right-sided pneumothorax", "PROBLEM", 30, 58], ["chest", "ANATOMY", 2, 7], ["tube", "OBSERVATION", 8, 12], ["right", "ANATOMY_MODIFIER", 34, 39], ["sided", "ANATOMY_MODIFIER", 40, 45], ["pneumothorax", "OBSERVATION", 46, 58]]], ["Pneumomediastinum and contralateral pneumothorax remained stable on several follow-up images throughout the hospital stay, including CT scan for characterisation (Fig. 6 , right).", [["Pneumomediastinum", "DISEASE", 0, 17], ["pneumothorax", "DISEASE", 36, 48], ["Pneumomediastinum", "PROBLEM", 0, 17], ["contralateral pneumothorax", "PROBLEM", 22, 48], ["CT scan", "TEST", 133, 140], ["characterisation", "TEST", 145, 161], ["contralateral", "ANATOMY_MODIFIER", 22, 35], ["pneumothorax", "OBSERVATION", 36, 48], ["stable", "OBSERVATION_MODIFIER", 58, 64], ["right", "ANATOMY_MODIFIER", 172, 177]]], ["Upper gastrointestinal endoscopy excluded mucosal tear in the pharynx or oesophagus.", [["gastrointestinal", "ANATOMY", 6, 22], ["mucosal", "ANATOMY", 42, 49], ["pharynx", "ANATOMY", 62, 69], ["oesophagus", "ANATOMY", 73, 83], ["gastrointestinal", "ORGANISM_SUBDIVISION", 6, 22], ["mucosal tear", "PATHOLOGICAL_FORMATION", 42, 54], ["pharynx", "ORGAN", 62, 69], ["oesophagus", "ORGAN", 73, 83], ["Upper gastrointestinal endoscopy", "TEST", 0, 32], ["mucosal tear in the pharynx or oesophagus", "PROBLEM", 42, 83], ["gastrointestinal", "ANATOMY", 6, 22], ["mucosal tear", "OBSERVATION", 42, 54], ["pharynx", "ANATOMY", 62, 69], ["oesophagus", "ANATOMY", 73, 83]]], ["She was successfully extubated on day 7, and chest tube was removed on day 9.DiscussionSJS is an acute mucocutaneous eruption with blisters of the skin and haemorrhagic erosions of mucous membranes.", [["chest tube", "ANATOMY", 45, 55], ["blisters", "ANATOMY", 131, 139], ["skin", "ANATOMY", 147, 151], ["mucous membranes", "ANATOMY", 181, 197], ["erosions", "DISEASE", 169, 177], ["chest tube", "MULTI-TISSUE_STRUCTURE", 45, 55], ["skin", "ORGAN", 147, 151], ["mucous membranes", "MULTI-TISSUE_STRUCTURE", 181, 197], ["chest tube", "TREATMENT", 45, 55], ["an acute mucocutaneous eruption", "PROBLEM", 94, 125], ["blisters of the skin", "PROBLEM", 131, 151], ["haemorrhagic erosions of mucous membranes", "PROBLEM", 156, 197], ["chest", "ANATOMY", 45, 50], ["tube", "OBSERVATION", 51, 55], ["acute", "OBSERVATION_MODIFIER", 97, 102], ["mucocutaneous", "OBSERVATION_MODIFIER", 103, 116], ["eruption", "OBSERVATION", 117, 125], ["blisters", "OBSERVATION", 131, 139], ["skin", "ANATOMY", 147, 151], ["haemorrhagic", "OBSERVATION_MODIFIER", 156, 168], ["erosions", "OBSERVATION", 169, 177], ["mucous membranes", "ANATOMY", 181, 197]]], ["The cause of SJS in this patient's case remains unclear.", [["SJS", "DISEASE", 13, 16], ["patient", "ORGANISM", 25, 32], ["patient", "SPECIES", 25, 32], ["SJS", "PROBLEM", 13, 16], ["SJS", "OBSERVATION", 13, 16]]], ["Although case reports suggest that a single dose co-amoxiclav is sufficient for eruption [2] , application of a stringent definition of \"probable index day\" shows that her SJS process had likely already started prior to medication exposure [3] .", [["co-amoxiclav", "CHEMICAL", 49, 61], ["eruption", "DISEASE", 80, 88], ["SJS", "DISEASE", 172, 175], ["co-amoxiclav", "CHEMICAL", 49, 61], ["co-amoxiclav", "SIMPLE_CHEMICAL", 49, 61], ["a single dose co-amoxiclav", "TREATMENT", 35, 61], ["eruption", "PROBLEM", 80, 88], ["her SJS process", "PROBLEM", 168, 183], ["SJS", "OBSERVATION", 172, 175]]], ["Rather, prescription of co-amoxiclav and symptomatic medications were reflective of prodromal symptoms of SJS that were already marking disease onset (protopathic bias) [4] .", [["co-amoxiclav", "CHEMICAL", 24, 36], ["SJS", "DISEASE", 106, 109], ["co-amoxiclav", "CHEMICAL", 24, 36], ["co-amoxiclav", "SIMPLE_CHEMICAL", 24, 36], ["co-amoxiclav", "TREATMENT", 24, 36], ["symptomatic medications", "TREATMENT", 41, 64], ["prodromal symptoms", "PROBLEM", 84, 102], ["SJS", "PROBLEM", 106, 109], ["SJS", "OBSERVATION", 106, 109], ["marking disease", "OBSERVATION", 128, 143]]], ["SJS is driven by cytotoxic T cell destruction of the epidermis.", [["T cell", "ANATOMY", 27, 33], ["epidermis", "ANATOMY", 53, 62], ["SJS", "DISEASE", 0, 3], ["T cell", "CELL", 27, 33], ["epidermis", "TISSUE", 53, 62], ["SJS", "PROBLEM", 0, 3], ["cytotoxic T cell destruction of the epidermis", "PROBLEM", 17, 62], ["cytotoxic T cell destruction", "OBSERVATION", 17, 45], ["epidermis", "ANATOMY", 53, 62]]], ["T cells produce cytolytic proteins such as granulysin.", [["T cells", "ANATOMY", 0, 7], ["T cells", "CELL", 0, 7], ["granulysin", "GENE_OR_GENE_PRODUCT", 43, 53], ["T cells", "CELL_TYPE", 0, 7], ["cytolytic proteins", "PROTEIN", 16, 34], ["granulysin", "PROTEIN", 43, 53], ["cytolytic proteins", "PROBLEM", 16, 34], ["granulysin", "PROBLEM", 43, 53], ["cytolytic proteins", "OBSERVATION", 16, 34]]], ["The link between drug/infectious agent exposure and T cell-mediated destruction of the epidermis remains poorly delineated.", [["T cell", "ANATOMY", 52, 58], ["epidermis", "ANATOMY", 87, 96], ["T cell", "CELL", 52, 58], ["epidermis", "ORGAN", 87, 96], ["drug/infectious agent exposure", "TREATMENT", 17, 47], ["T cell-mediated destruction of the epidermis", "PROBLEM", 52, 96], ["infectious", "OBSERVATION_MODIFIER", 22, 32], ["destruction", "OBSERVATION", 68, 79], ["epidermis", "ANATOMY", 87, 96], ["poorly delineated", "OBSERVATION_MODIFIER", 105, 122]]], ["Therapeutic principles for management of SJS include removal of culprit agent, multi-disciplinary care of the patient, and transfer of patient to tertiary care in severe cases.", [["SJS", "DISEASE", 41, 44], ["patient", "ORGANISM", 110, 117], ["patient", "ORGANISM", 135, 142], ["patient", "SPECIES", 110, 117], ["patient", "SPECIES", 135, 142], ["Therapeutic principles", "TREATMENT", 0, 22], ["management", "TREATMENT", 27, 37], ["SJS", "PROBLEM", 41, 44], ["removal of culprit agent", "TREATMENT", 53, 77]]], ["Meticulous daily attention to involved mucosal surfaces, pain requirements, fluid demands, thromboprophylaxis, and calorific requirements are the tenets of ICU care.", [["mucosal", "ANATOMY", 39, 46], ["pain", "DISEASE", 57, 61], ["mucosal surfaces", "MULTI-TISSUE_STRUCTURE", 39, 55], ["mucosal surfaces", "TREATMENT", 39, 55], ["pain requirements", "PROBLEM", 57, 74], ["fluid demands", "TREATMENT", 76, 89], ["thromboprophylaxis", "TREATMENT", 91, 109], ["calorific requirements", "TREATMENT", 115, 137], ["ICU care", "TREATMENT", 156, 164], ["mucosal", "ANATOMY", 39, 46]]], ["Active therapy may be instigated as part of expert multi-disciplinary decision making.", [["Active therapy", "TREATMENT", 0, 14], ["therapy", "OBSERVATION", 7, 14]]], ["We point readers to current guidelines for further reading [5] .DiscussionThis case report describes a combination of acute renal failure and acute respiratory failure in a patient with otherwise relatively limited skin manifestations of SJS.", [["renal", "ANATOMY", 124, 129], ["respiratory", "ANATOMY", 148, 159], ["skin", "ANATOMY", 215, 219], ["acute renal failure", "DISEASE", 118, 137], ["acute respiratory failure", "DISEASE", 142, 167], ["SJS", "DISEASE", 238, 241], ["renal", "ORGAN", 124, 129], ["patient", "ORGANISM", 173, 180], ["skin", "ORGAN", 215, 219], ["patient", "SPECIES", 173, 180], ["acute renal failure", "PROBLEM", 118, 137], ["acute respiratory failure", "PROBLEM", 142, 167], ["otherwise relatively limited skin manifestations of SJS", "PROBLEM", 186, 241], ["acute", "OBSERVATION_MODIFIER", 118, 123], ["renal", "ANATOMY", 124, 129], ["failure", "OBSERVATION", 130, 137], ["acute", "OBSERVATION_MODIFIER", 142, 147], ["respiratory failure", "OBSERVATION", 148, 167], ["SJS", "OBSERVATION", 238, 241]]], ["Extensive literature search done independently by all the listed authors revealed only one other case with a similar presentation albeit detected only at autopsy; a Spanish case report from paediatric population showed renal and pulmonary epithelial sloughing on post-mortem examination [6] .", [["renal", "ANATOMY", 219, 224], ["pulmonary epithelial", "ANATOMY", 229, 249], ["renal", "CANCER", 219, 224], ["pulmonary epithelial", "TISSUE", 229, 249], ["renal and pulmonary epithelial sloughing", "PROBLEM", 219, 259], ["post-mortem examination", "TEST", 263, 286], ["renal", "ANATOMY", 219, 224], ["pulmonary", "ANATOMY", 229, 238], ["epithelial", "ANATOMY_MODIFIER", 239, 249], ["sloughing", "OBSERVATION", 250, 259]]], ["The unfortunate 9-year-old female patient died after developing massive endobronchial haemorrhage and haematuria with anuria.", [["endobronchial", "ANATOMY", 72, 85], ["endobronchial haemorrhage", "DISEASE", 72, 97], ["haematuria", "DISEASE", 102, 112], ["anuria", "DISEASE", 118, 124], ["female", "ORGANISM", 27, 33], ["patient", "ORGANISM", 34, 41], ["patient", "SPECIES", 34, 41], ["massive endobronchial haemorrhage", "PROBLEM", 64, 97], ["haematuria", "PROBLEM", 102, 112], ["anuria", "PROBLEM", 118, 124], ["massive", "OBSERVATION_MODIFIER", 64, 71], ["endobronchial", "ANATOMY", 72, 85], ["haemorrhage", "OBSERVATION", 86, 97], ["haematuria", "OBSERVATION", 102, 112], ["anuria", "OBSERVATION", 118, 124]]], ["Autopsy demonstrated normal glomeruli tubules and interstitium, but foci of epithelial necrosis in the urinary tract, haemorrhagic ureteric submucosa, and total necrolysis of the epithelium of all smalland medium-sized bronchial tubules are consistent with the observed clinical course in our report.Post-renal acute kidney injury in SJSIncidence of renal failure is high in SJS and is an independent predictor of mortality [7] .", [["glomeruli tubules", "ANATOMY", 28, 45], ["interstitium", "ANATOMY", 50, 62], ["foci", "ANATOMY", 68, 72], ["epithelial", "ANATOMY", 76, 86], ["urinary tract", "ANATOMY", 103, 116], ["ureteric submucosa", "ANATOMY", 131, 149], ["epithelium", "ANATOMY", 179, 189], ["bronchial tubules", "ANATOMY", 219, 236], ["renal", "ANATOMY", 305, 310], ["kidney", "ANATOMY", 317, 323], ["renal", "ANATOMY", 350, 355], ["necrosis", "DISEASE", 87, 95], ["necrolysis", "DISEASE", 161, 171], ["acute kidney injury", "DISEASE", 311, 330], ["renal failure", "DISEASE", 350, 363], ["SJS", "DISEASE", 375, 378], ["glomeruli tubules", "TISSUE", 28, 45], ["interstitium", "TISSUE", 50, 62], ["epithelial", "TISSUE", 76, 86], ["urinary tract", "ORGANISM_SUBDIVISION", 103, 116], ["ureteric submucosa", "MULTI-TISSUE_STRUCTURE", 131, 149], ["epithelium", "TISSUE", 179, 189], ["bronchial tubules", "MULTI-TISSUE_STRUCTURE", 219, 236], ["renal", "ORGAN", 305, 310], ["kidney", "ORGAN", 317, 323], ["renal", "ORGAN", 350, 355], ["Autopsy", "TEST", 0, 7], ["epithelial necrosis in the urinary tract", "PROBLEM", 76, 116], ["haemorrhagic ureteric submucosa", "PROBLEM", 118, 149], ["total necrolysis of the epithelium", "PROBLEM", 155, 189], ["renal acute kidney injury", "PROBLEM", 305, 330], ["renal failure", "PROBLEM", 350, 363], ["normal", "OBSERVATION", 21, 27], ["glomeruli tubules", "OBSERVATION", 28, 45], ["interstitium", "ANATOMY_MODIFIER", 50, 62], ["foci", "OBSERVATION_MODIFIER", 68, 72], ["epithelial", "ANATOMY_MODIFIER", 76, 86], ["necrosis", "OBSERVATION", 87, 95], ["urinary tract", "ANATOMY", 103, 116], ["haemorrhagic", "OBSERVATION_MODIFIER", 118, 130], ["ureteric submucosa", "ANATOMY", 131, 149], ["total", "OBSERVATION_MODIFIER", 155, 160], ["necrolysis", "OBSERVATION", 161, 171], ["epithelium", "ANATOMY_MODIFIER", 179, 189], ["all", "OBSERVATION_MODIFIER", 193, 196], ["smalland", "OBSERVATION_MODIFIER", 197, 205], ["medium", "OBSERVATION_MODIFIER", 206, 212], ["sized", "OBSERVATION_MODIFIER", 213, 218], ["bronchial tubules", "OBSERVATION", 219, 236], ["consistent with", "UNCERTAINTY", 241, 256], ["renal", "ANATOMY", 305, 310], ["acute", "OBSERVATION_MODIFIER", 311, 316], ["kidney", "ANATOMY", 317, 323], ["injury", "OBSERVATION", 324, 330], ["renal", "ANATOMY", 350, 355], ["failure", "OBSERVATION", 356, 363], ["high", "OBSERVATION_MODIFIER", 367, 371], ["SJS", "OBSERVATION", 375, 378]]], ["In a retrospective analysis of 96 patients with SJS in Taiwan, Hung et al. demonstrated high frequency of acute renal failure (20.8%), the need for temporary dialysis (3.1%), and long-term dialysis (1%) [8] .", [["renal", "ANATOMY", 112, 117], ["SJS", "DISEASE", 48, 51], ["acute renal failure", "DISEASE", 106, 125], ["patients", "ORGANISM", 34, 42], ["renal", "ORGAN", 112, 117], ["patients", "SPECIES", 34, 42], ["a retrospective analysis", "TEST", 3, 27], ["SJS", "PROBLEM", 48, 51], ["acute renal failure", "PROBLEM", 106, 125], ["temporary dialysis", "TREATMENT", 148, 166], ["long-term dialysis", "TREATMENT", 179, 197], ["high", "OBSERVATION_MODIFIER", 88, 92], ["acute", "OBSERVATION_MODIFIER", 106, 111], ["renal", "ANATOMY", 112, 117], ["failure", "OBSERVATION", 118, 125]]], ["The authors attributed causation of acute renal failure equally between prerenal azotemia and intrinsic kidney insult without any mention of post-renal aetiology.", [["renal", "ANATOMY", 42, 47], ["prerenal", "ANATOMY", 72, 80], ["kidney", "ANATOMY", 104, 110], ["post-renal", "ANATOMY", 141, 151], ["acute renal failure", "DISEASE", 36, 55], ["azotemia", "DISEASE", 81, 89], ["kidney insult", "DISEASE", 104, 117], ["renal", "ORGAN", 42, 47], ["kidney", "ORGAN", 104, 110], ["acute renal failure", "PROBLEM", 36, 55], ["prerenal azotemia", "PROBLEM", 72, 89], ["intrinsic kidney insult", "PROBLEM", 94, 117], ["post-renal aetiology", "PROBLEM", 141, 161], ["acute", "OBSERVATION_MODIFIER", 36, 41], ["renal", "ANATOMY", 42, 47], ["failure", "OBSERVATION", 48, 55], ["prerenal", "OBSERVATION_MODIFIER", 72, 80], ["azotemia", "OBSERVATION", 81, 89], ["kidney", "ANATOMY", 104, 110], ["insult", "OBSERVATION", 111, 117], ["post-renal", "OBSERVATION", 141, 151]]], ["Similarly, there has been no mention of obstructive uropathy as a cause of acute renal failure in patients with SJS, despite a significant number of published case series [8] [9] [10] [11] .Post-renal acute kidney injury in SJSAlthough microscopic haematuria is reported in up to 23% of cases [12] , frank haematuria is uncommon.", [["renal", "ANATOMY", 81, 86], ["renal", "ANATOMY", 195, 200], ["kidney", "ANATOMY", 207, 213], ["obstructive uropathy", "DISEASE", 40, 60], ["acute renal failure", "DISEASE", 75, 94], ["SJS", "DISEASE", 112, 115], ["acute kidney injury", "DISEASE", 201, 220], ["haematuria", "DISEASE", 248, 258], ["haematuria", "DISEASE", 306, 316], ["renal", "ORGAN", 81, 86], ["patients", "ORGANISM", 98, 106], ["[8] [9] [10", "SIMPLE_CHEMICAL", 171, 182], ["renal", "ORGAN", 195, 200], ["kidney", "ORGAN", 207, 213], ["patients", "SPECIES", 98, 106], ["obstructive uropathy", "PROBLEM", 40, 60], ["acute renal failure", "PROBLEM", 75, 94], ["SJS", "PROBLEM", 112, 115], ["renal acute kidney injury", "PROBLEM", 195, 220], ["microscopic haematuria", "PROBLEM", 236, 258], ["frank haematuria", "PROBLEM", 300, 316], ["no mention of", "UNCERTAINTY", 26, 39], ["obstructive", "OBSERVATION_MODIFIER", 40, 51], ["uropathy", "OBSERVATION", 52, 60], ["acute", "OBSERVATION_MODIFIER", 75, 80], ["renal", "ANATOMY", 81, 86], ["failure", "OBSERVATION", 87, 94], ["SJS", "OBSERVATION", 112, 115], ["renal", "ANATOMY", 195, 200], ["acute", "OBSERVATION_MODIFIER", 201, 206], ["kidney", "ANATOMY", 207, 213], ["injury", "OBSERVATION", 214, 220], ["haematuria", "OBSERVATION", 248, 258], ["haematuria", "OBSERVATION", 306, 316]]], ["A urological series in paediatric population described frank haematuria in one patient only, attributed to a genital lesion [13] .", [["genital lesion", "ANATOMY", 109, 123], ["haematuria", "DISEASE", 61, 71], ["genital lesion", "DISEASE", 109, 123], ["patient", "ORGANISM", 79, 86], ["genital", "ORGANISM_SUBDIVISION", 109, 116], ["patient", "SPECIES", 79, 86], ["A urological series", "TEST", 0, 19], ["frank haematuria", "PROBLEM", 55, 71], ["a genital lesion", "PROBLEM", 107, 123], ["frank", "OBSERVATION_MODIFIER", 55, 60], ["haematuria", "OBSERVATION", 61, 71], ["genital", "ANATOMY", 109, 116], ["lesion", "OBSERVATION", 117, 123]]], ["A separate 20-year retrospective study at a Thai paediatric tertiary referral centre recorded frank haematuria with concurrent rising creatinine again in only one patient [14] , although there was no mention of etiopathogenesis.Post-renal acute kidney injury in SJSEpithelial detachment severe enough to result in eventual renal dysfunction from an obstructive cause is rare and has been described in only a very few case reports [6, 15, 16] .", [["renal", "ANATOMY", 233, 238], ["kidney", "ANATOMY", 245, 251], ["renal", "ANATOMY", 323, 328], ["haematuria", "DISEASE", 100, 110], ["creatinine", "CHEMICAL", 134, 144], ["acute kidney injury", "DISEASE", 239, 258], ["SJSEpithelial detachment", "DISEASE", 262, 286], ["renal dysfunction", "DISEASE", 323, 340], ["creatinine", "CHEMICAL", 134, 144], ["creatinine", "SIMPLE_CHEMICAL", 134, 144], ["patient", "ORGANISM", 163, 170], ["renal", "ORGAN", 233, 238], ["kidney", "ORGAN", 245, 251], ["renal", "ORGAN", 323, 328], ["patient", "SPECIES", 163, 170], ["retrospective study", "TEST", 19, 38], ["frank haematuria", "PROBLEM", 94, 110], ["concurrent rising creatinine", "PROBLEM", 116, 144], ["etiopathogenesis", "PROBLEM", 211, 227], ["renal acute kidney injury", "PROBLEM", 233, 258], ["SJSEpithelial detachment", "PROBLEM", 262, 286], ["eventual renal dysfunction", "PROBLEM", 314, 340], ["an obstructive cause", "PROBLEM", 346, 366], ["haematuria", "OBSERVATION", 100, 110], ["no mention of", "UNCERTAINTY", 197, 210], ["etiopathogenesis", "OBSERVATION", 211, 227], ["renal", "ANATOMY", 233, 238], ["acute", "OBSERVATION_MODIFIER", 239, 244], ["kidney", "ANATOMY", 245, 251], ["injury", "OBSERVATION", 252, 258], ["SJSEpithelial", "OBSERVATION_MODIFIER", 262, 275], ["detachment", "OBSERVATION", 276, 286], ["renal", "ANATOMY", 323, 328], ["dysfunction", "OBSERVATION", 329, 340], ["obstructive", "OBSERVATION", 349, 360]]], ["Baccaro et al. reported the first published case of an adult toxic epidermal necrolysis patient with ureteropelvic mucosa damage, haematuria, extensive ureteral mucosal sloughing, and acute renal failure secondary to ureteral obstruction and perforation [15] .", [["ureteropelvic mucosa", "ANATOMY", 101, 121], ["ureteral mucosal", "ANATOMY", 152, 168], ["renal", "ANATOMY", 190, 195], ["ureteral", "ANATOMY", 217, 225], ["toxic epidermal necrolysis", "DISEASE", 61, 87], ["ureteropelvic mucosa damage", "DISEASE", 101, 128], ["haematuria", "DISEASE", 130, 140], ["ureteral mucosal sloughing", "DISEASE", 152, 178], ["acute renal failure", "DISEASE", 184, 203], ["ureteral obstruction", "DISEASE", 217, 237], ["perforation", "DISEASE", 242, 253], ["patient", "ORGANISM", 88, 95], ["ureteropelvic mucosa", "MULTI-TISSUE_STRUCTURE", 101, 121], ["ureteral mucosal", "PATHOLOGICAL_FORMATION", 152, 168], ["renal", "ORGAN", 190, 195], ["ureteral obstruction", "PATHOLOGICAL_FORMATION", 217, 237], ["patient", "SPECIES", 88, 95], ["an adult toxic epidermal necrolysis", "PROBLEM", 52, 87], ["ureteropelvic mucosa damage", "PROBLEM", 101, 128], ["haematuria", "PROBLEM", 130, 140], ["extensive ureteral mucosal sloughing", "PROBLEM", 142, 178], ["acute renal failure", "PROBLEM", 184, 203], ["ureteral obstruction", "PROBLEM", 217, 237], ["perforation", "PROBLEM", 242, 253], ["toxic", "OBSERVATION_MODIFIER", 61, 66], ["epidermal necrolysis", "OBSERVATION", 67, 87], ["ureteropelvic mucosa", "ANATOMY", 101, 121], ["haematuria", "OBSERVATION", 130, 140], ["extensive", "OBSERVATION_MODIFIER", 142, 151], ["ureteral", "ANATOMY_MODIFIER", 152, 160], ["mucosal", "ANATOMY", 161, 168], ["sloughing", "OBSERVATION", 169, 178], ["acute", "OBSERVATION_MODIFIER", 184, 189], ["renal", "ANATOMY", 190, 195], ["failure", "OBSERVATION", 196, 203], ["ureteral", "ANATOMY", 217, 225], ["obstruction", "OBSERVATION", 226, 237], ["perforation", "OBSERVATION", 242, 253]]], ["A subsequent case report described a case of SJS with ureteropelvic mucosal involvement resulting in gross haematuria [16] .", [["ureteropelvic mucosal", "ANATOMY", 54, 75], ["SJS", "DISEASE", 45, 48], ["ureteropelvic mucosal involvement", "DISEASE", 54, 87], ["haematuria", "DISEASE", 107, 117], ["ureteropelvic mucosal", "PATHOLOGICAL_FORMATION", 54, 75], ["SJS", "PROBLEM", 45, 48], ["ureteropelvic mucosal involvement", "PROBLEM", 54, 87], ["gross haematuria", "PROBLEM", 101, 117], ["ureteropelvic mucosal", "ANATOMY", 54, 75], ["gross", "OBSERVATION_MODIFIER", 101, 106], ["haematuria", "OBSERVATION", 107, 117]]], ["Further examination of the urinary sediment with the phase-contrast microscope indicated a urological cause for the observed haematuria, and a plain and enhanced CT of the whole abdomen confirmed thickening and enhancement of the walls of the renal pelvis and ureter, although ureteroscopy was not performed.", [["urinary sediment", "ANATOMY", 27, 43], ["abdomen", "ANATOMY", 178, 185], ["walls", "ANATOMY", 230, 235], ["renal pelvis", "ANATOMY", 243, 255], ["ureter", "ANATOMY", 260, 266], ["haematuria", "DISEASE", 125, 135], ["urinary", "ORGANISM_SUBDIVISION", 27, 34], ["abdomen", "ORGAN", 178, 185], ["renal pelvis", "MULTI-TISSUE_STRUCTURE", 243, 255], ["ureter", "ORGAN", 260, 266], ["Further examination", "TEST", 0, 19], ["the urinary sediment", "TEST", 23, 43], ["the phase-contrast microscope", "TEST", 49, 78], ["a urological cause", "PROBLEM", 89, 107], ["the observed haematuria", "PROBLEM", 112, 135], ["a plain and enhanced CT of the whole abdomen", "TEST", 141, 185], ["thickening", "PROBLEM", 196, 206], ["enhancement of the walls of the renal pelvis and ureter", "PROBLEM", 211, 266], ["ureteroscopy", "TEST", 277, 289], ["urinary", "ANATOMY", 27, 34], ["sediment", "OBSERVATION", 35, 43], ["haematuria", "OBSERVATION", 125, 135], ["abdomen", "ANATOMY", 178, 185], ["thickening", "OBSERVATION", 196, 206], ["enhancement", "OBSERVATION", 211, 222], ["walls", "ANATOMY_MODIFIER", 230, 235], ["renal pelvis", "ANATOMY", 243, 255], ["ureter", "ANATOMY", 260, 266], ["ureteroscopy", "OBSERVATION", 277, 289]]], ["The aforementioned post-mortem study in a 9-year-old girl who died of respiratory and renal complications demonstrated haemorrhagic ureteric submucosa with normal glomeruli, tubules, and interstitium [6] .Air-leak syndromeAlthough respiratory failure has been documented in cohorts of patients with SJS [17, 18] , air-leak syndrome (pneumomediastinum and/or pneumothorax) is a rare complication.", [["respiratory", "ANATOMY", 70, 81], ["renal", "ANATOMY", 86, 91], ["ureteric submucosa", "ANATOMY", 132, 150], ["glomeruli", "ANATOMY", 163, 172], ["tubules", "ANATOMY", 174, 181], ["interstitium", "ANATOMY", 187, 199], ["respiratory", "ANATOMY", 231, 242], ["respiratory and renal complications", "DISEASE", 70, 105], ["respiratory failure", "DISEASE", 231, 250], ["SJS", "DISEASE", 299, 302], ["leak syndrome", "DISEASE", 318, 331], ["pneumomediastinum", "DISEASE", 333, 350], ["pneumothorax", "DISEASE", 358, 370], ["girl", "ORGANISM", 53, 57], ["renal", "ORGAN", 86, 91], ["ureteric submucosa", "MULTI-TISSUE_STRUCTURE", 132, 150], ["glomeruli", "MULTI-TISSUE_STRUCTURE", 163, 172], ["tubules", "TISSUE", 174, 181], ["patients", "ORGANISM", 285, 293], ["girl", "SPECIES", 53, 57], ["patients", "SPECIES", 285, 293], ["The aforementioned post-mortem study", "TEST", 0, 36], ["respiratory and renal complications", "PROBLEM", 70, 105], ["haemorrhagic ureteric submucosa", "PROBLEM", 119, 150], ["Air-leak syndromeAlthough", "PROBLEM", 205, 230], ["respiratory failure", "PROBLEM", 231, 250], ["SJS", "TEST", 299, 302], ["air-leak syndrome", "PROBLEM", 314, 331], ["pneumomediastinum", "PROBLEM", 333, 350], ["pneumothorax", "PROBLEM", 358, 370], ["a rare complication", "PROBLEM", 375, 394], ["respiratory", "ANATOMY", 70, 81], ["renal", "ANATOMY", 86, 91], ["complications", "OBSERVATION", 92, 105], ["haemorrhagic", "OBSERVATION", 119, 131], ["ureteric submucosa", "ANATOMY", 132, 150], ["normal glomeruli", "OBSERVATION", 156, 172], ["tubules", "OBSERVATION_MODIFIER", 174, 181], ["interstitium", "ANATOMY_MODIFIER", 187, 199], ["leak", "OBSERVATION", 209, 213], ["respiratory failure", "OBSERVATION", 231, 250], ["air-", "ANATOMY", 314, 318], ["leak syndrome", "OBSERVATION", 318, 331], ["pneumomediastinum", "OBSERVATION", 333, 350], ["pneumothorax", "OBSERVATION", 358, 370], ["rare", "OBSERVATION_MODIFIER", 377, 381], ["complication", "OBSERVATION", 382, 394]]], ["Notably, in a 4-year-long retrospective series of 221 adult cases of SJS where chest radiographs were monitored as part of the study protocol, there was not a single record of pneumothorax or pneumomediastinum [18] .", [["chest", "ANATOMY", 79, 84], ["SJS", "DISEASE", 69, 72], ["pneumothorax", "DISEASE", 176, 188], ["pneumomediastinum", "DISEASE", 192, 209], ["chest radiographs", "TEST", 79, 96], ["the study protocol", "TEST", 123, 141], ["pneumothorax", "PROBLEM", 176, 188], ["pneumomediastinum", "PROBLEM", 192, 209], ["chest", "ANATOMY", 79, 84], ["pneumothorax", "OBSERVATION", 176, 188], ["pneumomediastinum", "OBSERVATION", 192, 209]]], ["A Japanese 6-year registry of adult and paediatric cases of SJS described mediastinal and subcutaneous emphysema as observed complications, but did not comment upon the incidence of air-leak nor age of patients involved [19] .", [["mediastinal", "ANATOMY", 74, 85], ["subcutaneous emphysema", "ANATOMY", 90, 112], ["SJS", "DISEASE", 60, 63], ["emphysema", "DISEASE", 103, 112], ["air-leak", "DISEASE", 182, 190], ["patients", "ORGANISM", 202, 210], ["patients", "SPECIES", 202, 210], ["SJS", "PROBLEM", 60, 63], ["mediastinal and subcutaneous emphysema", "PROBLEM", 74, 112], ["air-leak", "PROBLEM", 182, 190], ["SJS", "OBSERVATION", 60, 63], ["mediastinal", "ANATOMY", 74, 85], ["subcutaneous", "ANATOMY", 90, 102], ["emphysema", "OBSERVATION", 103, 112]]], ["Literature search yielded only seven reported cases of air-leak; the majority are paediatric cases [20] [21] [22] [23] [24] [25] , with only one case described in a young adult [26] .", [["air-leak", "DISEASE", 55, 63], ["[20] [21] [22] [23", "SIMPLE_CHEMICAL", 99, 117], ["Literature search", "TEST", 0, 17], ["air-leak", "PROBLEM", 55, 63], ["leak", "OBSERVATION", 59, 63]]], ["Air leak presented as pneumomediastinum in all of these cases, with subcutaneous emphysema documented in six of the seven cases.", [["subcutaneous emphysema", "ANATOMY", 68, 90], ["pneumomediastinum", "DISEASE", 22, 39], ["emphysema", "DISEASE", 81, 90], ["Air leak", "PROBLEM", 0, 8], ["pneumomediastinum", "PROBLEM", 22, 39], ["subcutaneous emphysema", "PROBLEM", 68, 90], ["leak", "OBSERVATION", 4, 8], ["pneumomediastinum", "OBSERVATION", 22, 39], ["subcutaneous", "ANATOMY", 68, 80], ["emphysema", "OBSERVATION", 81, 90]]], ["Pneumothorax was described in three cases only: unilateral in two cases and bilateral in one case.Air-leak syndromeThe aetiology for air leak/pneumothorax in the setting of SJS is unclear.", [["Pneumothorax", "DISEASE", 0, 12], ["Air-leak syndrome", "DISEASE", 98, 115], ["air leak", "DISEASE", 133, 141], ["pneumothorax", "DISEASE", 142, 154], ["SJS", "DISEASE", 173, 176], ["Pneumothorax", "PROBLEM", 0, 12], ["Air-leak syndrome", "PROBLEM", 98, 115], ["air leak", "PROBLEM", 133, 141], ["pneumothorax", "PROBLEM", 142, 154], ["SJS", "PROBLEM", 173, 176], ["bilateral", "ANATOMY_MODIFIER", 76, 85], ["leak syndrome", "OBSERVATION", 102, 115], ["air leak", "OBSERVATION", 133, 141], ["pneumothorax", "OBSERVATION", 142, 154], ["SJS", "OBSERVATION", 173, 176]]], ["Patients in the previous case series [17, 18] demonstrated severe epithelial injury and bronchial mucosal detachment on bronchoscopic evaluation.", [["epithelial", "ANATOMY", 66, 76], ["bronchial mucosal", "ANATOMY", 88, 105], ["epithelial injury", "DISEASE", 66, 83], ["Patients", "ORGANISM", 0, 8], ["epithelial", "TISSUE", 66, 76], ["mucosal", "PATHOLOGICAL_FORMATION", 98, 105], ["Patients", "SPECIES", 0, 8], ["severe epithelial injury", "PROBLEM", 59, 83], ["bronchial mucosal detachment", "PROBLEM", 88, 116], ["bronchoscopic evaluation", "TEST", 120, 144], ["severe", "OBSERVATION_MODIFIER", 59, 65], ["epithelial", "ANATOMY_MODIFIER", 66, 76], ["injury", "OBSERVATION", 77, 83], ["bronchial mucosal", "ANATOMY", 88, 105], ["detachment", "OBSERVATION", 106, 116]]], ["Pathologically, injury was characterised by denuded basement membrane.", [["basement membrane", "ANATOMY", 52, 69], ["basement membrane", "CELLULAR_COMPONENT", 52, 69], ["injury", "PROBLEM", 16, 22], ["injury", "OBSERVATION", 16, 22], ["denuded", "OBSERVATION_MODIFIER", 44, 51], ["basement membrane", "OBSERVATION", 52, 69]]], ["The ulceration remained limited to epithelial surface, whilst the basement membrane and lamina propria remained intact.Air-leak syndromeA likely hypothesis for air leak is that mucosal debris causes obstructive airway pathology leading to air trapping and rupture of alveoli.", [["epithelial surface", "ANATOMY", 35, 53], ["basement membrane", "ANATOMY", 66, 83], ["lamina propria", "ANATOMY", 88, 102], ["mucosal", "ANATOMY", 177, 184], ["airway", "ANATOMY", 211, 217], ["alveoli", "ANATOMY", 267, 274], ["air leak", "DISEASE", 160, 168], ["rupture", "DISEASE", 256, 263], ["ulceration", "PATHOLOGICAL_FORMATION", 4, 14], ["epithelial surface", "TISSUE", 35, 53], ["basement membrane", "CELLULAR_COMPONENT", 66, 83], ["lamina propria", "TISSUE", 88, 102], ["mucosal", "PATHOLOGICAL_FORMATION", 177, 184], ["airway", "MULTI-TISSUE_STRUCTURE", 211, 217], ["alveoli", "MULTI-TISSUE_STRUCTURE", 267, 274], ["The ulceration", "PROBLEM", 0, 14], ["Air-leak syndromeA", "PROBLEM", 119, 137], ["air leak", "PROBLEM", 160, 168], ["mucosal debris", "PROBLEM", 177, 191], ["obstructive airway pathology", "PROBLEM", 199, 227], ["air trapping", "PROBLEM", 239, 251], ["rupture of alveoli", "PROBLEM", 256, 274], ["ulceration", "OBSERVATION", 4, 14], ["epithelial", "ANATOMY_MODIFIER", 35, 45], ["surface", "OBSERVATION_MODIFIER", 46, 53], ["basement membrane", "ANATOMY", 66, 83], ["lamina", "ANATOMY_MODIFIER", 88, 94], ["propria", "ANATOMY_MODIFIER", 95, 102], ["intact", "OBSERVATION", 112, 118], ["leak syndromeA", "OBSERVATION", 123, 137], ["air leak", "OBSERVATION", 160, 168], ["mucosal", "ANATOMY", 177, 184], ["debris", "OBSERVATION", 185, 191], ["obstructive", "OBSERVATION_MODIFIER", 199, 210], ["airway", "ANATOMY", 211, 217], ["pathology", "OBSERVATION", 218, 227], ["air trapping", "OBSERVATION", 239, 251], ["rupture", "OBSERVATION", 256, 263], ["alveoli", "ANATOMY_MODIFIER", 267, 274]]], ["Pneumomediastinum is then the consequence of released alveolar air dissecting through the pulmonary interstitium along the broncho-vascular sheaths toward the pulmonary hila, into the mediastinum [27] .", [["alveolar air", "ANATOMY", 54, 66], ["pulmonary interstitium", "ANATOMY", 90, 112], ["broncho-vascular sheaths", "ANATOMY", 123, 147], ["pulmonary hila", "ANATOMY", 159, 173], ["mediastinum", "ANATOMY", 184, 195], ["Pneumomediastinum", "DISEASE", 0, 17], ["alveolar air", "MULTI-TISSUE_STRUCTURE", 54, 66], ["pulmonary interstitium", "MULTI-TISSUE_STRUCTURE", 90, 112], ["broncho-vascular sheaths", "TISSUE", 123, 147], ["pulmonary", "ORGAN", 159, 168], ["mediastinum", "ORGAN", 184, 195], ["Pneumomediastinum", "PROBLEM", 0, 17], ["released alveolar air", "PROBLEM", 45, 66], ["alveolar air", "OBSERVATION", 54, 66], ["pulmonary", "ANATOMY", 90, 99], ["interstitium", "ANATOMY_MODIFIER", 100, 112], ["broncho", "ANATOMY_MODIFIER", 123, 130], ["-vascular", "ANATOMY_MODIFIER", 130, 139], ["sheaths", "ANATOMY_MODIFIER", 140, 147], ["pulmonary hila", "ANATOMY", 159, 173], ["mediastinum", "ANATOMY", 184, 195]]], ["This hypothesis may also explain the predominance of paediatric cases due to smaller calibre airways.", [["airways", "ANATOMY", 93, 100], ["airways", "MULTI-TISSUE_STRUCTURE", 93, 100], ["smaller calibre airways", "PROBLEM", 77, 100], ["may also explain", "UNCERTAINTY", 16, 32], ["smaller", "OBSERVATION_MODIFIER", 77, 84], ["calibre", "OBSERVATION_MODIFIER", 85, 92], ["airways", "ANATOMY", 93, 100]]], ["Forceful coughing due to hypersecretion and irritation from bronchial denudement may also contribute to alveolar rupture.", [["bronchial", "ANATOMY", 60, 69], ["alveolar", "ANATOMY", 104, 112], ["coughing", "DISEASE", 9, 17], ["hypersecretion", "DISEASE", 25, 39], ["irritation", "DISEASE", 44, 54], ["alveolar rupture", "DISEASE", 104, 120], ["alveolar", "TISSUE", 104, 112], ["Forceful coughing", "PROBLEM", 0, 17], ["hypersecretion", "PROBLEM", 25, 39], ["irritation", "PROBLEM", 44, 54], ["bronchial denudement", "PROBLEM", 60, 80], ["alveolar rupture", "PROBLEM", 104, 120], ["coughing", "OBSERVATION", 9, 17], ["hypersecretion", "OBSERVATION", 25, 39], ["irritation", "OBSERVATION", 44, 54], ["bronchial", "ANATOMY", 60, 69], ["denudement", "OBSERVATION", 70, 80], ["may also contribute to", "UNCERTAINTY", 81, 103], ["alveolar", "ANATOMY_MODIFIER", 104, 112], ["rupture", "OBSERVATION", 113, 120]]], ["Our patient had thick bronchorrhea and difficulty managing her secretions prior to respiratory deterioration.", [["secretions", "ANATOMY", 63, 73], ["respiratory", "ANATOMY", 83, 94], ["bronchorrhea", "DISEASE", 22, 34], ["respiratory deterioration", "DISEASE", 83, 108], ["patient", "ORGANISM", 4, 11], ["patient", "SPECIES", 4, 11], ["thick bronchorrhea", "PROBLEM", 16, 34], ["difficulty managing her secretions", "PROBLEM", 39, 73], ["respiratory deterioration", "PROBLEM", 83, 108], ["deterioration", "OBSERVATION", 95, 108]]], ["Bronchorrhea in the setting of SJS is described as clear yellow fluid, without the presence of any bronchial casts and may represent part of the exudative process of SJS rather than secondary to denudement [17] .", [["yellow fluid", "ANATOMY", 57, 69], ["bronchial", "ANATOMY", 99, 108], ["Bronchorrhea", "DISEASE", 0, 12], ["SJS", "DISEASE", 31, 34], ["SJS", "DISEASE", 166, 169], ["denudement", "DISEASE", 195, 205], ["Bronchorrhea", "PROBLEM", 0, 12], ["SJS", "PROBLEM", 31, 34], ["clear yellow fluid", "PROBLEM", 51, 69], ["any bronchial casts", "PROBLEM", 95, 114], ["the exudative process", "PROBLEM", 141, 162], ["SJS", "PROBLEM", 166, 169], ["SJS", "OBSERVATION", 31, 34], ["clear", "OBSERVATION_MODIFIER", 51, 56], ["yellow", "OBSERVATION_MODIFIER", 57, 63], ["fluid", "OBSERVATION", 64, 69], ["bronchial", "ANATOMY", 99, 108], ["casts", "OBSERVATION", 109, 114], ["may represent", "UNCERTAINTY", 119, 132], ["exudative", "OBSERVATION_MODIFIER", 145, 154], ["process", "OBSERVATION", 155, 162], ["SJS", "OBSERVATION", 166, 169]]], ["Mechanical ventilation could be a contributing factor in our patient, although previously published case reports had air leak at presentation to hospital and therefore unrelated to the onset of mechanical ventilation.", [["patient", "ORGANISM", 61, 68], ["patient", "SPECIES", 61, 68], ["Mechanical ventilation", "TREATMENT", 0, 22], ["air leak", "PROBLEM", 117, 125], ["mechanical ventilation", "TREATMENT", 194, 216], ["ventilation", "OBSERVATION", 11, 22], ["air leak", "OBSERVATION", 117, 125], ["mechanical ventilation", "OBSERVATION", 194, 216]]], ["In the only other published adult case report of pneumomediastinum/ pneumothorax in SJS, air leak occurred prior to the onset of mechanical ventilation [26] .ConclusionsRenal and respiratory involvement in SJS has been documented in SJS cohort studies; however, air leak and obstructive uropathy are rare complications due to systemic epithelial sloughing.", [["Renal", "ANATOMY", 169, 174], ["respiratory", "ANATOMY", 179, 190], ["epithelial", "ANATOMY", 335, 345], ["pneumomediastinum", "DISEASE", 49, 66], ["pneumothorax", "DISEASE", 68, 80], ["SJS", "DISEASE", 84, 87], ["air leak", "DISEASE", 89, 97], ["SJS", "DISEASE", 206, 209], ["SJS", "DISEASE", 233, 236], ["obstructive uropathy", "DISEASE", 275, 295], ["Renal", "ORGAN", 169, 174], ["epithelial", "TISSUE", 335, 345], ["pneumomediastinum", "PROBLEM", 49, 66], ["pneumothorax in SJS", "PROBLEM", 68, 87], ["air leak", "PROBLEM", 89, 97], ["mechanical ventilation", "TREATMENT", 129, 151], ["Renal and respiratory involvement in SJS", "PROBLEM", 169, 209], ["SJS cohort studies", "TEST", 233, 251], ["air leak", "PROBLEM", 262, 270], ["obstructive uropathy", "PROBLEM", 275, 295], ["rare complications", "PROBLEM", 300, 318], ["systemic epithelial sloughing", "PROBLEM", 326, 355], ["pneumomediastinum", "OBSERVATION", 49, 66], ["pneumothorax", "OBSERVATION", 68, 80], ["SJS", "OBSERVATION", 84, 87], ["air leak", "OBSERVATION", 89, 97], ["mechanical ventilation", "OBSERVATION", 129, 151], ["Renal", "ANATOMY", 169, 174], ["respiratory", "ANATOMY", 179, 190], ["involvement", "OBSERVATION", 191, 202], ["SJS", "OBSERVATION", 206, 209], ["air leak", "OBSERVATION", 262, 270], ["obstructive", "OBSERVATION_MODIFIER", 275, 286], ["uropathy", "OBSERVATION", 287, 295], ["systemic", "OBSERVATION_MODIFIER", 326, 334], ["epithelial", "ANATOMY_MODIFIER", 335, 345], ["sloughing", "OBSERVATION", 346, 355]]], ["Acute care physicians should be aware that significant organ involvement can occur despite relatively limited skin manifestations.", [["organ", "ANATOMY", 55, 60], ["skin", "ANATOMY", 110, 114], ["organ", "ORGAN", 55, 60], ["skin", "ORGAN", 110, 114], ["significant organ involvement", "PROBLEM", 43, 72], ["relatively limited skin manifestations", "PROBLEM", 91, 129]]], ["Post-renal causes for acute kidney injury must be considered in Stevens-Johnson Syndrome, especially in the setting of gross haematuria and bedside point-of-care ultrasonography may be a useful tool for excluding obstructive uropathy.", [["renal", "ANATOMY", 5, 10], ["kidney", "ANATOMY", 28, 34], ["acute kidney injury", "DISEASE", 22, 41], ["Stevens-Johnson Syndrome", "DISEASE", 64, 88], ["haematuria", "DISEASE", 125, 135], ["obstructive uropathy", "DISEASE", 213, 233], ["renal", "ORGAN", 5, 10], ["kidney", "ORGAN", 28, 34], ["acute kidney injury", "PROBLEM", 22, 41], ["Johnson Syndrome", "PROBLEM", 72, 88], ["gross haematuria", "PROBLEM", 119, 135], ["ultrasonography", "TEST", 162, 177], ["obstructive uropathy", "PROBLEM", 213, 233], ["renal", "ANATOMY", 5, 10], ["acute", "OBSERVATION_MODIFIER", 22, 27], ["kidney", "ANATOMY", 28, 34], ["injury", "OBSERVATION", 35, 41], ["Johnson Syndrome", "OBSERVATION", 72, 88], ["haematuria", "OBSERVATION", 125, 135], ["obstructive", "OBSERVATION_MODIFIER", 213, 224], ["uropathy", "OBSERVATION", 225, 233]]], ["Pneumothorax is a rare but documented complication of SJS in paediatric cases and, to a lesser extent, adult patients.", [["Pneumothorax", "DISEASE", 0, 12], ["SJS", "DISEASE", 54, 57], ["patients", "ORGANISM", 109, 117], ["patients", "SPECIES", 109, 117], ["Pneumothorax", "PROBLEM", 0, 12], ["SJS", "PROBLEM", 54, 57], ["complication", "OBSERVATION", 38, 50], ["SJS", "OBSERVATION", 54, 57], ["lesser extent", "OBSERVATION_MODIFIER", 88, 101]]], ["Extra care should be exercised when caring for mechanically ventilated patients.", [["patients", "ORGANISM", 71, 79], ["patients", "SPECIES", 71, 79], ["Extra care", "TREATMENT", 0, 10]]]]}